No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4qv4O, 1.0000, 0.00, 1.000, 250, 250, YCP BETA5-M45T MUTANT
2, 4qv8O, 0.9999, 0.04, 1.000, 250, 250, YCP BETA5-C52F MUTANT
3, 4qv8A, 0.9999, 0.04, 1.000, 250, 250, YCP BETA5-C52F MUTANT
4, 4qv7O, 0.9999, 0.04, 1.000, 250, 250, YCP BETA5-A50V MUTANT
5, 4qv7A, 0.9999, 0.04, 1.000, 250, 250, YCP BETA5-A50V MUTANT
6, 4qv5O, 0.9999, 0.04, 1.000, 250, 250, YCP BETA5-M45I MUTANT
7, 4qv5A, 0.9999, 0.04, 1.000, 250, 250, YCP BETA5-M45I MUTANT
8, 4qv4A, 0.9999, 0.00, 1.000, 250, 250, YCP BETA5-M45T MUTANT
9, 4qv3O, 0.9999, 0.05, 1.000, 250, 250, YCP BETA5-M45V MUTANT
10, 4qv3A, 0.9999, 0.05, 1.000, 250, 250, YCP BETA5-M45V MUTANT
11, 4qv1O, 0.9999, 0.03, 1.000, 250, 250, YCP BETA5-M45A MUTANT
12, 4qv1A, 0.9999, 0.03, 1.000, 250, 250, YCP BETA5-M45A MUTANT
13, 4qv0O, 0.9999, 0.06, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT
14, 4qv0A, 0.9999, 0.06, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT
15, 5lttO, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
16, 5lttA, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
17, 5l6cO, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
18, 5l6cA, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
19, 5l6bO, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
20, 5l6bA, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
21, 5l6aO, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
22, 5l6aA, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
23, 5l67O, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
24, 5l67A, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
25, 5l65O, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
26, 5l65A, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
27, 5l64O, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
28, 5l64A, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
29, 5l63O, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
30, 5l63A, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
31, 5l62O, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
32, 5l62A, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
33, 5l61O, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
34, 5l61A, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
35, 5l5wO, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
36, 5l5wA, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
37, 5l5uO, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
38, 5l5uA, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
39, 5l5sO, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
40, 5l5sA, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
41, 5l5qO, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
42, 5l5qA, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
43, 5l5pO, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
44, 5l5pA, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
45, 5l5oO, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
46, 5l5oA, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
47, 5l5hO, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
48, 5l5hA, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
49, 5l5fO, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
50, 5l5fA, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
51, 5l5dO, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
52, 5l5dA, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
53, 5l5aO, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
54, 5l5aA, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
55, 5fgaO, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
56, 5fgaA, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
57, 5fg7O, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T1A MUTANT
58, 5fg7A, 0.9998, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T1A MUTANT
59, 5czaO, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT
60, 5czaA, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT
61, 5cz6O, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
62, 5cz6A, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
63, 5bxlA, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT
64, 4ya1O, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT
65, 4ya1A, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT
66, 4y9yO, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT
67, 4y9yA, 0.9998, 0.07, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT
68, 4qzzO, 0.9998, 0.06, 1.000, 250, 250, YCP IN COMPLEX WITH OMURALIDE
69, 4qzzA, 0.9998, 0.06, 1.000, 250, 250, YCP IN COMPLEX WITH OMURALIDE
70, 4qw1O, 0.9998, 0.07, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
71, 4qw1A, 0.9998, 0.07, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
72, 4qvyO, 0.9998, 0.08, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
73, 4qvyA, 0.9998, 0.08, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
74, 4qvwO, 0.9998, 0.08, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
75, 4qvlO, 0.9998, 0.07, 1.000, 250, 250, YCP IN COMPLEX WITH BORTEZOMIB
76, 4qvlA, 0.9998, 0.07, 1.000, 250, 250, YCP IN COMPLEX WITH BORTEZOMIB
77, 4quyO, 0.9998, 0.07, 1.000, 250, 250, YCP BETA5-A49S-MUTANT
78, 4quyA, 0.9998, 0.07, 1.000, 250, 250, YCP BETA5-A49S-MUTANT
79, 4quxO, 0.9998, 0.08, 1.000, 250, 250, YCP BETA5-A49T-MUTANT
80, 4quxA, 0.9998, 0.08, 1.000, 250, 250, YCP BETA5-A49T-MUTANT
81, 5m2bO, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
82, 5m2bA, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
83, 5l68O, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
84, 5l68A, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
85, 5l66O, 0.9997, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
86, 5l66A, 0.9997, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
87, 5l5zO, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
88, 5l5zA, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
89, 5l5xO, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
90, 5l5xA, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
91, 5l5tO, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
92, 5l5tA, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
93, 5l5rO, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
94, 5l5rA, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
95, 5l5jO, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
96, 5l5jA, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
97, 5l5iO, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
98, 5l5iA, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
99, 5l5eO, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
100, 5l5eA, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
101, 5l5bO, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
102, 5l5bA, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
103, 5fg9O, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
104, 5fg9A, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
105, 5d0wO, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT
106, 5d0wA, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT
107, 5cz7O, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
108, 5cz7A, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
109, 5cgfO, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT
110, 5cgfA, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT
111, 5bxnO, 0.9997, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
112, 5bxnA, 0.9997, 0.08, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
113, 4ya4O, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT
114, 4ya4A, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT
115, 4y8rO, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT
116, 4y8rA, 0.9997, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT
117, 4y8mO, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
118, 4y8mA, 0.9997, 0.09, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
119, 4r00O, 0.9997, 0.09, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
120, 4r00A, 0.9997, 0.09, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
121, 4qvwA, 0.9997, 0.08, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
122, 4qvpO, 0.9997, 0.09, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
123, 4qvpA, 0.9997, 0.09, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
124, 4qvnO, 0.9997, 0.09, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
125, 4qvnA, 0.9997, 0.09, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
126, 4qv9O, 0.9997, 0.10, 1.000, 250, 250, YCP BETA5-C63F MUTANT
127, 4qv9A, 0.9997, 0.10, 1.000, 250, 250, YCP BETA5-C63F MUTANT
128, 6gopO, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
129, 6gopA, 0.9996, 0.10, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
130, 5l69O, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
131, 5l69A, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
132, 5l60O, 0.9996, 0.12, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
133, 5l60A, 0.9996, 0.12, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
134, 5l5yO, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
135, 5l5yA, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
136, 5l5vO, 0.9996, 0.11, 1.000, 250, 250,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
137, 5l5vA, 0.9996, 0.11, 1.000, 250, 250,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
138, 5bouO, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
139, 5bouA, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
140, 4z1lO, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
141, 4z1lA, 0.9996, 0.11, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
142, 4qwuO, 0.9996, 0.10, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
143, 4qwuA, 0.9996, 0.10, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
144, 5dkjO, 0.9995, 0.13, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
145, 5dkjA, 0.9995, 0.13, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
146, 5d0tO, 0.9995, 0.13, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
147, 5d0tA, 0.9995, 0.13, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
148, 4y6vO, 0.9995, 0.12, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
149, 4y6vA, 0.9995, 0.12, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
150, 4rurO, 0.9995, 0.12, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
151, 4rurA, 0.9995, 0.12, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
152, 4qvqO, 0.9995, 0.12, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
153, 4qvqA, 0.9995, 0.12, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
154, 4qv6O, 0.9995, 0.13, 1.000, 250, 250, YCP BETA5-A49V MUTANT
155, 4qv6A, 0.9995, 0.13, 1.000, 250, 250, YCP BETA5-A49V MUTANT
156, 5l55O, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
157, 5l55A, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
158, 5cghO, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
159, 5cghA, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
160, 5cggO, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
161, 5cggA, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
162, 4y8uO, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
163, 4y8uA, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
164, 4y8tO, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
165, 4y8tA, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
166, 4y8nO, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
167, 4y8nA, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
168, 4y6aO, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
169, 4y6aA, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
170, 4y69O, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
171, 4y69A, 0.9994, 0.14, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
172, 4qwlO, 0.9994, 0.14, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
173, 4qwlA, 0.9994, 0.14, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
174, 4qw0O, 0.9994, 0.14, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
175, 4qw0A, 0.9994, 0.14, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
176, 5lajO, 0.9993, 0.15, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
177, 5lajA, 0.9993, 0.15, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
178, 5l52O, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
179, 5l52A, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
180, 5jhrO, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
181, 5jhrA, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
182, 5d0xO, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
183, 5d0xA, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
184, 5d0vO, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
185, 5d0vA, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
186, 5d0sO, 0.9993, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
187, 5d0sA, 0.9993, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
188, 5bxlO, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT
189, 4y8pO, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
190, 4y8pA, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
191, 4y75O, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
192, 4y75A, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
193, 4r18O, 0.9993, 0.15, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
194, 4r18A, 0.9993, 0.15, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
195, 4qz7O, 0.9993, 0.14, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
196, 4qz7A, 0.9993, 0.15, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
197, 4qz6O, 0.9993, 0.15, 1.000, 250, 250, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
198, 4qz6A, 0.9993, 0.15, 1.000, 250, 250, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
199, 4qz4O, 0.9993, 0.15, 1.000, 250, 250, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
200, 4qz4A, 0.9993, 0.15, 1.000, 250, 250, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
201, 4qz3O, 0.9993, 0.16, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
202, 4qz3A, 0.9993, 0.16, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
203, 4qwxO, 0.9993, 0.16, 1.000, 250, 250, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
204, 4qw6O, 0.9993, 0.15, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
205, 4qw6A, 0.9993, 0.16, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
206, 4qvmO, 0.9993, 0.14, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
207, 4qvmA, 0.9993, 0.14, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
208, 4jsqO, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
209, 4jsqA, 0.9993, 0.15, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
210, 5laiO, 0.9992, 0.16, 1.000, 250, 250, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
211, 5laiA, 0.9992, 0.16, 1.000, 250, 250, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
212, 5fggO, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
213, 5fggA, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
214, 5d0zO, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
215, 5d0zA, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
216, 5ahjO, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
217, 5ahjA, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
218, 4ya9O, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
219, 4ya9A, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
220, 4ya7O, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
221, 4ya7A, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
222, 4ya5O, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
223, 4ya5A, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
224, 4y9zO, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
225, 4y9zA, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
226, 4y8sO, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
227, 4y8sA, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
228, 4y77O, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
229, 4y77A, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
230, 4qz5O, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
231, 4qz5A, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
232, 4qz0O, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
233, 4qz0A, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
234, 4qwxA, 0.9992, 0.16, 1.000, 250, 250, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
235, 4qw7O, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
236, 4qw7A, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
237, 4qw5O, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
238, 4qw5A, 0.9992, 0.16, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
239, 4no1O, 0.9992, 0.16, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
240, 4no1A, 0.9992, 0.16, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
241, 4jsuO, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
242, 4jsuA, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
243, 4inrA, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
244, 3un8O, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
245, 3un8A, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
246, 3un4O, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
247, 3un4A, 0.9992, 0.16, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
248, 3nzxA, 0.9992, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
249, 3nzjO, 0.9992, 0.16, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
250, 3nzjA, 0.9992, 0.16, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
251, 5l54O, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
252, 5l54A, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
253, 5jhsO, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
254, 5jhsA, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
255, 5fghO, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
256, 5fghA, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
257, 5fgfO, 0.9991, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
258, 5fgfA, 0.9991, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
259, 5cz9O, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
260, 5cz9A, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
261, 5cgiO, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
262, 5cgiA, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
263, 4y8kO, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
264, 4y8kA, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
265, 4r02O, 0.9991, 0.18, 1.000, 250, 250, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
266, 4qzwO, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
267, 4qzwA, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
268, 4qwfO, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
269, 4qwfA, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
270, 4qltO, 0.9991, 0.17, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
271, 4qltA, 0.9991, 0.17, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
272, 4qlsO, 0.9991, 0.17, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
273, 4qlsA, 0.9991, 0.17, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
274, 4no8O, 0.9991, 0.17, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
275, 4no8A, 0.9991, 0.17, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
276, 4nnnO, 0.9991, 0.18, 1.000, 250, 250, YCP IN COMPLEX WITH MG132
277, 4nnnA, 0.9991, 0.17, 1.000, 250, 250, YCP IN COMPLEX WITH MG132
278, 4ltcO, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
279, 4ltcA, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
280, 4jt0O, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
281, 4jt0A, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
282, 4inuO, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
283, 4inuA, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
284, 4intO, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
285, 4intA, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
286, 4inrO, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
287, 3nzxO, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
288, 3nzwO, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
289, 3nzwA, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
290, 3hyeA, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
291, 3gpwO, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
292, 3gpwA, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
293, 3gptO, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
294, 3gptA, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
295, 2fakO, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
296, 2fakA, 0.9991, 0.17, 1.000, 250, 250, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
297, 4ya2O, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
298, 4ya2A, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
299, 4y8lO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
300, 4y8lA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
301, 4y8hO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
302, 4y8hA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
303, 4y8gO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
304, 4y8gA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
305, 4y82O, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
306, 4y82A, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
307, 4qz2O, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
308, 4qz2A, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
309, 4qw4O, 0.9990, 0.19, 1.000, 250, 250, YCP IN COMPLEX WITH CARFILZOMIB
310, 4qw4A, 0.9990, 0.19, 1.000, 250, 250, YCP IN COMPLEX WITH CARFILZOMIB
311, 4qlqO, 0.9990, 0.18, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
312, 4qlqA, 0.9990, 0.18, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
313, 4lqiO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
314, 4lqiA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
315, 3mg0A, 0.9990, 0.18, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
316, 3hyeO, 0.9990, 0.18, 1.000, 250, 250, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
317, 5fgeO, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
318, 5fgeA, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
319, 5cz8O, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
320, 5cz8A, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
321, 5cz4O, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
322, 5cz4A, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
323, 4y8qO, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
324, 4y8qA, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
325, 4y8jO, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
326, 4y8jA, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
327, 4y74O, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
328, 4y74A, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
329, 4y70O, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
330, 4y70A, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
331, 4r02A, 0.9989, 0.19, 1.000, 250, 250, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
332, 4qwrO, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
333, 4qwrA, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
334, 4qvvO, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
335, 4qvvA, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
336, 3tddO, 0.9989, 0.19, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
337, 3tddA, 0.9989, 0.19, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
338, 3shjO, 0.9989, 0.19, 1.000, 250, 250, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
339, 3shjA, 0.9989, 0.19, 1.000, 250, 250, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
340, 3okjO, 0.9989, 0.19, 1.000, 250, 250, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
341, 3okjA, 0.9989, 0.19, 1.000, 250, 250, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
342, 2gplO, 0.9989, 0.19, 1.000, 250, 250, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
343, 2gplA, 0.9989, 0.19, 1.000, 250, 250, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
344, 5fhsO, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
345, 5fhsA, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
346, 5dkiO, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
347, 5dkiA, 0.9988, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
348, 4y8iO, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
349, 4y8iA, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
350, 4y84O, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
351, 4y84A, 0.9988, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
352, 4y81O, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
353, 4y81A, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
354, 4y7yO, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
355, 4y7yA, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
356, 4y7xO, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
357, 4y7xA, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
358, 4y7wO, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
359, 4y7wA, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
360, 4qzxA, 0.9988, 0.20, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
361, 4qluO, 0.9988, 0.20, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
362, 4qluA, 0.9988, 0.20, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
363, 3e47O, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
364, 3e47A, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
365, 2f16O, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
366, 2f16A, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
367, 4ya3O, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
368, 4ya3A, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
369, 4y8oO, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
370, 4y8oA, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
371, 4y80O, 0.9987, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
372, 4y80A, 0.9987, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
373, 4qzxO, 0.9987, 0.20, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
374, 4qz1O, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
375, 4qz1A, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
376, 4qwiO, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
377, 4qwiA, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
378, 4qlvA, 0.9987, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
379, 4q1sA, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
380, 4no9O, 0.9987, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
381, 4no9A, 0.9987, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
382, 4j70A, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
383, 3mg0O, 0.9987, 0.20, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
384, 5fgdO, 0.9986, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
385, 5fgdA, 0.9986, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
386, 5cz5O, 0.9986, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
387, 5cz5A, 0.9986, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
388, 4ya0A, 0.9986, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
389, 4qxjO, 0.9986, 0.22, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
390, 4qxjA, 0.9986, 0.22, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
391, 4qw3O, 0.9986, 0.21, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
392, 4qw3A, 0.9986, 0.21, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
393, 4qlvO, 0.9986, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
394, 4gk7O, 0.9986, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
395, 4gk7A, 0.9986, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
396, 3dy3O, 0.9986, 0.21, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
397, 3dy3A, 0.9986, 0.21, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
398, 3d29O, 0.9986, 0.22, 1.000, 250, 250, PROTEASOME INHIBITION BY FELLUTAMIDE B
399, 3d29A, 0.9986, 0.21, 1.000, 250, 250, PROTEASOME INHIBITION BY FELLUTAMIDE B
400, 4ya0O, 0.9985, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
401, 4y6zO, 0.9985, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
402, 4y6zA, 0.9985, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
403, 4qwkO, 0.9985, 0.23, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
404, 4qwkA, 0.9985, 0.23, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
405, 4no6O, 0.9985, 0.22, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
406, 4no6A, 0.9985, 0.22, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
407, 4nnwO, 0.9985, 0.23, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
408, 4nnwA, 0.9985, 0.23, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
409, 4j70O, 0.9985, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
410, 3dy4A, 0.9985, 0.23, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
411, 2zcyO, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
412, 2zcyA, 0.9985, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
413, 4y78A, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
414, 4fzcO, 0.9984, 0.23, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
415, 4fzcA, 0.9984, 0.23, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
416, 3gpjA, 0.9984, 0.23, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
417, 3dy4O, 0.9984, 0.23, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
418, 4y78O, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
419, 4qwjO, 0.9983, 0.24, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
420, 4qwjA, 0.9983, 0.24, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
421, 3gpjO, 0.9983, 0.23, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
422, 4fzgO, 0.9982, 0.24, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
423, 4fzgA, 0.9982, 0.24, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
424, 4qbyO, 0.9981, 0.26, 1.000, 250, 250, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
425, 4qbyA, 0.9981, 0.26, 1.000, 250, 250, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
426, 4qwsO, 0.9980, 0.26, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
427, 4qwsA, 0.9980, 0.26, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
428, 4q1sO, 0.9980, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
429, 3bdmO, 0.9980, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
430, 3bdmA, 0.9980, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
431, 5nifP, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
432, 4hnpA, 0.9979, 0.26, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
433, 3mg4A, 0.9979, 0.27, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
434, 4zzgP, 0.9978, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
435, 4hnpO, 0.9978, 0.28, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
436, 1rypB, 0.9978, 0.27, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
437, 4qwgO, 0.9975, 0.30, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
438, 4hrdO, 0.9975, 0.29, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
439, 1rypP, 0.9975, 0.29, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
440, 4qwgA, 0.9974, 0.30, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
441, 4hrdA, 0.9973, 0.31, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
442, 3oevA, 0.9973, 0.31, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
443, 3mg6A, 0.9973, 0.31, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
444, 3oeuA, 0.9971, 0.32, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
445, 3mg8A, 0.9970, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
446, 1g65A, 0.9970, 0.32, 1.000, 250, 250, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
447, 5nifB, 0.9969, 0.33, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
448, 3sdkO, 0.9969, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
449, 3sdkA, 0.9969, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
450, 3oeuO, 0.9969, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
451, 3mg7A, 0.9969, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
452, 4zzgB, 0.9968, 0.33, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
453, 3mg8O, 0.9968, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
454, 3mg7O, 0.9968, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
455, 1g65O, 0.9967, 0.33, 1.000, 250, 250, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
456, 3oevO, 0.9964, 0.35, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
457, 3mg6O, 0.9964, 0.35, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
458, 3mg4O, 0.9961, 0.37, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
459, 1jd2A, 0.9957, 0.38, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
460, 4r17O, 0.9955, 0.12, 1.000, 249, 249, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
461, 4r17A, 0.9955, 0.12, 1.000, 249, 249, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
462, 1jd2V, 0.9952, 0.41, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
463, 5fgiO, 0.9950, 0.18, 1.000, 249, 249, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
464, 5fgiA, 0.9950, 0.18, 1.000, 249, 249, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
465, 3wxrB, 0.9941, 0.25, 1.000, 249, 249, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
466, 4x6zP, 0.9935, 0.30, 0.996, 249, 249, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
467, 4hrcO, 0.9933, 0.30, 1.000, 249, 249, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
468, 4hrcA, 0.9931, 0.32, 1.000, 249, 249, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
469, 4eu2B, 0.9928, 0.34, 1.000, 249, 249, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
470, 3wxrP, 0.9923, 0.36, 1.000, 249, 249, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
471, 4eu2P, 0.9913, 0.43, 0.996, 249, 249, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
472, 4x6zB, 0.9897, 0.28, 1.000, 248, 248, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
473, 3jcpKA, 0.9890, 0.62, 1.000, 250, 250, 
474, 3jcpK, 0.9890, 0.62, 1.000, 250, 250, 
475, 5mp9B, 0.9859, 0.62, 1.000, 250, 250, 26S PROTEASOME IN PRESENCE OF ATP (S1)
476, 3jcoKA, 0.9829, 0.70, 1.000, 250, 250, 
477, 3jcoK, 0.9829, 0.78, 1.000, 250, 250, 
478, 3sdiA, 0.9826, 0.78, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
479, 3sdiO, 0.9816, 0.78, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
480, 5mp9b, 0.9813, 0.22, 1.000, 246, 246, 26S PROTEASOME IN PRESENCE OF ATP (S1)
481, 1g0uA, 0.9810, 0.28, 1.000, 246, 246, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
482, 1g0uO, 0.9806, 0.90, 1.000, 250, 250, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
483, 4g4sB, 0.9794, 0.32, 1.000, 246, 246, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
484, 5mpab, 0.9768, 0.35, 1.000, 246, 246, 26S PROTEASOME IN PRESENCE OF ATP (S2)
485, 5mpaB, 0.9751, 0.41, 1.000, 246, 246, 26S PROTEASOME IN PRESENCE OF ATP (S2)
486, 5wvkW, 0.9722, 1.00, 1.000, 250, 250, 
487, 5wvkP, 0.9704, 0.95, 1.000, 250, 250, 
488, 4cr2B, 0.9597, 1.02, 1.000, 250, 250, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
489, 5mpbB, 0.9571, 1.05, 1.000, 250, 250, 
490, 5wviOA, 0.9546, 1.28, 1.000, 250, 250, 
491, 5mpbP, 0.9538, 1.33, 1.000, 250, 250, 
492, 5wviDA, 0.9529, 1.32, 1.000, 250, 250, 
493, 1z7qP, 0.9522, 1.35, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
494, 1z7qB, 0.9522, 1.34, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
495, 1fntP, 0.9519, 0.94, 1.000, 249, 243, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
496, 1fntB, 0.9519, 0.94, 1.000, 249, 243, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
497, 4cr4B, 0.9463, 1.06, 1.000, 247, 243, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
498, 5a5bB, 0.9426, 1.06, 1.000, 247, 243, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
499, 4cr3B, 0.9426, 1.52, 1.000, 250, 250, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
500, 5mpcB, 0.9350, 1.52, 1.000, 250, 250, 
501, 5mpcP, 0.9338, 1.52, 1.000, 250, 250, 
502, 4v7oB, 0.9168, 1.41, 1.000, 250, 244, 
503, 4v7oXA, 0.9167, 1.47, 1.000, 250, 244, 
504, 4v7oP, 0.9167, 0.53, 1.000, 231, 231, 
505, 4v7oJA, 0.9167, 1.76, 0.285, 234, 221, 
506, 4r3oP, 0.9042, 0.54, 1.000, 231, 231, HUMAN CONSTITUTIVE 20S PROTEASOME
507, 4r3oB, 0.9042, 0.54, 1.000, 231, 231, HUMAN CONSTITUTIVE 20S PROTEASOME
508, 4r67r, 0.9033, 0.54, 1.000, 231, 231, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
509, 4r67P, 0.9033, 1.04, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
510, 4r67d, 0.9033, 1.04, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
511, 4r67B, 0.9031, 1.06, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
512, 5gjqC, 0.9022, 1.06, 0.608, 233, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
513, 5l4gP, 0.9020, 1.06, 0.608, 233, 232, 
514, 5gjrHA, 0.9016, 1.06, 0.608, 233, 232, 
515, 5gjrT, 0.9015, 1.09, 0.608, 233, 232, 
516, 5l4gB, 0.9010, 1.08, 0.608, 233, 232, 
517, 3uneO, 0.9008, 1.00, 0.606, 231, 231, MOUSE CONSTITUTIVE 20S PROTEASOME
518, 1iruP, 0.9004, 1.01, 0.606, 231, 231, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
519, 5lezO, 0.9003, 1.16, 0.608, 233, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
520, 5lexO, 0.9003, 1.12, 0.608, 233, 232, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
521, 5leyO, 0.9001, 1.12, 0.608, 233, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
522, 5lf1O, 0.9000, 0.94, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
523, 5lf7O, 0.8999, 0.94, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
524, 5lf3O, 0.8999, 0.94, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
525, 5lf4O, 0.8998, 0.95, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
526, 5lf6O, 0.8997, 0.95, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
527, 5lezA, 0.8997, 0.95, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
528, 5lexA, 0.8997, 0.95, 0.613, 230, 230, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
529, 5le5O, 0.8997, 0.96, 0.613, 230, 230, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
530, 3unec, 0.8996, 0.96, 0.613, 230, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
531, 3unbq, 0.8996, 0.96, 0.613, 230, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
532, 3unbA, 0.8995, 0.95, 0.613, 230, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
533, 3uneq, 0.8994, 1.14, 0.603, 233, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
534, 3unbO, 0.8993, 1.05, 0.606, 231, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
535, 3unbc, 0.8993, 1.05, 0.606, 231, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
536, 5lf0O, 0.8992, 1.16, 0.603, 233, 232, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
537, 5leyA, 0.8990, 1.06, 0.606, 231, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
538, 5lf6A, 0.8989, 1.06, 0.606, 231, 231, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
539, 5gjqi, 0.8989, 0.97, 0.613, 230, 230, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
540, 5lf4A, 0.8988, 0.97, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
541, 5lf3A, 0.8987, 0.98, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
542, 5lf1A, 0.8987, 1.06, 0.602, 231, 231, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
543, 5lf7A, 0.8984, 0.98, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
544, 1iruB, 0.8984, 0.98, 0.613, 230, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
545, 5lf0A, 0.8983, 0.98, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
546, 5le5A, 0.8983, 0.99, 0.613, 230, 230, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
547, 3uneA, 0.8980, 1.19, 0.608, 233, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
548, 6avoP, 0.8967, 0.99, 0.613, 230, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
549, 6avob, 0.8967, 0.99, 0.613, 230, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
550, 3unhO, 0.8941, 1.19, 0.603, 233, 232, MOUSE 20S IMMUNOPROTEASOME
551, 3unhA, 0.8941, 1.01, 0.613, 230, 230, MOUSE 20S IMMUNOPROTEASOME
552, 3unfO, 0.8934, 1.01, 0.613, 230, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
553, 3unfA, 0.8934, 1.09, 0.609, 230, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
554, 5m32O, 0.8923, 1.09, 0.609, 230, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
555, 5m32A, 0.8923, 1.11, 0.609, 230, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
556, 5vfsAA, 0.8922, 1.11, 0.609, 230, 230, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
557, 5vfsB, 0.8919, 1.09, 0.613, 230, 230, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
558, 5vfoh, 0.8912, 1.09, 0.613, 230, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
559, 5vfqAA, 0.8910, 1.19, 0.610, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
560, 5vfpZ, 0.8907, 1.20, 0.610, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
561, 5vfrh, 0.8901, 2.23, 0.352, 250, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
562, 5vfuS, 0.8898, 1.20, 0.602, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
563, 5vftH, 0.8897, 1.21, 0.606, 232, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
564, 5t0cZA, 0.8896, 1.21, 0.602, 232, 231, 
565, 5t0cT, 0.8896, 1.22, 0.602, 232, 231, 
566, 5vfuGA, 0.8863, 1.23, 0.610, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
567, 5vfth, 0.8863, 1.23, 0.610, 232, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
568, 5t0gH, 0.8850, 1.24, 0.610, 232, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
569, 5ln3B, 0.8751, 1.24, 0.610, 232, 231, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
570, 5t0hH, 0.8747, 1.29, 0.610, 232, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
571, 4r02P, 0.8725, 1.29, 0.610, 232, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
572, 1rypQ, 0.8714, 1.45, 0.608, 233, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
573, 4eu2Q, 0.8712, 1.54, 0.616, 234, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
574, 3unfP, 0.8711, 1.50, 0.606, 232, 231, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
575, 3unfB, 0.8711, 2.14, 0.357, 244, 235, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
576, 2gplP, 0.8711, 2.18, 0.362, 244, 235, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
577, 2gplB, 0.8710, 2.17, 0.357, 244, 235, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
578, 3nzjP, 0.8709, 1.97, 0.356, 248, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
579, 5bouP, 0.8708, 1.97, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
580, 4qluP, 0.8708, 2.20, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
581, 4q1sP, 0.8708, 2.20, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
582, 3nzjB, 0.8708, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
583, 3hyeP, 0.8708, 2.16, 0.357, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
584, 5lajP, 0.8707, 2.18, 0.357, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
585, 5fgaP, 0.8707, 2.24, 0.362, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
586, 5cgfP, 0.8707, 2.21, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
587, 5bouB, 0.8707, 2.20, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
588, 4rurP, 0.8707, 2.17, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
589, 4r18P, 0.8707, 2.16, 0.357, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
590, 4qluB, 0.8707, 2.16, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
591, 4qlqP, 0.8707, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
592, 3wxrQ, 0.8707, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
593, 3hyeB, 0.8707, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
594, 2fakP, 0.8707, 2.18, 0.357, 244, 235, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
595, 5lajB, 0.8706, 2.17, 0.357, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
596, 5fgaB, 0.8706, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
597, 5cgfB, 0.8706, 2.20, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
598, 4y9yP, 0.8706, 2.21, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
599, 4y6vP, 0.8706, 2.17, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
600, 4rurB, 0.8706, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
601, 4r18B, 0.8706, 2.16, 0.357, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
602, 4r17P, 0.8706, 2.16, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
603, 4r17B, 0.8706, 2.17, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
604, 4qltP, 0.8706, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
605, 4qlqB, 0.8706, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
606, 3nzwP, 0.8706, 2.16, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
607, 2fakB, 0.8706, 2.16, 0.357, 244, 235, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
608, 1g65P, 0.8706, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
609, 5lf4B, 0.8705, 2.17, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
610, 5laiP, 0.8705, 2.21, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
611, 5bxlP, 0.8705, 2.21, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
612, 5bxlB, 0.8705, 2.21, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
613, 4z1lP, 0.8705, 1.97, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
614, 4z1lB, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
615, 4ya4P, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
616, 4y9yB, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
617, 4y8sP, 0.8705, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
618, 4y8rP, 0.8705, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
619, 4y6vB, 0.8705, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
620, 4y69P, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
621, 4y69B, 0.8705, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
622, 4qvyP, 0.8705, 2.15, 0.357, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
623, 4qltB, 0.8705, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
624, 4lqiP, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
625, 3unhP, 0.8705, 2.17, 0.357, 244, 235, MOUSE 20S IMMUNOPROTEASOME
626, 3unhB, 0.8705, 2.17, 0.357, 244, 235, MOUSE 20S IMMUNOPROTEASOME
627, 3nzwB, 0.8705, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
628, 5le5B, 0.8704, 2.22, 0.362, 244, 235, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
629, 5laiB, 0.8704, 1.98, 0.356, 248, 233, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
630, 5l54P, 0.8704, 1.98, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
631, 5l54B, 0.8704, 2.21, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
632, 5fg7P, 0.8704, 1.97, 0.356, 248, 233, YEAST 20S PROTEASOME BETA2-T1A MUTANT
633, 5fg7B, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
634, 5dkiP, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
635, 5cz6P, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
636, 5cz4P, 0.8704, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
637, 4ya5P, 0.8704, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
638, 4ya4B, 0.8704, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
639, 4ya1P, 0.8704, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
640, 4ya0P, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
641, 4y8sB, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
642, 4y8rB, 0.8704, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
643, 4y8nP, 0.8704, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
644, 4qz2P, 0.8704, 2.18, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
645, 4qwfP, 0.8704, 2.17, 0.357, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
646, 4qwfB, 0.8704, 2.15, 0.357, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
647, 4qw6P, 0.8704, 2.17, 0.357, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
648, 4qw1P, 0.8704, 2.18, 0.353, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
649, 4qw1B, 0.8704, 2.18, 0.353, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
650, 4qvyB, 0.8704, 2.18, 0.353, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
651, 4qvwP, 0.8704, 2.18, 0.353, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
652, 4qvwB, 0.8704, 2.16, 0.357, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
653, 4qvlP, 0.8704, 2.16, 0.357, 244, 235, YCP IN COMPLEX WITH BORTEZOMIB
654, 4qlsP, 0.8704, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
655, 4lqiB, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
656, 3tddP, 0.8704, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
657, 3e47P, 0.8704, 2.16, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
658, 5lezB, 0.8703, 2.19, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
659, 5gjqD, 0.8703, 2.22, 0.362, 244, 235, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
660, 5fg9P, 0.8703, 2.21, 0.362, 244, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
661, 5fg9B, 0.8703, 2.22, 0.362, 244, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
662, 5dkiB, 0.8703, 1.98, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
663, 5d0wP, 0.8703, 1.97, 0.356, 250, 233, YEAST 20S PROTEASOME BETA5-T1S MUTANT
664, 5d0tP, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
665, 5czaP, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
666, 5cz6B, 0.8703, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
667, 5cz4B, 0.8703, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
668, 4ya5B, 0.8703, 2.17, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
669, 4ya1B, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
670, 4ya0B, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
671, 4y8uP, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
672, 4y8nB, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
673, 4y8mP, 0.8703, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
674, 4y8iP, 0.8703, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
675, 4qz2B, 0.8703, 2.17, 0.357, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
676, 4qz1P, 0.8703, 2.17, 0.357, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
677, 4qw6B, 0.8703, 2.16, 0.357, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
678, 4qvmP, 0.8703, 2.19, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
679, 4qvmB, 0.8703, 2.18, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
680, 4qvlB, 0.8703, 2.18, 0.353, 244, 235, YCP IN COMPLEX WITH BORTEZOMIB
681, 4qlsB, 0.8703, 2.18, 0.353, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
682, 4intP, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
683, 3tddB, 0.8703, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
684, 3gpwP, 0.8703, 2.16, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
685, 3e47B, 0.8703, 2.19, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
686, 5lf7B, 0.8702, 2.22, 0.362, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
687, 5lf3B, 0.8702, 2.21, 0.362, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
688, 5l65P, 0.8702, 2.21, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
689, 5l65B, 0.8702, 2.22, 0.362, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
690, 5l5sP, 0.8702, 1.97, 0.356, 248, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
691, 5l5iP, 0.8702, 1.97, 0.356, 248, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
692, 5dkjP, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
693, 5d0xP, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
694, 5d0xB, 0.8702, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
695, 5d0wB, 0.8702, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
696, 5d0tB, 0.8702, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
697, 5czaB, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
698, 5cz8P, 0.8702, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
699, 4ya3P, 0.8702, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
700, 4y8uB, 0.8702, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
701, 4y8mB, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
702, 4y8iB, 0.8702, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
703, 4qz7P, 0.8702, 2.18, 0.353, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
704, 4qz1B, 0.8702, 2.17, 0.357, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
705, 4qxjP, 0.8702, 2.16, 0.357, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
706, 4qwuP, 0.8702, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
707, 4qwuB, 0.8702, 2.17, 0.357, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
708, 4qw7P, 0.8702, 2.18, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
709, 4qw4P, 0.8702, 2.18, 0.353, 244, 235, YCP IN COMPLEX WITH CARFILZOMIB
710, 4qw0P, 0.8702, 2.16, 0.357, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
711, 4qw0B, 0.8702, 2.16, 0.357, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
712, 4qvpP, 0.8702, 2.18, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
713, 4qvpB, 0.8702, 2.19, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
714, 5l69P, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
715, 5l69B, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
716, 5l60P, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
717, 5l5zP, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
718, 5l5sB, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
719, 5l5iB, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
720, 5l5eP, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
721, 5gjrIA, 0.8701, 2.18, 0.357, 244, 235, 
722, 5fghP, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
723, 5dkjB, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
724, 5cz8B, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
725, 5cz7P, 0.8701, 1.97, 0.356, 250, 233, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
726, 5cz7B, 0.8701, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
727, 4ya9P, 0.8701, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
728, 4ya3B, 0.8701, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
729, 4ya2P, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
730, 4ya2B, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
731, 4y8gP, 0.8701, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
732, 4y84P, 0.8701, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
733, 4y6aP, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
734, 4qz7B, 0.8701, 2.18, 0.357, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
735, 4qz5P, 0.8701, 2.19, 0.357, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
736, 4qz4P, 0.8701, 2.19, 0.357, 244, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
737, 4qz4B, 0.8701, 2.17, 0.357, 244, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
738, 4qz0P, 0.8701, 2.17, 0.357, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
739, 4qz0B, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
740, 4qxjB, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
741, 4qw7B, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
742, 4qw4B, 0.8701, 2.18, 0.353, 244, 235, YCP IN COMPLEX WITH CARFILZOMIB
743, 4qvvP, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
744, 4qvvB, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
745, 4qvqP, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
746, 4qvnP, 0.8701, 2.19, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
747, 4qvnB, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
748, 4qv6P, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-A49V MUTANT
749, 4qv6B, 0.8701, 2.17, 0.357, 244, 235, YCP BETA5-A49V MUTANT
750, 4quxP, 0.8701, 2.17, 0.357, 244, 235, YCP BETA5-A49T-MUTANT
751, 4quxB, 0.8701, 2.17, 0.357, 244, 235, YCP BETA5-A49T-MUTANT
752, 4nnwP, 0.8701, 2.16, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
753, 4nnwB, 0.8701, 2.16, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
754, 4ltcP, 0.8701, 2.18, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
755, 3gpwB, 0.8701, 2.18, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
756, 5m2bP, 0.8700, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
757, 5lttP, 0.8700, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
758, 5lf0B, 0.8700, 2.19, 0.362, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
759, 5lezP, 0.8700, 2.21, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
760, 5leyB, 0.8700, 2.18, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
761, 5l60B, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
762, 5l5zB, 0.8700, 1.98, 0.356, 248, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
763, 5l5tP, 0.8700, 2.00, 0.356, 247, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
764, 5l5tB, 0.8700, 1.98, 0.356, 248, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
765, 5l5hP, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
766, 5l5fP, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
767, 5l5fB, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
768, 5l5eB, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
769, 5l5aP, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
770, 5fgiP, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
771, 5fghB, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
772, 5bxnP, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
773, 5bxnB, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
774, 4ya9B, 0.8700, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
775, 4y9zP, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
776, 4y8lP, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
777, 4y8gB, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
778, 4y84B, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
779, 4y6aB, 0.8700, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
780, 4qz6P, 0.8700, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
781, 4qz6B, 0.8700, 2.19, 0.357, 244, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
782, 4qz5B, 0.8700, 2.19, 0.357, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
783, 4qwiP, 0.8700, 2.17, 0.357, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
784, 4qw5P, 0.8700, 2.18, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
785, 4qw5B, 0.8700, 2.18, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
786, 4qvqB, 0.8700, 2.18, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
787, 4quyP, 0.8700, 2.19, 0.353, 244, 235, YCP BETA5-A49S-MUTANT
788, 4hrdP, 0.8700, 2.18, 0.353, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
789, 3nzxP, 0.8700, 2.19, 0.353, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
790, 3mg4P, 0.8700, 2.17, 0.357, 244, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
791, 6gopP, 0.8699, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
792, 6epfB, 0.8699, 2.19, 0.362, 244, 235, GROUND STATE 26S PROTEASOME (GS1)
793, 5m2bB, 0.8699, 2.22, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
794, 5lttB, 0.8699, 2.24, 0.362, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
795, 5lf1B, 0.8699, 2.17, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
796, 5l6bP, 0.8699, 1.64, 0.608, 234, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
797, 5l6bB, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
798, 5l68P, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
799, 5l68B, 0.8699, 1.98, 0.356, 248, 233, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
800, 5l66P, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
801, 5l66B, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
802, 5l63P, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
803, 5l5yP, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
804, 5l5xP, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
805, 5l5xB, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
806, 5l5uP, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
807, 5l5uB, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
808, 5l5pP, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
809, 5l5jP, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
810, 5l5jB, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
811, 5l5hB, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
812, 5l5dP, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
813, 5l5dB, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
814, 5l5aB, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
815, 5jhsP, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
816, 5jhsB, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
817, 5fgiB, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
818, 5d0vP, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
819, 5d0vB, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
820, 5cgiP, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
821, 5cgiB, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
822, 4y9zB, 0.8699, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
823, 4y8pP, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
824, 4y8oP, 0.8699, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
825, 4y8lB, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
826, 4y8jP, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
827, 4y8hP, 0.8699, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
828, 4y8hB, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
829, 4y7xP, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
830, 4y7xB, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
831, 4qzzP, 0.8699, 2.18, 0.357, 244, 235, YCP IN COMPLEX WITH OMURALIDE
832, 4qzzB, 0.8699, 2.19, 0.357, 244, 235, YCP IN COMPLEX WITH OMURALIDE
833, 4qzxP, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
834, 4qzwP, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
835, 4qwxP, 0.8699, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
836, 4qwlP, 0.8699, 2.17, 0.357, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
837, 4qwlB, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
838, 4qwiB, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
839, 4qw3P, 0.8699, 2.18, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
840, 4qw3B, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
841, 4quyB, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-A49S-MUTANT
842, 3nzxB, 0.8699, 2.19, 0.353, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
843, 3dy4P, 0.8699, 2.18, 0.353, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
844, 3dy3P, 0.8699, 2.18, 0.353, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
845, 3d29P, 0.8699, 2.16, 0.357, 244, 235, PROTEASOME INHIBITION BY FELLUTAMIDE B
846, 3d29B, 0.8699, 2.22, 0.357, 244, 235, PROTEASOME INHIBITION BY FELLUTAMIDE B
847, 6gopB, 0.8698, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
848, 5lexB, 0.8698, 2.24, 0.357, 244, 235, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
849, 5l6cP, 0.8698, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
850, 5l6cB, 0.8698, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
851, 5l67P, 0.8698, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
852, 5l67B, 0.8698, 1.99, 0.356, 248, 233, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
853, 5l64P, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
854, 5l64B, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
855, 5l63B, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
856, 5l5yB, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
857, 5l5wP, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
858, 5l5qP, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
859, 5l5qB, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
860, 5l5pB, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
861, 5l5oP, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
862, 5jhrP, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
863, 5gjrU, 0.8698, 2.18, 0.357, 244, 235, 
864, 5fgfP, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
865, 5fgfB, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
866, 5fgdP, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
867, 5fgdB, 0.8698, 1.98, 0.356, 250, 233, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
868, 5d0zP, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
869, 5cghP, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
870, 4y8tP, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
871, 4y8pB, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
872, 4y8oB, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
873, 4y8jB, 0.8698, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
874, 4y7yP, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
875, 4y77P, 0.8698, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
876, 4y77B, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
877, 4qzxB, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
878, 4qzwB, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
879, 4qz3P, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
880, 4qz3B, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
881, 4qwxB, 0.8698, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
882, 4qwrP, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
883, 4qwkP, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
884, 4qv9P, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT
885, 4qv8P, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT
886, 4qv7P, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A50V MUTANT
887, 3mg0P, 0.8698, 2.19, 0.353, 244, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
888, 3gptP, 0.8698, 2.16, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
889, 3dy4B, 0.8698, 2.18, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
890, 3dy3B, 0.8698, 2.18, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
891, 2f16P, 0.8698, 2.26, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
892, 5l62P, 0.8697, 2.21, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
893, 5l5wB, 0.8697, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
894, 5l5vP, 0.8697, 2.24, 0.357, 244, 235,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
895, 5l5rP, 0.8697, 2.22, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
896, 5l5oB, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
897, 5l55P, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
898, 5l52P, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
899, 5l52B, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
900, 5jhrB, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
901, 5d0zB, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
902, 5cz9P, 0.8697, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
903, 5cz5P, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
904, 5cghB, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
905, 4ya7P, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
906, 4ya7B, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
907, 4y8tB, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
908, 4y8qP, 0.8697, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
909, 4y82P, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
910, 4y81P, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
911, 4y80P, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
912, 4y80B, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
913, 4y7yB, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
914, 4y78P, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
915, 4y78B, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
916, 4r00P, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
917, 4qwrB, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
918, 4qwkB, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
919, 4qwjP, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
920, 4qwjB, 0.8697, 2.18, 0.357, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
921, 4qv9B, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT
922, 4qv8B, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT
923, 4qv7B, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-A50V MUTANT
924, 4qv0P, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
925, 4intB, 0.8697, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
926, 4inrP, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
927, 4gk7P, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
928, 3gptB, 0.8697, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
929, 5l6aP, 0.8696, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
930, 5l62B, 0.8696, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
931, 5l61P, 0.8696, 2.22, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
932, 5l5vB, 0.8696, 2.22, 0.357, 244, 235,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
933, 5l5rB, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
934, 5l5bP, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
935, 5l55B, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
936, 5fhsP, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
937, 5fhsB, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
938, 5fgeP, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
939, 5fgeB, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
940, 5d0sP, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
941, 5cz9B, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
942, 5cz5B, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
943, 5cggP, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
944, 4y8qB, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
945, 4y8kP, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
946, 4y82B, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
947, 4y81B, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
948, 4y7wP, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
949, 4y75P, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
950, 4y75B, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
951, 4y74P, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
952, 4y70P, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
953, 4y70B, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
954, 4r00B, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
955, 4qv1P, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-M45A MUTANT
956, 4qv1B, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-M45A MUTANT
957, 4qv0B, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
958, 4jsuP, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
959, 4hnpP, 0.8696, 2.18, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
960, 4gk7B, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
961, 2f16B, 0.8696, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
962, 5lf6B, 0.8695, 2.21, 0.362, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
963, 5l6aB, 0.8695, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
964, 5l61B, 0.8695, 2.22, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
965, 5l5bB, 0.8695, 2.23, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
966, 5fggP, 0.8695, 1.99, 0.356, 248, 233, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
967, 5fggB, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
968, 5d0sB, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
969, 5cggB, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
970, 4y8kB, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
971, 4y7wB, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
972, 4y74B, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
973, 4qwsP, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
974, 4qwsB, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
975, 4qv4P, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-M45T MUTANT
976, 4jsuB, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
977, 3okjP, 0.8695, 2.19, 0.353, 244, 235, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
978, 3gpjP, 0.8695, 2.19, 0.353, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
979, 3gpjB, 0.8695, 2.18, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
980, 4y6zP, 0.8694, 2.21, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
981, 4qv4B, 0.8694, 2.23, 0.357, 244, 235, YCP BETA5-M45T MUTANT
982, 4qlvP, 0.8694, 2.23, 0.362, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
983, 4qlvB, 0.8694, 2.23, 0.362, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
984, 4qbyP, 0.8694, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
985, 4no9P, 0.8694, 2.18, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
986, 4nnnP, 0.8694, 2.18, 0.357, 244, 235, YCP IN COMPLEX WITH MG132
987, 4nnnB, 0.8694, 2.18, 0.357, 244, 235, YCP IN COMPLEX WITH MG132
988, 4fzcP, 0.8694, 2.17, 0.353, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
989, 3unbB, 0.8694, 2.21, 0.353, 244, 235, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
990, 3okjB, 0.8694, 2.20, 0.357, 244, 235, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
991, 5t0iH, 0.8693, 2.20, 0.357, 244, 235, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
992, 5lf4P, 0.8693, 2.24, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
993, 5le5P, 0.8693, 2.01, 0.356, 248, 233, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
994, 5ahjP, 0.8693, 2.23, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
995, 4y6zB, 0.8693, 1.58, 0.609, 233, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
996, 4qv5P, 0.8693, 1.99, 0.356, 248, 233, YCP BETA5-M45I MUTANT
997, 4qv3P, 0.8693, 1.99, 0.356, 247, 233, YCP BETA5-M45V MUTANT
998, 4qbyB, 0.8693, 2.19, 0.357, 244, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
999, 4no9B, 0.8693, 2.20, 0.353, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1000, 4j70P, 0.8693, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1001, 4inrB, 0.8693, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1002, 4fzcB, 0.8693, 2.17, 0.353, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1003, 3bdmP, 0.8693, 2.21, 0.353, 244, 235, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1004, 3bdmB, 0.8693, 2.26, 0.353, 244, 235, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1005, 1g65B, 0.8693, 2.23, 0.362, 244, 235, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1006, 5lf1P, 0.8692, 2.25, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1007, 5ahjB, 0.8692, 2.26, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1008, 4r02B, 0.8692, 2.26, 0.362, 244, 235, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1009, 4qv5B, 0.8692, 2.22, 0.357, 244, 235, YCP BETA5-M45I MUTANT
1010, 4qv3B, 0.8692, 2.00, 0.356, 248, 233, YCP BETA5-M45V MUTANT
1011, 3unfC, 0.8692, 2.19, 0.357, 244, 235, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1012, 1rypC, 0.8692, 2.20, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1013, 4no6P, 0.8691, 2.19, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1014, 4no1P, 0.8691, 2.19, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1015, 4no1B, 0.8691, 1.51, 0.336, 238, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1016, 4inuP, 0.8691, 2.21, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1017, 3unfQ, 0.8691, 2.20, 0.357, 244, 235, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1018, 4no6B, 0.8690, 2.19, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1019, 4jsqP, 0.8690, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1020, 3unhQ, 0.8690, 2.24, 0.362, 244, 235, MOUSE 20S IMMUNOPROTEASOME
1021, 3unbP, 0.8690, 1.51, 0.336, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1022, 3unbd, 0.8690, 2.20, 0.357, 244, 235, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1023, 2zcyP, 0.8690, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1024, 2zcyB, 0.8690, 1.52, 0.336, 238, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1025, 5nifS, 0.8689, 2.02, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1026, 5lf7P, 0.8689, 2.02, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1027, 4zzgS, 0.8689, 2.25, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1028, 4jsqB, 0.8689, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1029, 3unhC, 0.8689, 1.64, 0.329, 236, 228, MOUSE 20S IMMUNOPROTEASOME
1030, 3un4P, 0.8689, 2.00, 0.356, 247, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1031, 3shjP, 0.8689, 1.64, 0.329, 236, 228, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1032, 5lf6P, 0.8688, 2.24, 0.362, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1033, 4qwgP, 0.8688, 1.52, 0.336, 238, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1034, 4qwgB, 0.8688, 2.23, 0.362, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1035, 4no8P, 0.8688, 2.24, 0.362, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1036, 4hrcP, 0.8688, 2.01, 0.356, 248, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1037, 3un8P, 0.8688, 2.21, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1038, 3un4B, 0.8688, 2.21, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1039, 5lf3P, 0.8687, 2.20, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1040, 5lf0P, 0.8687, 2.26, 0.362, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1041, 4x6zQ, 0.8687, 2.24, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1042, 4no8B, 0.8687, 2.23, 0.362, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1043, 4jt0P, 0.8687, 2.01, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1044, 4j70B, 0.8687, 2.01, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1045, 3shjB, 0.8687, 2.22, 0.357, 244, 235, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1046, 3dy3R, 0.8687, 2.20, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1047, 3dy3D, 0.8687, 2.23, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1048, 5lezC, 0.8686, 2.26, 0.353, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1049, 5lexP, 0.8686, 2.24, 0.362, 244, 235, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1050, 4q1sB, 0.8686, 1.60, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1051, 4jt0B, 0.8686, 1.60, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1052, 4inuB, 0.8686, 1.45, 0.338, 236, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1053, 4hnpB, 0.8686, 2.02, 0.356, 247, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1054, 4eu2S, 0.8686, 2.20, 0.362, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1055, 4j70D, 0.8685, 2.23, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1056, 4fzgP, 0.8685, 2.25, 0.362, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1057, 4ltcB, 0.8684, 2.23, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1058, 4j70R, 0.8684, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1059, 3unbr, 0.8684, 1.61, 0.329, 242, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1060, 3mg0R, 0.8684, 2.26, 0.357, 244, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1061, 5leyP, 0.8683, 2.21, 0.362, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1062, 4fzgB, 0.8683, 1.61, 0.329, 242, 228, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1063, 3mg0D, 0.8682, 2.03, 0.356, 248, 233, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1064, 2gplR, 0.8682, 1.60, 0.329, 242, 228, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1065, 2gplD, 0.8682, 2.01, 0.356, 247, 233, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1066, 2fakR, 0.8682, 2.26, 0.357, 244, 235, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1067, 2fakD, 0.8682, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1068, 3tddD, 0.8681, 1.60, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1069, 3mg0B, 0.8681, 1.60, 0.329, 242, 228, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1070, 3dy4R, 0.8681, 1.60, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1071, 3dy4D, 0.8681, 1.60, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1072, 5l4gQ, 0.8680, 1.61, 0.329, 242, 228, 
1073, 4lqiR, 0.8680, 2.28, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1074, 4lqiD, 0.8680, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1075, 3tddR, 0.8680, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1076, 3nzjR, 0.8680, 2.00, 0.356, 250, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1077, 3nzjD, 0.8680, 1.60, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1078, 2zcyR, 0.8680, 1.60, 0.329, 242, 228, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1079, 2zcyD, 0.8680, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1080, 5nifQ, 0.8679, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1081, 5mp9c, 0.8679, 1.61, 0.329, 242, 228, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1082, 5lf7C, 0.8679, 1.61, 0.329, 242, 228, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1083, 4zzgQ, 0.8679, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1084, 4hrdB, 0.8679, 2.00, 0.361, 242, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1085, 4eu2E, 0.8679, 2.15, 0.353, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1086, 5le5C, 0.8678, 1.45, 0.338, 236, 228, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1087, 5gjqj, 0.8678, 2.01, 0.361, 242, 233, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1088, 4gk7D, 0.8677, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1089, 4fzgD, 0.8677, 1.65, 0.329, 242, 228, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1090, 3un8B, 0.8677, 1.46, 0.338, 236, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1091, 3gpwD, 0.8677, 1.99, 0.356, 250, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1092, 3d29D, 0.8677, 1.60, 0.329, 242, 228, PROTEASOME INHIBITION BY FELLUTAMIDE B
1093, 2f16R, 0.8677, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1094, 2f16D, 0.8677, 2.26, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1095, 1jd2W, 0.8677, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1096, 5lf4C, 0.8676, 1.61, 0.329, 242, 228, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1097, 5leyC, 0.8676, 1.61, 0.329, 242, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1098, 4q1sD, 0.8676, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1099, 4intR, 0.8676, 2.25, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1100, 4gk7R, 0.8676, 1.46, 0.338, 236, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1101, 4fzgR, 0.8676, 1.46, 0.338, 236, 228, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1102, 3unbe, 0.8676, 1.66, 0.329, 242, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1103, 3un4R, 0.8676, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1104, 3un4D, 0.8676, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1105, 3gpwR, 0.8676, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1106, 3gptR, 0.8676, 1.53, 0.332, 239, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1107, 3gptD, 0.8676, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1108, 3gpjD, 0.8676, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1109, 3e47D, 0.8676, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1110, 3d29R, 0.8676, 1.62, 0.329, 242, 228, PROTEASOME INHIBITION BY FELLUTAMIDE B
1111, 5lf1C, 0.8675, 1.62, 0.329, 242, 228, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1112, 5lexC, 0.8675, 1.62, 0.329, 242, 228, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1113, 4jt0R, 0.8675, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1114, 4jt0D, 0.8675, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1115, 4inrD, 0.8675, 1.47, 0.338, 236, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1116, 3okjR, 0.8675, 1.46, 0.338, 236, 228, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1117, 3okjD, 0.8675, 1.62, 0.329, 242, 228, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1118, 3hyeR, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1119, 3hyeD, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1120, 3gpjR, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1121, 3e47R, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1122, 5lf3C, 0.8674, 1.62, 0.329, 242, 228, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1123, 4q1sR, 0.8674, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1124, 4jsuR, 0.8674, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1125, 4jsuD, 0.8674, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1126, 4inuD, 0.8674, 1.46, 0.338, 236, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1127, 3nzwR, 0.8674, 1.64, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1128, 3nzwD, 0.8674, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1129, 5lf6C, 0.8673, 1.62, 0.329, 242, 228, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1130, 4inrR, 0.8673, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1131, 4hrcB, 0.8673, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1132, 3nzxD, 0.8673, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1133, 5lf0C, 0.8672, 1.47, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1134, 4intD, 0.8672, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1135, 3shjD, 0.8672, 2.28, 0.357, 244, 235, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1136, 3nzxR, 0.8672, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1137, 4jsqR, 0.8671, 1.47, 0.338, 236, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1138, 4jsqD, 0.8671, 1.68, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1139, 4fzcR, 0.8671, 1.61, 0.329, 242, 228, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1140, 4fzcD, 0.8671, 1.62, 0.329, 242, 228, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1141, 4eu2C, 0.8671, 1.63, 0.329, 242, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1142, 3uneP, 0.8671, 1.62, 0.329, 242, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
1143, 3shjR, 0.8671, 1.61, 0.329, 242, 228, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1144, 4r67Q, 0.8670, 1.61, 0.329, 242, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1145, 4ltcR, 0.8670, 2.26, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1146, 4inuR, 0.8670, 2.04, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1147, 4r67s, 0.8669, 1.61, 0.329, 242, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1148, 4r67e, 0.8669, 2.03, 0.356, 250, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1149, 4r67C, 0.8669, 1.64, 0.329, 242, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1150, 4r3oQ, 0.8669, 1.63, 0.329, 242, 228, HUMAN CONSTITUTIVE 20S PROTEASOME
1151, 4r3oC, 0.8669, 2.03, 0.356, 250, 233, HUMAN CONSTITUTIVE 20S PROTEASOME
1152, 4ltcD, 0.8669, 2.03, 0.356, 250, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1153, 3wxrS, 0.8669, 2.03, 0.356, 250, 233, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1154, 3un8D, 0.8669, 2.03, 0.356, 250, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1155, 1g65D, 0.8668, 2.03, 0.356, 250, 233, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1156, 4hrcD, 0.8667, 1.64, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1157, 3unbQ, 0.8667, 1.47, 0.330, 238, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1158, 3unbs, 0.8666, 1.63, 0.329, 242, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1159, 3mg8R, 0.8666, 1.64, 0.329, 242, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1160, 1jd2B, 0.8666, 1.65, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1161, 5lttR, 0.8665, 1.54, 0.336, 239, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1162, 5lttD, 0.8665, 1.54, 0.336, 239, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1163, 5l60R, 0.8665, 1.47, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1164, 5l60D, 0.8665, 2.26, 0.353, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1165, 5l4gC, 0.8665, 1.57, 0.330, 235, 227, 
1166, 3unbC, 0.8665, 1.57, 0.330, 235, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1167, 3un8R, 0.8665, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1168, 3mg7R, 0.8665, 1.57, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1169, 5l62R, 0.8664, 2.03, 0.356, 250, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1170, 5l62D, 0.8664, 1.56, 0.328, 239, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1171, 5l5zR, 0.8664, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1172, 5l5zD, 0.8664, 1.46, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1173, 5l5yR, 0.8664, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1174, 5l5yD, 0.8664, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1175, 5l5xD, 0.8664, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1176, 4ya0R, 0.8664, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1177, 4ya0D, 0.8664, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1178, 3oeuD, 0.8664, 1.57, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1179, 3bdmD, 0.8664, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1180, 5l61R, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1181, 5l61D, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1182, 5l5xR, 0.8663, 1.47, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1183, 5l5wR, 0.8663, 1.45, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1184, 5l5wD, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1185, 5l5vR, 0.8663, 1.58, 0.330, 235, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1186, 5l5vD, 0.8663, 1.58, 0.330, 235, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1187, 5l5sR, 0.8663, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1188, 5l5sD, 0.8663, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1189, 5cz4R, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1190, 5cz4D, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1191, 4ya3R, 0.8663, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1192, 4ya3D, 0.8663, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1193, 4y8uR, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1194, 4y8uD, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1195, 4y69R, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1196, 4y69D, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1197, 4qw3R, 0.8663, 1.58, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1198, 4qw3D, 0.8663, 1.58, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1199, 4qvvR, 0.8663, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1200, 4qvvD, 0.8663, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1201, 4hrdD, 0.8663, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1202, 4hrcR, 0.8663, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1203, 3mg8D, 0.8663, 1.58, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1204, 3dy4C, 0.8663, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1205, 3bdmR, 0.8663, 1.48, 0.330, 242, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1206, 1rypE, 0.8663, 1.68, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1207, 5l6cR, 0.8662, 1.48, 0.330, 242, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1208, 5l6cD, 0.8662, 1.54, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1209, 5l64R, 0.8662, 1.45, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1210, 5l64D, 0.8662, 1.46, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1211, 5l63R, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1212, 5l63D, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1213, 5l5tR, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1214, 5l5tD, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1215, 5l5pD, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1216, 5l5iR, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1217, 5l5iD, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1218, 5l5eR, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1219, 5l5eD, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1220, 5l5aD, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1221, 5fghR, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1222, 5fghD, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1223, 5dkiR, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1224, 5dkiD, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1225, 4zzgD, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1226, 4ya5R, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1227, 4ya5D, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1228, 4q1sC, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1229, 4hnpR, 0.8662, 1.55, 0.362, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1230, 3uner, 0.8662, 1.58, 0.330, 235, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
1231, 3oevR, 0.8662, 1.58, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1232, 3mg6R, 0.8662, 1.55, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1233, 3mg4B, 0.8662, 1.46, 0.330, 242, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1234, 3dy4Q, 0.8662, 2.06, 0.356, 248, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1235, 2zcyC, 0.8662, 1.47, 0.330, 242, 227, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1236, 5nifD, 0.8661, 1.47, 0.330, 242, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1237, 5l68R, 0.8661, 2.31, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1238, 5l68D, 0.8661, 1.54, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1239, 5l67R, 0.8661, 1.54, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1240, 5l67D, 0.8661, 1.55, 0.362, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1241, 5l65R, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1242, 5l65D, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1243, 5l5qR, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1244, 5l5qD, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1245, 5l5pR, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1246, 5l5jR, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1247, 5l5jD, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1248, 5l5fR, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1249, 5l5fD, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1250, 5l5aR, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1251, 5d0xR, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1252, 5d0xD, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1253, 4y8nR, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1254, 4y8nD, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1255, 4y6vR, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1256, 4y6vD, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1257, 4rurD, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1258, 4hnpD, 0.8661, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1259, 3mg4R, 0.8661, 1.58, 0.330, 235, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1260, 2zcyQ, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1261, 5lajR, 0.8660, 1.58, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1262, 5lajD, 0.8660, 1.46, 0.330, 242, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1263, 5l6bR, 0.8660, 1.47, 0.330, 242, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1264, 5l6bD, 0.8660, 1.54, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1265, 5l69R, 0.8660, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1266, 5l69D, 0.8660, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1267, 5l5oR, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1268, 5l5oD, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1269, 5l5hR, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1270, 5l5hD, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1271, 5dkjR, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1272, 5dkjD, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1273, 5d0tD, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1274, 5cz7R, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1275, 5cz7D, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1276, 5bouR, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1277, 5bouD, 0.8660, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1278, 4y6aR, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1279, 4y6aD, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1280, 4rurR, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1281, 4qwjR, 0.8660, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1282, 4qwjD, 0.8660, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1283, 4qw0R, 0.8660, 1.58, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1284, 4qw0D, 0.8660, 1.58, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1285, 4qvmR, 0.8660, 1.58, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1286, 4qvmD, 0.8660, 1.58, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1287, 3jcpLA, 0.8660, 1.58, 0.330, 235, 227, 
1288, 3jcpL, 0.8660, 1.58, 0.330, 235, 227, 
1289, 1g65R, 0.8660, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1290, 6avoZ, 0.8659, 1.58, 0.330, 235, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1291, 6avoO, 0.8659, 2.21, 0.362, 244, 235, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1292, 5m2bR, 0.8659, 2.21, 0.362, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1293, 5m2bD, 0.8659, 2.21, 0.362, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1294, 5l66R, 0.8659, 1.65, 0.329, 242, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1295, 5l66D, 0.8659, 2.04, 0.356, 240, 233, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1296, 5l5uR, 0.8659, 2.04, 0.356, 240, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1297, 5l5uD, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1298, 5fgaD, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1299, 5fg9R, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1300, 5fg9D, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1301, 5d0tR, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1302, 4y9yD, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1303, 4quxR, 0.8659, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT
1304, 4quxD, 0.8659, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT
1305, 4hrdR, 0.8659, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1306, 3mg6D, 0.8659, 1.59, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1307, 3dy3C, 0.8659, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1308, 5laiR, 0.8658, 1.58, 0.330, 235, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1309, 5laiD, 0.8658, 1.58, 0.330, 235, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1310, 5l5rD, 0.8658, 1.49, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1311, 5fgdR, 0.8658, 1.48, 0.330, 242, 227, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1312, 5fgdD, 0.8658, 1.54, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1313, 5fgaR, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1314, 5cz6R, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1315, 5cz6D, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1316, 5cgfR, 0.8658, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1317, 5cgfD, 0.8658, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1318, 4z1lR, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1319, 4z1lD, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1320, 4y9yR, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1321, 4y8mD, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1322, 4y8iR, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1323, 4y8iD, 0.8658, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1324, 4y78R, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1325, 4y78D, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1326, 4x6zC, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1327, 4qwiR, 0.8658, 1.58, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1328, 4qwiD, 0.8658, 1.58, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1329, 3uned, 0.8658, 1.58, 0.330, 235, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
1330, 3oevD, 0.8658, 1.58, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1331, 3oeuR, 0.8658, 2.30, 0.357, 244, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1332, 3mg4D, 0.8658, 1.58, 0.330, 235, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1333, 3dy3Q, 0.8658, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1334, 1rypS, 0.8658, 2.07, 0.356, 248, 233, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1335, 5l6aR, 0.8657, 1.48, 0.330, 242, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1336, 5l6aD, 0.8657, 1.53, 0.330, 236, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1337, 5l5rR, 0.8657, 1.51, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1338, 5l5dR, 0.8657, 1.54, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1339, 5l5dD, 0.8657, 1.46, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1340, 5fg7R, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1341, 4y8oR, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1342, 4y8oD, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1343, 4y8mR, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1344, 4r18R, 0.8657, 1.58, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1345, 4r18D, 0.8657, 1.58, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1346, 4r00R, 0.8657, 1.58, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1347, 4r00D, 0.8657, 1.58, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1348, 4qwkR, 0.8657, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1349, 4qwkD, 0.8657, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1350, 4qvyR, 0.8657, 1.59, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1351, 4qvyD, 0.8657, 1.59, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1352, 4qvwR, 0.8657, 1.59, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1353, 4qvwD, 0.8657, 1.58, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1354, 4q1sQ, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1355, 3mg7D, 0.8657, 1.58, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1356, 1iruQ, 0.8657, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1357, 1iruC, 0.8657, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1358, 5l5bR, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1359, 5l5bD, 0.8656, 1.54, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1360, 5fg7D, 0.8656, 1.48, 0.330, 242, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1361, 5bxlR, 0.8656, 2.03, 0.356, 250, 233, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1362, 5bxlD, 0.8656, 2.03, 0.356, 250, 233, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1363, 4ya1R, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1364, 4ya1D, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1365, 4y8tR, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1366, 4y8tD, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1367, 4y8qR, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1368, 4y8qD, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1369, 4y8jR, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1370, 4y8jD, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1371, 4y80R, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1372, 4y80D, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1373, 4y7yR, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1374, 4y7yD, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1375, 4y7xR, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1376, 4y7xD, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1377, 4y7wR, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1378, 4y7wD, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1379, 4r67t, 0.8656, 1.58, 0.330, 235, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1380, 4r67f, 0.8656, 1.58, 0.330, 235, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1381, 4r3oR, 0.8656, 1.59, 0.330, 235, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
1382, 4qzxR, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1383, 4qzxD, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1384, 4qz7R, 0.8656, 1.56, 0.336, 243, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1385, 4qz7D, 0.8656, 1.56, 0.336, 243, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1386, 4qz5R, 0.8656, 1.56, 0.341, 243, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1387, 4qz5D, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1388, 4qz1R, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1389, 4qz1D, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1390, 4qwsR, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1391, 4qwsD, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1392, 4qw4R, 0.8656, 1.58, 0.330, 235, 227, YCP IN COMPLEX WITH CARFILZOMIB
1393, 4qw4D, 0.8656, 1.58, 0.330, 235, 227, YCP IN COMPLEX WITH CARFILZOMIB
1394, 4qvqR, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1395, 4qvqD, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1396, 4qvlR, 0.8656, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH BORTEZOMIB
1397, 4qvlD, 0.8656, 1.58, 0.330, 235, 227, YCP IN COMPLEX WITH BORTEZOMIB
1398, 4qv8D, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-C52F MUTANT
1399, 5czaR, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1400, 5czaD, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1401, 4y8lR, 0.8655, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1402, 4y8lD, 0.8655, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1403, 4y81R, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1404, 4y81D, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1405, 4y70R, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1406, 4y70D, 0.8655, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1407, 4r67D, 0.8655, 1.58, 0.330, 235, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1408, 4r3oD, 0.8655, 1.58, 0.330, 235, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
1409, 4qzzR, 0.8655, 1.58, 0.330, 235, 227, YCP IN COMPLEX WITH OMURALIDE
1410, 4qzzD, 0.8655, 1.58, 0.330, 235, 227, YCP IN COMPLEX WITH OMURALIDE
1411, 4qzwR, 0.8655, 1.58, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1412, 4qzwD, 0.8655, 1.56, 0.336, 243, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1413, 4qz3R, 0.8655, 1.56, 0.341, 243, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1414, 4qz3D, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1415, 4qxjR, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1416, 4qxjD, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1417, 4qwgD, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1418, 4qw1R, 0.8655, 1.58, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1419, 4qw1D, 0.8655, 1.58, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1420, 4qvpR, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1421, 4qvpD, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1422, 4qv8R, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT
1423, 4qv7R, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT
1424, 4qv7D, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT
1425, 5jhsR, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1426, 5jhsD, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1427, 5cz9R, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1428, 5cz9D, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1429, 5cgiR, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1430, 5cgiD, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1431, 4zzgR, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1432, 4y9zR, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1433, 4y9zD, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1434, 4y8sR, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1435, 4y8sD, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1436, 4y8rR, 0.8654, 1.56, 0.362, 241, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1437, 4y8rD, 0.8654, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1438, 4y82R, 0.8654, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1439, 4y82D, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1440, 4qz6R, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1441, 4qz6D, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1442, 4qwgR, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1443, 4qw7D, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1444, 4qv4R, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT
1445, 4qv4D, 0.8654, 1.58, 0.330, 235, 227, YCP BETA5-M45T MUTANT
1446, 4qv3D, 0.8654, 1.58, 0.330, 235, 227, YCP BETA5-M45V MUTANT
1447, 4qv0R, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1448, 4qv0D, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1449, 4quyD, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-A49S-MUTANT
1450, 3wxrE, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1451, 3wxrC, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1452, 6gopQ, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1453, 6gopC, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1454, 5nifR, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1455, 5mp9C, 0.8653, 1.68, 0.329, 239, 228, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1456, 5d0wR, 0.8653, 2.09, 0.361, 242, 233, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1457, 5d0wD, 0.8653, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1458, 4ya4R, 0.8653, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1459, 4ya4D, 0.8653, 1.57, 0.362, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1460, 4y74R, 0.8653, 2.22, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1461, 4y74D, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1462, 4y6zR, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1463, 4y6zD, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1464, 4r67R, 0.8653, 1.59, 0.330, 235, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1465, 4r17D, 0.8653, 1.58, 0.330, 235, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1466, 4qwuR, 0.8653, 1.58, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1467, 4qwuD, 0.8653, 1.58, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1468, 4qwfR, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1469, 4qwfD, 0.8653, 1.56, 0.336, 243, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1470, 4qw7R, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1471, 4qv5R, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45I MUTANT
1472, 4qv5D, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45I MUTANT
1473, 4qv3R, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45V MUTANT
1474, 4qv1R, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT
1475, 4qv1D, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT
1476, 4quyR, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-A49S-MUTANT
1477, 6gopD, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1478, 5lajC, 0.8652, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1479, 5bxnD, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1480, 4y8pR, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1481, 4y8pD, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1482, 4y77D, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1483, 4r17R, 0.8652, 1.55, 0.367, 240, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1484, 4r02C, 0.8652, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1485, 4qz4R, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1486, 4qz4D, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1487, 4qwxR, 0.8652, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1488, 4qwxD, 0.8652, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1489, 4qw6R, 0.8652, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1490, 4qw6D, 0.8652, 1.58, 0.330, 235, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1491, 4qvvC, 0.8652, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1492, 6gopR, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1493, 5lajQ, 0.8651, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1494, 5d0zR, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1495, 5d0zD, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1496, 5d0vR, 0.8651, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1497, 5d0vD, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1498, 5d0tQ, 0.8651, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1499, 5d0tC, 0.8651, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1500, 5bxnR, 0.8651, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1501, 4zzgC, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1502, 4ya9R, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1503, 4ya9D, 0.8651, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1504, 4ya7R, 0.8651, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1505, 4ya7D, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1506, 4y77R, 0.8651, 2.04, 0.362, 241, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1507, 4y75D, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1508, 4qw5D, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1509, 4qvvQ, 0.8651, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1510, 4qv9R, 0.8651, 1.58, 0.330, 235, 227, YCP BETA5-C63F MUTANT
1511, 4qv9D, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-C63F MUTANT
1512, 4qv6Q, 0.8651, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT
1513, 4qv6D, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT
1514, 4qv6C, 0.8651, 1.55, 0.367, 240, 229, YCP BETA5-A49V MUTANT
1515, 3d29Q, 0.8651, 1.59, 0.330, 235, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1516, 3d29C, 0.8651, 1.59, 0.330, 235, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1517, 5nifC, 0.8650, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1518, 5l52R, 0.8650, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1519, 5l52D, 0.8650, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1520, 5jhrR, 0.8650, 1.55, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1521, 5jhrD, 0.8650, 1.55, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1522, 4y75R, 0.8650, 2.04, 0.362, 241, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1523, 4x6zR, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1524, 4x6zE, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1525, 4qwuQ, 0.8650, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1526, 4qwuC, 0.8650, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1527, 4qwlD, 0.8650, 1.58, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1528, 4qv6R, 0.8650, 1.56, 0.367, 241, 229, YCP BETA5-A49V MUTANT
1529, 4qv0Q, 0.8650, 1.54, 0.330, 242, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1530, 4qv0C, 0.8650, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1531, 4qlsD, 0.8650, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1532, 4nnnR, 0.8650, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH MG132
1533, 4nnnD, 0.8650, 1.58, 0.330, 235, 227, YCP IN COMPLEX WITH MG132
1534, 4eu2D, 0.8650, 1.56, 0.367, 240, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1535, 3uneB, 0.8650, 1.56, 0.367, 240, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
1536, 3sdkC, 0.8650, 1.60, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1537, 3mg6C, 0.8650, 1.59, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1538, 5fgfD, 0.8649, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1539, 5dkjQ, 0.8649, 1.56, 0.362, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1540, 5dkjC, 0.8649, 2.08, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1541, 5dkiQ, 0.8649, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1542, 5dkiC, 0.8649, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1543, 5cggR, 0.8649, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1544, 5cggD, 0.8649, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1545, 4r00Q, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1546, 4r00C, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1547, 4qzzQ, 0.8649, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH OMURALIDE
1548, 4qzzC, 0.8649, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH OMURALIDE
1549, 4qz0R, 0.8649, 1.60, 0.330, 235, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1550, 4qz0D, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1551, 4qwlR, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1552, 4qw1Q, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1553, 4qw1C, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1554, 4qvpQ, 0.8649, 1.60, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1555, 4qvpC, 0.8649, 1.60, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1556, 4qvnR, 0.8649, 1.59, 0.330, 235, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1557, 4qvnD, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1558, 4qlsR, 0.8649, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1559, 4hrcC, 0.8649, 1.56, 0.367, 240, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1560, 5l54R, 0.8648, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1561, 5l54D, 0.8648, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1562, 5fggR, 0.8648, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1563, 5fggD, 0.8648, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1564, 5fgfR, 0.8648, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1565, 5d0xC, 0.8648, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1566, 5cz8Q, 0.8648, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1567, 5cz8C, 0.8648, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1568, 5cgfC, 0.8648, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1569, 4x6zD, 0.8648, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1570, 4qz6Q, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1571, 4qz6C, 0.8648, 1.56, 0.362, 240, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1572, 4qz5Q, 0.8648, 1.56, 0.362, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1573, 4qz5C, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1574, 4qwjQ, 0.8648, 1.56, 0.367, 241, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1575, 4qwjC, 0.8648, 1.57, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1576, 4qw0Q, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1577, 4qw0C, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1578, 4qv8Q, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT
1579, 4qv8C, 0.8648, 1.56, 0.362, 240, 229, YCP BETA5-C52F MUTANT
1580, 4qv7Q, 0.8648, 1.56, 0.362, 240, 229, YCP BETA5-A50V MUTANT
1581, 4qv7C, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT
1582, 4fzcC, 0.8648, 1.56, 0.367, 240, 229, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1583, 3gpjQ, 0.8648, 1.56, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1584, 3gpjC, 0.8648, 1.56, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1585, 5l55R, 0.8647, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1586, 5l55D, 0.8647, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1587, 5gjrJA, 0.8647, 1.56, 0.367, 241, 229, 
1588, 5fhsR, 0.8647, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1589, 5fhsD, 0.8647, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1590, 5fgeR, 0.8647, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1591, 5fgeD, 0.8647, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1592, 5fgaQ, 0.8647, 1.57, 0.341, 243, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1593, 5fgaC, 0.8647, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1594, 5d0xQ, 0.8647, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1595, 5cz5R, 0.8647, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1596, 5cz5D, 0.8647, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1597, 5cgfQ, 0.8647, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1598, 4r18C, 0.8647, 1.56, 0.367, 240, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1599, 4r02R, 0.8647, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1600, 4qzwQ, 0.8647, 1.41, 0.332, 235, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1601, 4qzwC, 0.8647, 1.41, 0.332, 235, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1602, 4qz3C, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1603, 4qvqC, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1604, 4qv9Q, 0.8647, 1.60, 0.330, 235, 227, YCP BETA5-C63F MUTANT
1605, 4qv9C, 0.8647, 1.57, 0.367, 240, 229, YCP BETA5-C63F MUTANT
1606, 4qlvR, 0.8647, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1607, 4qlvD, 0.8647, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1608, 4no8D, 0.8647, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1609, 4nnwR, 0.8647, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1610, 4nnwD, 0.8647, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1611, 4fzcQ, 0.8647, 1.61, 0.330, 235, 227, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1612, 3uneQ, 0.8647, 1.61, 0.330, 235, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
1613, 3mg0C, 0.8647, 1.60, 0.330, 235, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1614, 1rypD, 0.8647, 1.59, 0.330, 235, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1615, 1g65C, 0.8647, 1.59, 0.330, 235, 227, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1616, 5gjrV, 0.8646, 1.56, 0.367, 241, 229, 
1617, 5fgiR, 0.8646, 1.56, 0.341, 239, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1618, 5fgiD, 0.8646, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1619, 5cz8R, 0.8646, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1620, 5cz8D, 0.8646, 1.56, 0.362, 241, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1621, 5cz7Q, 0.8646, 1.57, 0.341, 243, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1622, 5cz7C, 0.8646, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1623, 4z1lQ, 0.8646, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1624, 4z1lC, 0.8646, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1625, 4y9yC, 0.8646, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1626, 4r18Q, 0.8646, 1.56, 0.367, 240, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1627, 4qz3Q, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1628, 4qxjC, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1629, 4qwrR, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1630, 4qwrD, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1631, 4qwlQ, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1632, 4qwlC, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1633, 4qwkC, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1634, 4qw7Q, 0.8646, 1.41, 0.332, 235, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1635, 4qw7C, 0.8646, 1.40, 0.332, 235, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1636, 4qw6Q, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1637, 4qw6C, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1638, 4qvwC, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1639, 4qvqQ, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1640, 4qvmQ, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1641, 4qvmC, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1642, 4qvlQ, 0.8646, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH BORTEZOMIB
1643, 4qvlC, 0.8646, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH BORTEZOMIB
1644, 4qv3C, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-M45V MUTANT
1645, 4quyQ, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A49S-MUTANT
1646, 4quyC, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A49S-MUTANT
1647, 4qlqR, 0.8646, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1648, 4qlqD, 0.8646, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1649, 4no8R, 0.8646, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1650, 3oeuC, 0.8646, 1.56, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1651, 3bdmQ, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1652, 3bdmC, 0.8646, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1653, 5l52C, 0.8645, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1654, 5jhsQ, 0.8645, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1655, 5jhsC, 0.8645, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1656, 5fghQ, 0.8645, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1657, 5fghC, 0.8645, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1658, 5fg7Q, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1659, 5fg7C, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1660, 5cgiQ, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1661, 5cgiC, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1662, 5cghR, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1663, 5cghD, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1664, 4ya2R, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1665, 4ya2D, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1666, 4y9yQ, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1667, 4y8uQ, 0.8645, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1668, 4y8uC, 0.8645, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1669, 4y8rQ, 0.8645, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1670, 4y8rC, 0.8645, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1671, 4y84R, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1672, 4y84D, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1673, 4r02D, 0.8645, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1674, 4qzxC, 0.8645, 1.56, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1675, 4qz4Q, 0.8645, 1.56, 0.367, 240, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1676, 4qz4C, 0.8645, 1.60, 0.330, 235, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1677, 4qz2C, 0.8645, 1.60, 0.330, 235, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1678, 4qxjQ, 0.8645, 1.61, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1679, 4qwkQ, 0.8645, 1.57, 0.362, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1680, 4qw5Q, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1681, 4qw5C, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1682, 4qvyQ, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1683, 4qvyC, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1684, 4qvwQ, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1685, 4qv3Q, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT
1686, 4qltR, 0.8645, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1687, 4qltD, 0.8645, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1688, 4hnpC, 0.8645, 1.56, 0.367, 240, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1689, 3shjQ, 0.8645, 1.56, 0.367, 240, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1690, 3shjC, 0.8645, 1.56, 0.367, 240, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1691, 3hyeC, 0.8645, 1.61, 0.330, 235, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1692, 5l52Q, 0.8644, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1693, 5gjqE, 0.8644, 1.58, 0.367, 241, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1694, 5fhsC, 0.8644, 1.56, 0.362, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1695, 5fggQ, 0.8644, 1.56, 0.362, 241, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1696, 5fggC, 0.8644, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1697, 5fg9Q, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1698, 5fg9C, 0.8644, 1.58, 0.341, 243, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1699, 5d0zQ, 0.8644, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1700, 5d0zC, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1701, 5d0wQ, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1702, 5d0wC, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1703, 5d0vQ, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1704, 5d0vC, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1705, 5d0sQ, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1706, 5d0sC, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1707, 5czaQ, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1708, 5czaC, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1709, 5cz5Q, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1710, 5cz5C, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1711, 4y8sC, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1712, 4y8iC, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1713, 4qzxQ, 0.8644, 1.56, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1714, 4qz2R, 0.8644, 1.57, 0.362, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1715, 4qz2Q, 0.8644, 1.57, 0.362, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1716, 4qz2D, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1717, 4qz0C, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1718, 4qwiQ, 0.8644, 1.57, 0.362, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1719, 4qwiC, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1720, 4qwfQ, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1721, 4qwfC, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1722, 4qw4C, 0.8644, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH CARFILZOMIB
1723, 4qv1Q, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT
1724, 4qv1C, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT
1725, 4no6R, 0.8644, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1726, 4no6D, 0.8644, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1727, 4eu2R, 0.8644, 1.57, 0.367, 240, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1728, 3hyeQ, 0.8644, 1.57, 0.367, 240, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1729, 1rypR, 0.8644, 1.57, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1730, 5lttQ, 0.8643, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1731, 5lttC, 0.8643, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1732, 5l5sC, 0.8643, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1733, 5l55Q, 0.8643, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1734, 5l55C, 0.8643, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1735, 5fhsQ, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1736, 5fgiQ, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1737, 5fgiC, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1738, 5fgfQ, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1739, 5fgfC, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1740, 5cz9Q, 0.8643, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1741, 5cz9C, 0.8643, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1742, 5bxnQ, 0.8643, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1743, 5bxnC, 0.8643, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1744, 5bxlQ, 0.8643, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1745, 5bxlC, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1746, 4ya4Q, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1747, 4ya4C, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1748, 4ya0Q, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1749, 4ya0C, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1750, 4y9zC, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1751, 4y8sQ, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1752, 4y8lQ, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1753, 4y8lC, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1754, 4y8iQ, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1755, 4y7yQ, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1756, 4y7yC, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1757, 4qz7Q, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1758, 4qz7C, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1759, 4qz0Q, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1760, 4qwrC, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1761, 4qw5R, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1762, 4qw4Q, 0.8643, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH CARFILZOMIB
1763, 4qw3Q, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1764, 4qw3C, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1765, 4qvnQ, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1766, 4qvnC, 0.8643, 1.41, 0.332, 235, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1767, 4qv4Q, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45T MUTANT
1768, 4qv4C, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45T MUTANT
1769, 4quxC, 0.8643, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT
1770, 4no1R, 0.8643, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1771, 4no1D, 0.8643, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1772, 5l60C, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1773, 5l5xQ, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1774, 5l5xC, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1775, 5l5uQ, 0.8642, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1776, 5l5uC, 0.8642, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1777, 5l5sQ, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1778, 5fgdC, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1779, 5cz6Q, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1780, 5cz6C, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1781, 5cggC, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1782, 4y9zQ, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1783, 4y8kR, 0.8642, 1.57, 0.362, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1784, 4y8kD, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1785, 4y8jQ, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1786, 4y8jC, 0.8642, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1787, 4y8hR, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1788, 4y8gR, 0.8642, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1789, 4y8gD, 0.8642, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1790, 4y69Q, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1791, 4qwrQ, 0.8642, 1.57, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1792, 4qv5Q, 0.8642, 1.61, 0.330, 235, 227, YCP BETA5-M45I MUTANT
1793, 4qv5C, 0.8642, 1.61, 0.330, 235, 227, YCP BETA5-M45I MUTANT
1794, 4quxQ, 0.8642, 1.61, 0.330, 235, 227, YCP BETA5-A49T-MUTANT
1795, 4lqiQ, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1796, 4lqiC, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1797, 4j70C, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1798, 3nzwC, 0.8642, 1.57, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1799, 3gpwC, 0.8642, 1.57, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1800, 3gptC, 0.8642, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1801, 3e47C, 0.8642, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1802, 5nifE, 0.8641, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1803, 5l65Q, 0.8641, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1804, 5l65C, 0.8641, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1805, 5l60Q, 0.8641, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1806, 5l5zC, 0.8641, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1807, 5l5vC, 0.8641, 1.42, 0.332, 236, 226,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1808, 5l5eQ, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1809, 5l5eC, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1810, 5jhrQ, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1811, 5jhrC, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1812, 5fgdQ, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1813, 5d0sR, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1814, 5d0sD, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1815, 5cggQ, 0.8641, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1816, 4ya3Q, 0.8641, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1817, 4ya3C, 0.8641, 1.58, 0.362, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1818, 4ya1Q, 0.8641, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1819, 4ya1C, 0.8641, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1820, 4y8hD, 0.8641, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1821, 4y78C, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1822, 4y69C, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1823, 4x6zS, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1824, 4qz1Q, 0.8641, 1.57, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1825, 4qz1C, 0.8641, 1.61, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1826, 4qwxQ, 0.8641, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1827, 4qwxC, 0.8641, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1828, 4qluR, 0.8641, 1.56, 0.330, 242, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1829, 4qluD, 0.8641, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1830, 4fzgC, 0.8641, 1.58, 0.367, 240, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1831, 3nzwQ, 0.8641, 1.58, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1832, 3gpwQ, 0.8641, 1.58, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1833, 3gptQ, 0.8641, 1.62, 0.330, 235, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1834, 3e47Q, 0.8641, 1.62, 0.330, 235, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1835, 5l67Q, 0.8640, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1836, 5l67C, 0.8640, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1837, 5l64Q, 0.8640, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1838, 5l64C, 0.8640, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1839, 5l62Q, 0.8640, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1840, 5l62C, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1841, 5l61Q, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1842, 5l61C, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1843, 5l5zQ, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1844, 5l5vQ, 0.8640, 1.57, 0.367, 240, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1845, 5l5qQ, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1846, 5l5qC, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1847, 5l5hQ, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1848, 5l5hC, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1849, 5fgeQ, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1850, 5fgeC, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1851, 5cz4Q, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1852, 5cz4C, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1853, 4ya9Q, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1854, 4ya9C, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1855, 4ya7Q, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1856, 4ya7C, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1857, 4ya5Q, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1858, 4ya5C, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1859, 4ya2Q, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1860, 4ya2C, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1861, 4y8qC, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1862, 4y8pQ, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1863, 4y8pC, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1864, 4y8mQ, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1865, 4y8mC, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1866, 4y80C, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1867, 4y78Q, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1868, 4rurQ, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1869, 4rurC, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1870, 4no9R, 0.8640, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1871, 4no9D, 0.8640, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1872, 4inrQ, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1873, 4fzgQ, 0.8640, 1.57, 0.367, 240, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1874, 3un8Q, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1875, 3un8C, 0.8640, 1.62, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1876, 3tddC, 0.8640, 1.62, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1877, 3oeuP, 0.8640, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1878, 3nzjQ, 0.8640, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1879, 3nzjC, 0.8640, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1880, 3mg0Q, 0.8640, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1881, 5mpaC, 0.8639, 1.57, 0.367, 241, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1882, 5l6cQ, 0.8639, 1.83, 0.357, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1883, 5l6cC, 0.8639, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1884, 5l6bQ, 0.8639, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1885, 5l6bC, 0.8639, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1886, 5l63Q, 0.8639, 2.27, 0.353, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1887, 5l63C, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1888, 5l5yQ, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1889, 5l5yC, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1890, 5l5wQ, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1891, 5l5wC, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1892, 5l5iQ, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1893, 5l5iC, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1894, 5l5fQ, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1895, 5l5fC, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1896, 5cghQ, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1897, 5cghC, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1898, 5bouQ, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1899, 5bouC, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1900, 4y8qQ, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1901, 4y8nQ, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1902, 4y8nC, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1903, 4y80Q, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1904, 4y7xQ, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1905, 4y7xC, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1906, 4y7wQ, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1907, 4y7wC, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1908, 4y70Q, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1909, 4y70C, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1910, 4y6vQ, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1911, 4y6vC, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1912, 4qwsC, 0.8639, 1.58, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1913, 4inrC, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1914, 3tddQ, 0.8639, 1.58, 0.367, 240, 229, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1915, 3oevC, 0.8639, 1.57, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1916, 3nzxQ, 0.8639, 1.57, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1917, 3nzxC, 0.8639, 1.58, 0.362, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1918, 3mg8C, 0.8639, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1919, 5l66Q, 0.8638, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1920, 5l66C, 0.8638, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1921, 5l5tQ, 0.8638, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1922, 5l5tC, 0.8638, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1923, 4zzgE, 0.8638, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1924, 4y6aQ, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1925, 4y6aC, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1926, 4qwsQ, 0.8638, 1.57, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1927, 4qbyR, 0.8638, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1928, 4qbyD, 0.8638, 1.43, 0.332, 236, 226, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1929, 4nnnQ, 0.8638, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH MG132
1930, 4ltcC, 0.8638, 1.57, 0.367, 240, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1931, 4j70Q, 0.8638, 1.58, 0.362, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1932, 4gk7Q, 0.8638, 1.62, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1933, 4gk7C, 0.8638, 1.62, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1934, 3un4Q, 0.8638, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1935, 3un4C, 0.8638, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1936, 2fakQ, 0.8638, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1937, 2fakC, 0.8638, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1938, 2f16C, 0.8638, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1939, 1g65Q, 0.8638, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1940, 5l69Q, 0.8637, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1941, 5l69C, 0.8637, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1942, 5l5pQ, 0.8637, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1943, 5l5pC, 0.8637, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1944, 5l5jQ, 0.8637, 1.58, 0.362, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1945, 5l5jC, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1946, 5l54Q, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1947, 5l54C, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1948, 5ahjQ, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1949, 5ahjC, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1950, 4y8oQ, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1951, 4y8oC, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1952, 4y82C, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1953, 4y77Q, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1954, 4y77C, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1955, 4nnnC, 0.8637, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH MG132
1956, 4ltcQ, 0.8637, 1.58, 0.367, 240, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1957, 4jsuQ, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1958, 4jsuC, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1959, 4intC, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1960, 4hrdC, 0.8637, 1.58, 0.367, 240, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1961, 3uneC, 0.8637, 1.58, 0.367, 241, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
1962, 2f16Q, 0.8637, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1963, 5l6aQ, 0.8636, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1964, 5l6aC, 0.8636, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1965, 5l68Q, 0.8636, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1966, 5l68C, 0.8636, 1.58, 0.336, 239, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1967, 5l5oQ, 0.8636, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1968, 5l5oC, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1969, 4y8tQ, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1970, 4y8tC, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1971, 4y82Q, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1972, 3mg8Q, 0.8636, 1.58, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1973, 1z7qQ, 0.8636, 1.58, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1974, 1z7qC, 0.8636, 1.58, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1975, 5l5aQ, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1976, 5l5aC, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1977, 4y81Q, 0.8635, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1978, 4y81C, 0.8635, 1.88, 0.355, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1979, 4y75Q, 0.8635, 1.88, 0.355, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1980, 4y75C, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1981, 4r17C, 0.8635, 1.58, 0.367, 240, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1982, 4qltQ, 0.8635, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1983, 4qltC, 0.8635, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1984, 4no6Q, 0.8635, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1985, 4no6C, 0.8635, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1986, 4jt0Q, 0.8635, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1987, 4jt0C, 0.8635, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1988, 4inuC, 0.8635, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1989, 4intQ, 0.8635, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1990, 3wxrD, 0.8635, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1991, 1fntC, 0.8635, 1.59, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1992, 5m2bQ, 0.8634, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1993, 5m2bC, 0.8634, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1994, 5laiQ, 0.8634, 1.58, 0.367, 241, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1995, 5laiC, 0.8634, 1.60, 0.362, 241, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1996, 5l5rQ, 0.8634, 2.02, 0.358, 241, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1997, 5l5rC, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1998, 5l5dQ, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1999, 5l5dC, 0.8634, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2000, 5l5bQ, 0.8634, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2001, 5ahjR, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2002, 5ahjD, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2003, 4y74Q, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2004, 4y74C, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2005, 4r17Q, 0.8634, 1.58, 0.367, 240, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2006, 4jsqQ, 0.8634, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2007, 4jsqC, 0.8634, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2008, 4inuQ, 0.8634, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2009, 3oevP, 0.8634, 1.59, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2010, 1fntQ, 0.8634, 1.57, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2011, 5l5bC, 0.8633, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2012, 4y8kQ, 0.8633, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2013, 4y8kC, 0.8633, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2014, 4qlsQ, 0.8633, 1.84, 0.357, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2015, 4qlsC, 0.8633, 2.02, 0.358, 241, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2016, 4qbyQ, 0.8633, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2017, 4qbyC, 0.8633, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2018, 3unee, 0.8633, 1.59, 0.367, 240, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
2019, 3okjQ, 0.8633, 1.59, 0.367, 240, 229, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2020, 3okjC, 0.8633, 1.59, 0.367, 240, 229, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2021, 4no9Q, 0.8632, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2022, 4no9C, 0.8632, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2023, 4hrcQ, 0.8632, 1.58, 0.341, 239, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2024, 3oevQ, 0.8632, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2025, 3oeuB, 0.8632, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2026, 3mg7C, 0.8632, 1.59, 0.362, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2027, 2gplC, 0.8632, 1.59, 0.362, 240, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2028, 4y8hQ, 0.8631, 1.59, 0.362, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2029, 4y8hC, 0.8631, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2030, 4y84Q, 0.8631, 1.76, 0.365, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2031, 4y6zQ, 0.8631, 1.60, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2032, 4y6zC, 0.8631, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2033, 4qlqC, 0.8631, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2034, 4hnpQ, 0.8631, 1.59, 0.367, 240, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2035, 3mg7P, 0.8631, 1.59, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2036, 3mg6Q, 0.8631, 1.59, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2037, 3mg6P, 0.8631, 1.59, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2038, 2gplQ, 0.8631, 1.59, 0.367, 240, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2039, 4y8gQ, 0.8630, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2040, 4y8gC, 0.8630, 1.85, 0.357, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2041, 4y84C, 0.8630, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2042, 4r02Q, 0.8630, 1.86, 0.357, 235, 230, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2043, 4qlqQ, 0.8630, 1.58, 0.367, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2044, 4no1Q, 0.8630, 1.60, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2045, 4no1C, 0.8630, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2046, 3sdkQ, 0.8630, 1.59, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2047, 4qwgQ, 0.8629, 1.59, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2048, 4qwgC, 0.8629, 1.59, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2049, 4qluC, 0.8629, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2050, 4hrdQ, 0.8629, 1.59, 0.367, 240, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2051, 3mg4Q, 0.8629, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2052, 1jd2D, 0.8629, 1.59, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2053, 4qluQ, 0.8628, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2054, 3sdiP, 0.8628, 1.60, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2055, 5vfqB, 0.8627, 1.60, 0.367, 241, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2056, 5mpad, 0.8627, 1.59, 0.367, 241, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2057, 3oeuQ, 0.8627, 1.52, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2058, 1fntS, 0.8626, 1.60, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2059, 4qlvQ, 0.8625, 1.86, 0.357, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2060, 4qlvC, 0.8625, 1.36, 0.609, 230, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2061, 4no8Q, 0.8625, 2.20, 0.352, 250, 233, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2062, 4no8C, 0.8625, 1.59, 0.362, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2063, 3mg4C, 0.8625, 1.60, 0.367, 241, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2064, 3mg8P, 0.8624, 1.58, 0.330, 244, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2065, 1jd2Y, 0.8624, 1.61, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2066, 1g0uP, 0.8624, 1.61, 0.367, 240, 229, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2067, 1fntE, 0.8624, 1.60, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2068, 5l4gR, 0.8623, 1.60, 0.367, 240, 229, 
2069, 4r3oS, 0.8623, 1.60, 0.367, 241, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
2070, 4r3oE, 0.8623, 1.87, 0.357, 235, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
2071, 3mg8B, 0.8623, 1.52, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2072, 1jd2C, 0.8623, 1.86, 0.357, 235, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2073, 5l4gD, 0.8622, 1.59, 0.330, 244, 227, 
2074, 4nnwQ, 0.8622, 1.62, 0.341, 243, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2075, 4nnwC, 0.8622, 1.74, 0.322, 234, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2076, 3unes, 0.8622, 1.74, 0.322, 234, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
2077, 1z7qS, 0.8622, 1.80, 0.365, 235, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2078, 1z7qE, 0.8622, 1.59, 0.362, 241, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2079, 1jd2X, 0.8622, 1.61, 0.332, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2080, 5m32P, 0.8621, 1.60, 0.367, 240, 229, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2081, 3sdkP, 0.8621, 1.60, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2082, 3mg7Q, 0.8621, 1.59, 0.341, 239, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2083, 3mg7B, 0.8620, 1.55, 0.330, 245, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2084, 4g4sC, 0.8619, 1.55, 0.330, 245, 227, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2085, 3oevB, 0.8617, 1.59, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2086, 3mg6B, 0.8617, 2.06, 0.356, 244, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2087, 3sdkB, 0.8616, 1.89, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2088, 5mp9d, 0.8615, 1.60, 0.367, 241, 229, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2089, 3jcpMA, 0.8614, 1.80, 0.365, 235, 230, 
2090, 3jcpM, 0.8614, 1.87, 0.357, 237, 230, 
2091, 1iruR, 0.8613, 1.81, 0.361, 235, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2092, 1iruD, 0.8613, 1.83, 0.361, 235, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2093, 4r67u, 0.8612, 1.81, 0.361, 235, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2094, 4r67S, 0.8612, 1.61, 0.362, 240, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2095, 4r67g, 0.8612, 1.60, 0.367, 241, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2096, 5vfoH, 0.8611, 1.60, 0.367, 241, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2097, 5gjqk, 0.8611, 1.60, 0.367, 241, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2098, 4r67E, 0.8611, 1.61, 0.336, 243, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2099, 1g0uB, 0.8611, 1.61, 0.336, 243, 229, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2100, 5mpac, 0.8610, 1.77, 0.326, 234, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2101, 6avoN, 0.8609, 1.77, 0.326, 234, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2102, 5mp9D, 0.8608, 1.77, 0.326, 234, 227, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2103, 5gjrW, 0.8608, 1.39, 0.609, 230, 225, 
2104, 5gjrKA, 0.8608, 1.62, 0.336, 243, 229, 
2105, 1iruS, 0.8607, 1.77, 0.326, 234, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2106, 1iruE, 0.8607, 1.88, 0.357, 235, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2107, 5wvkY, 0.8606, 2.21, 0.355, 244, 234, 
2108, 5vfpB, 0.8605, 1.61, 0.336, 232, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2109, 5vfrH, 0.8604, 1.63, 0.362, 240, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2110, 5lf6Q, 0.8603, 1.76, 0.322, 234, 227, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2111, 5lexR, 0.8603, 1.78, 0.322, 234, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2112, 3wxrR, 0.8603, 1.77, 0.322, 234, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2113, 3jcoLA, 0.8602, 1.77, 0.322, 234, 227, 
2114, 3jcoL, 0.8602, 1.58, 0.362, 241, 229, 
2115, 5lf1Q, 0.8601, 1.41, 0.609, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2116, 6avoI, 0.8599, 1.93, 0.336, 239, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2117, 5lf4Q, 0.8599, 1.40, 0.609, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2118, 5le5R, 0.8598, 1.59, 0.338, 238, 228, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2119, 5gjql, 0.8598, 1.75, 0.326, 233, 227, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2120, 4g4sE, 0.8598, 1.67, 0.367, 241, 229, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2121, 5mp9E, 0.8597, 2.27, 0.362, 244, 235, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2122, 5lf0Q, 0.8597, 2.27, 0.362, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2123, 5lexD, 0.8597, 2.27, 0.362, 244, 235, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2124, 3uneD, 0.8597, 1.59, 0.338, 238, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2125, 5gjqF, 0.8596, 1.63, 0.336, 232, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2126, 5lf7Q, 0.8594, 1.60, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2127, 5leyQ, 0.8594, 1.59, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2128, 3unbD, 0.8594, 1.60, 0.323, 234, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2129, 3sdiB, 0.8594, 1.57, 0.330, 249, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2130, 5lf3Q, 0.8592, 1.65, 0.330, 242, 227, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2131, 3sdkD, 0.8591, 1.60, 0.338, 238, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2132, 3uneR, 0.8590, 1.77, 0.326, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
2133, 5mp9e, 0.8589, 1.62, 0.327, 233, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2134, 5lf6R, 0.8589, 1.61, 0.323, 234, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2135, 5l4gE, 0.8589, 1.60, 0.338, 238, 228, 
2136, 3unhR, 0.8589, 1.61, 0.338, 239, 228, MOUSE 20S IMMUNOPROTEASOME
2137, 3unhD, 0.8589, 1.61, 0.323, 233, 226, MOUSE 20S IMMUNOPROTEASOME
2138, 3unfR, 0.8589, 1.95, 0.357, 235, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2139, 5mpaE, 0.8588, 1.61, 0.338, 238, 228, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2140, 5lf1R, 0.8588, 1.36, 0.335, 233, 224, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2141, 5lezD, 0.8588, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2142, 3unfD, 0.8588, 1.61, 0.330, 242, 227, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2143, 3unet, 0.8588, 1.61, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2144, 5lezR, 0.8587, 1.81, 0.326, 234, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2145, 5l4gS, 0.8587, 1.60, 0.327, 233, 226, 
2146, 3unbf, 0.8587, 1.60, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2147, 3jcpNA, 0.8587, 1.60, 0.327, 233, 226, 
2148, 3jcpN, 0.8587, 1.59, 0.330, 242, 227, 
2149, 5le5D, 0.8586, 1.61, 0.327, 233, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2150, 5lf3R, 0.8585, 1.78, 0.326, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2151, 3unef, 0.8584, 1.60, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2152, 5lf6D, 0.8583, 1.81, 0.326, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2153, 3unbR, 0.8583, 1.78, 0.326, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2154, 5lf7R, 0.8582, 1.63, 0.327, 234, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2155, 5lf7D, 0.8581, 1.62, 0.323, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2156, 5lf4R, 0.8581, 1.57, 0.330, 242, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2157, 5lf3D, 0.8581, 1.57, 0.330, 242, 227, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2158, 5lf0R, 0.8581, 1.57, 0.330, 242, 227, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2159, 5lf1D, 0.8580, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2160, 5leyR, 0.8578, 1.61, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2161, 5lf0D, 0.8577, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2162, 5leyD, 0.8577, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2163, 6avoM, 0.8576, 1.81, 0.326, 233, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2164, 3unbt, 0.8575, 1.62, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2165, 6avoH, 0.8574, 1.62, 0.327, 233, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2166, 3sdkR, 0.8574, 1.62, 0.327, 233, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2167, 5lf4D, 0.8573, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2168, 1j2qB, 0.8573, 1.61, 0.327, 233, 226, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2169, 1g0uD, 0.8573, 1.62, 0.327, 233, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2170, 3jcoMA, 0.8572, 1.62, 0.327, 233, 226, 
2171, 3jcoM, 0.8572, 1.62, 0.327, 233, 226, 
2172, 1j2qD, 0.8569, 1.62, 0.327, 233, 226, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2173, 1j2qF, 0.8568, 1.60, 0.327, 233, 226, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2174, 1j2qC, 0.8568, 1.82, 0.326, 233, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2175, 1j2qA, 0.8568, 1.61, 0.327, 233, 226, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2176, 1j2qG, 0.8567, 1.29, 0.336, 232, 223, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2177, 1j2qE, 0.8567, 1.63, 0.327, 233, 226, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2178, 1g0uR, 0.8565, 1.70, 0.388, 237, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2179, 5mpcC, 0.8559, 1.24, 0.341, 230, 223, 
2180, 5mpae, 0.8559, 1.67, 0.362, 241, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2181, 5m32C, 0.8557, 1.67, 0.362, 241, 229, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2182, 4cr2C, 0.8557, 1.67, 0.362, 241, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2183, 3sdiR, 0.8556, 1.71, 0.388, 237, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2184, 3sdiC, 0.8555, 1.71, 0.388, 237, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2185, 5mpaD, 0.8551, 1.71, 0.388, 237, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2186, 1g0uC, 0.8548, 1.71, 0.388, 237, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2187, 5wvkR, 0.8546, 1.71, 0.388, 237, 227, 
2188, 5mpbQ, 0.8545, 1.71, 0.388, 237, 227, 
2189, 5wvkZ, 0.8543, 1.26, 0.341, 230, 223, 
2190, 5l4gA, 0.8541, 2.14, 0.352, 244, 233, 
2191, 5gjqB, 0.8540, 1.74, 0.330, 242, 227, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2192, 1g0uQ, 0.8540, 1.77, 0.341, 234, 229, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2193, 5gjrS, 0.8539, 2.23, 0.362, 245, 235, 
2194, 5gjrGA, 0.8538, 1.20, 0.338, 229, 222, 
2195, 5gjqh, 0.8535, 1.53, 0.367, 238, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2196, 3sdiQ, 0.8535, 1.74, 0.362, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2197, 5l4gO, 0.8532, 1.54, 0.367, 238, 226, 
2198, 3jcoNA, 0.8530, 1.75, 0.358, 241, 229, 
2199, 3jcoN, 0.8530, 2.10, 0.352, 244, 233, 
2200, 3unbG, 0.8529, 1.70, 0.330, 242, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2201, 5m32Q, 0.8528, 1.78, 0.360, 244, 228, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2202, 3sdiD, 0.8523, 1.81, 0.360, 244, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2203, 5vfoi, 0.8522, 1.55, 0.367, 238, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2204, 5vfpAA, 0.8521, 1.81, 0.360, 244, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2205, 5mpbS, 0.8520, 1.80, 0.360, 244, 228, 
2206, 3unbw, 0.8520, 1.78, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2207, 3unbU, 0.8520, 1.56, 0.367, 238, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2208, 3unbi, 0.8519, 1.78, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2209, 6epcB, 0.8518, 1.65, 0.330, 242, 227, GROUND STATE 26S PROTEASOME (GS2)
2210, 3unhU, 0.8517, 1.65, 0.330, 242, 227, MOUSE 20S IMMUNOPROTEASOME
2211, 3unhG, 0.8517, 1.65, 0.330, 242, 227, MOUSE 20S IMMUNOPROTEASOME
2212, 4cr4C, 0.8516, 1.81, 0.360, 243, 228, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2213, 3unfU, 0.8515, 1.80, 0.341, 235, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2214, 3unfG, 0.8515, 1.19, 0.339, 228, 221, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2215, 5a0qQ, 0.8514, 2.18, 0.352, 250, 233, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2216, 5a0qC, 0.8514, 2.20, 0.352, 250, 233, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2217, 4v7oYA, 0.8514, 1.94, 0.325, 242, 228, 
2218, 4v7oQ, 0.8514, 1.83, 0.360, 243, 228, 
2219, 4cr2E, 0.8514, 1.82, 0.360, 243, 228, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2220, 4v7oKA, 0.8513, 1.83, 0.360, 243, 228, 
2221, 4v7oC, 0.8513, 1.93, 0.608, 234, 232, 
2222, 5vfqBA, 0.8512, 1.82, 0.360, 243, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2223, 3uneG, 0.8509, 1.82, 0.360, 243, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2224, 4r3oO, 0.8507, 2.39, 0.357, 245, 235, HUMAN CONSTITUTIVE 20S PROTEASOME
2225, 5vfsC, 0.8506, 1.82, 0.360, 243, 228, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2226, 1iruO, 0.8506, 1.82, 0.360, 243, 228, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2227, 4r3oA, 0.8505, 1.96, 0.368, 237, 228, HUMAN CONSTITUTIVE 20S PROTEASOME
2228, 1iruA, 0.8505, 1.96, 0.368, 237, 228, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2229, 5vfqC, 0.8504, 1.87, 0.357, 232, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2230, 5vfoI, 0.8504, 1.87, 0.357, 232, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2231, 5vfsD, 0.8503, 1.92, 0.329, 243, 228, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2232, 4r67q, 0.8503, 1.88, 0.357, 232, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2233, 4r67O, 0.8503, 1.88, 0.357, 232, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2234, 4r67c, 0.8503, 1.93, 0.341, 244, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2235, 4r67A, 0.8503, 2.20, 0.352, 250, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2236, 5vfri, 0.8502, 1.83, 0.360, 244, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2237, 5a5bC, 0.8500, 1.85, 0.360, 244, 228, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2238, 4cr3C, 0.8500, 2.22, 0.352, 250, 233, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2239, 5wvkS, 0.8499, 1.82, 0.336, 239, 229, 
2240, 3uneU, 0.8498, 1.86, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2241, 5vfrI, 0.8495, 1.86, 0.360, 244, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2242, 5a5bD, 0.8495, 1.86, 0.360, 244, 228, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2243, 4cr3D, 0.8495, 1.86, 0.352, 248, 230, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2244, 3unew, 0.8495, 1.94, 0.336, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
2245, 5vfsBA, 0.8494, 1.86, 0.352, 248, 230, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2246, 5ln3E, 0.8494, 1.78, 0.341, 239, 229, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2247, 5gjqn, 0.8492, 1.56, 0.326, 228, 224, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2248, 3unei, 0.8490, 1.85, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2249, 5vfpC, 0.8489, 1.85, 0.360, 244, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2250, 4v7oE, 0.8488, 1.85, 0.360, 244, 228, 
2251, 4v7oAB, 0.8488, 1.85, 0.360, 244, 228, 
2252, 4cr2D, 0.8488, 2.21, 0.352, 250, 233, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2253, 4v7oMA, 0.8487, 2.34, 0.362, 245, 235, 
2254, 4v7oS, 0.8486, 2.34, 0.362, 245, 235, 
2255, 5mpbC, 0.8485, 1.73, 0.330, 242, 227, 
2256, 5vfuU, 0.8483, 1.84, 0.360, 244, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2257, 5vftJ, 0.8483, 1.86, 0.352, 248, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2258, 5gjrMA, 0.8482, 1.80, 0.358, 242, 229, 
2259, 5gjrY, 0.8480, 1.80, 0.358, 242, 229, 
2260, 5vfuT, 0.8478, 1.85, 0.360, 244, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2261, 5vftI, 0.8478, 2.23, 0.352, 250, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2262, 6avoQ, 0.8477, 1.66, 0.327, 232, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2263, 6avoJ, 0.8477, 1.84, 0.295, 243, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2264, 5vfrK, 0.8474, 1.86, 0.360, 244, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2265, 5vfok, 0.8473, 1.87, 0.352, 248, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2266, 5vfsCA, 0.8472, 1.59, 0.321, 228, 224, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2267, 1j2pF, 0.8472, 1.86, 0.330, 250, 227, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2268, 5l4gU, 0.8471, 1.86, 0.330, 250, 227, 
2269, 3uneF, 0.8471, 1.77, 0.362, 242, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
2270, 1j2pG, 0.8470, 1.86, 0.330, 250, 227, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2271, 1j2pE, 0.8470, 1.86, 0.330, 250, 227, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2272, 1j2pD, 0.8470, 2.35, 0.359, 244, 234, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2273, 1j2pC, 0.8470, 1.81, 0.336, 239, 229, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2274, 1j2pA, 0.8470, 1.81, 0.336, 239, 229, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2275, 5mpcQ, 0.8469, 1.70, 0.296, 243, 226, 
2276, 1j2pB, 0.8469, 1.70, 0.296, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2277, 5vfqDA, 0.8468, 2.26, 0.352, 250, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2278, 5vfsDA, 0.8467, 2.26, 0.352, 250, 233, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2279, 5vfrk, 0.8467, 1.71, 0.296, 239, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2280, 3unbT, 0.8467, 1.71, 0.296, 239, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2281, 5vfqE, 0.8466, 1.55, 0.321, 228, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2282, 5l4gG, 0.8466, 1.57, 0.321, 228, 224, 
2283, 3unbv, 0.8466, 1.82, 0.336, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2284, 5vfsE, 0.8465, 1.72, 0.381, 243, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2285, 5t0cU, 0.8465, 1.86, 0.295, 241, 227, 
2286, 5t0cAB, 0.8465, 1.73, 0.296, 244, 226, 
2287, 3unev, 0.8464, 1.72, 0.381, 243, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2288, 3uneh, 0.8464, 1.72, 0.381, 243, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2289, 5vfpE, 0.8462, 1.72, 0.381, 243, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2290, 5vfoK, 0.8462, 1.72, 0.381, 243, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2291, 5vfpCA, 0.8460, 1.72, 0.381, 243, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2292, 2ku2A, 0.8460, 2.28, 0.356, 244, 233, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2293, 5t0cV, 0.8459, 1.72, 0.381, 243, 226, 
2294, 5t0cBB, 0.8459, 1.57, 0.321, 228, 224, 
2295, 5lf3F, 0.8457, 1.56, 0.326, 228, 224, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2296, 5lexT, 0.8457, 1.57, 0.321, 228, 224, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2297, 5lexF, 0.8456, 1.74, 0.296, 244, 226, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2298, 5gjqX, 0.8456, 1.56, 0.321, 228, 224, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2299, 5le5F, 0.8455, 1.73, 0.317, 238, 224, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2300, 5vfuHA, 0.8454, 2.14, 0.284, 242, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2301, 5vfti, 0.8454, 1.74, 0.296, 244, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2302, 5lf7F, 0.8454, 1.70, 0.324, 228, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2303, 5lf1F, 0.8454, 1.72, 0.317, 238, 224, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2304, 3unbF, 0.8454, 2.25, 0.352, 250, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2305, 5lf4F, 0.8453, 2.25, 0.352, 250, 233, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2306, 5lf0F, 0.8453, 1.75, 0.296, 244, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2307, 5lezT, 0.8453, 1.74, 0.296, 244, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2308, 5lezF, 0.8453, 1.57, 0.321, 228, 224, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2309, 5leyF, 0.8453, 1.90, 0.292, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2310, 2ku1A, 0.8452, 1.70, 0.320, 228, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2311, 5lf6F, 0.8451, 1.59, 0.321, 228, 224, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2312, 5lf1T, 0.8451, 1.85, 0.390, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2313, 5le5T, 0.8451, 1.83, 0.336, 239, 229, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2314, 5lf6T, 0.8449, 1.83, 0.336, 239, 229, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2315, 4r3oG, 0.8449, 1.74, 0.296, 239, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
2316, 5lf7T, 0.8448, 1.74, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2317, 5lf3T, 0.8448, 1.74, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2318, 5lf0T, 0.8447, 1.85, 0.288, 243, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2319, 4r3oU, 0.8447, 1.75, 0.296, 239, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
2320, 5lf4T, 0.8446, 2.29, 0.352, 250, 233, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2321, 5leyT, 0.8446, 2.29, 0.352, 250, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2322, 5mpcS, 0.8444, 1.75, 0.296, 239, 226, 
2323, 5m32R, 0.8442, 1.75, 0.296, 239, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2324, 5m32D, 0.8441, 1.76, 0.296, 244, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2325, 5vfsA, 0.8439, 1.75, 0.296, 239, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2326, 5lezQ, 0.8439, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2327, 5lexQ, 0.8439, 1.74, 0.296, 240, 226, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2328, 5wvkQ, 0.8438, 1.74, 0.296, 239, 226, 
2329, 5vfsZ, 0.8438, 1.75, 0.296, 239, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2330, 5mpbE, 0.8438, 1.94, 0.395, 237, 228, 
2331, 5le5Q, 0.8438, 1.76, 0.296, 239, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2332, 4r67w, 0.8438, 1.75, 0.296, 240, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2333, 4r67U, 0.8438, 1.75, 0.296, 240, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2334, 4r67i, 0.8438, 1.75, 0.296, 240, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2335, 4r67G, 0.8437, 1.88, 0.288, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2336, 1iruU, 0.8437, 1.75, 0.296, 240, 226, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2337, 1iruG, 0.8437, 1.75, 0.296, 240, 226, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2338, 5vfrG, 0.8436, 1.75, 0.296, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2339, 3h4pH, 0.8435, 1.88, 0.288, 245, 226, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2340, 3h4pD, 0.8435, 1.76, 0.296, 240, 226, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2341, 5vftK, 0.8434, 1.76, 0.296, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2342, 5m32U, 0.8433, 1.90, 0.335, 242, 227, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2343, 3uneT, 0.8433, 1.93, 0.310, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2344, 3h4pJ, 0.8432, 1.93, 0.310, 233, 226, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2345, 5vfoG, 0.8431, 1.19, 0.610, 232, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2346, 3h4pF, 0.8431, 1.93, 0.360, 240, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2347, 5wvkX, 0.8430, 1.55, 0.345, 234, 223, 
2348, 5vfuV, 0.8430, 1.55, 0.345, 233, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2349, 4cr4E, 0.8430, 2.52, 0.357, 244, 235, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2350, 3unhF, 0.8430, 1.93, 0.360, 240, 228, MOUSE 20S IMMUNOPROTEASOME
2351, 3h4pA, 0.8430, 1.86, 0.330, 242, 227, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2352, 5vftk, 0.8429, 1.55, 0.345, 233, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2353, 3unhT, 0.8429, 1.89, 0.288, 245, 226, MOUSE 20S IMMUNOPROTEASOME
2354, 3unbh, 0.8429, 1.89, 0.288, 245, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2355, 3h4pI, 0.8429, 1.89, 0.288, 245, 226, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2356, 5t0cYA, 0.8428, 1.89, 0.288, 245, 226, 
2357, 5t0cS, 0.8428, 1.78, 0.296, 245, 226, 
2358, 5vfog, 0.8427, 1.78, 0.296, 245, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2359, 3h4pN, 0.8425, 1.92, 0.360, 239, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2360, 3h4pE, 0.8425, 1.68, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2361, 3h4pC, 0.8425, 1.68, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2362, 3h4pL, 0.8424, 1.76, 0.329, 228, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2363, 6avoR, 0.8423, 1.84, 0.361, 241, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2364, 5vfqA, 0.8423, 1.92, 0.288, 244, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2365, 3unfT, 0.8423, 1.68, 0.364, 232, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2366, 3unfF, 0.8423, 1.93, 0.360, 239, 228, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2367, 3h4pB, 0.8423, 1.68, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2368, 3h4pM, 0.8422, 2.43, 0.361, 244, 233, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2369, 3h4pK, 0.8422, 1.77, 0.329, 228, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2370, 1z7qD, 0.8422, 1.83, 0.330, 243, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2371, 5vfqZ, 0.8421, 1.92, 0.288, 244, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2372, 5mpcE, 0.8421, 1.68, 0.364, 232, 225, 
2373, 1z7qR, 0.8421, 1.63, 0.326, 228, 224, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2374, 3h4pG, 0.8419, 1.92, 0.288, 244, 226, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2375, 5t0cW, 0.8418, 1.91, 0.288, 244, 226, 
2376, 5t0cCB, 0.8418, 1.69, 0.364, 232, 225, 
2377, 5dsvL, 0.8417, 1.94, 0.360, 240, 228, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2378, 5dsvF, 0.8417, 1.94, 0.360, 240, 228, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2379, 5vfpA, 0.8416, 1.93, 0.360, 240, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2380, 5l63T, 0.8416, 1.69, 0.364, 232, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2381, 5l63F, 0.8416, 1.70, 0.364, 232, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2382, 3sdiF, 0.8416, 1.69, 0.364, 232, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2383, 5t0gI, 0.8415, 1.69, 0.364, 232, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2384, 5m2bT, 0.8415, 1.94, 0.363, 240, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2385, 5m2bF, 0.8415, 1.21, 0.606, 232, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2386, 5dsvB, 0.8415, 1.93, 0.360, 239, 228, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2387, 5dsvA, 0.8415, 1.92, 0.288, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2388, 5vfuR, 0.8414, 1.92, 0.288, 244, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2389, 5l6aT, 0.8414, 1.70, 0.364, 232, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2390, 5l6aF, 0.8414, 1.70, 0.364, 232, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2391, 5l64T, 0.8414, 1.70, 0.364, 232, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2392, 5l64F, 0.8414, 1.80, 0.360, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2393, 5l61T, 0.8414, 1.94, 0.360, 240, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2394, 5l61F, 0.8414, 2.00, 0.329, 242, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2395, 5l5rT, 0.8414, 1.80, 0.360, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2396, 5l5rF, 0.8414, 1.70, 0.364, 232, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2397, 5l5dT, 0.8414, 1.77, 0.329, 228, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2398, 5l5dF, 0.8414, 1.77, 0.329, 228, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2399, 4r18F, 0.8414, 1.80, 0.296, 245, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2400, 6avoK, 0.8413, 1.80, 0.296, 244, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2401, 5vfuJA, 0.8413, 2.20, 0.352, 250, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2402, 5vftG, 0.8413, 1.94, 0.360, 239, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2403, 5l69T, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2404, 5l69F, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2405, 5l66T, 0.8413, 2.03, 0.335, 242, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2406, 5l66F, 0.8413, 2.31, 0.352, 250, 233, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2407, 5l65F, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2408, 5l5wT, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2409, 5l5wF, 0.8413, 1.81, 0.296, 245, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2410, 5dsvN, 0.8413, 1.80, 0.296, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2411, 5dsvI, 0.8413, 1.97, 0.360, 240, 228, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2412, 4r18T, 0.8413, 1.88, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2413, 5vfrg, 0.8412, 1.88, 0.336, 243, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2414, 5vfoj, 0.8412, 1.88, 0.336, 243, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2415, 5l65T, 0.8412, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2416, 5l62T, 0.8412, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2417, 5l62F, 0.8412, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2418, 5l5hT, 0.8412, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2419, 5l5hF, 0.8412, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2420, 4qv6F, 0.8412, 1.88, 0.336, 243, 226, YCP BETA5-A49V MUTANT
2421, 1fntD, 0.8412, 1.88, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2422, 5l6cT, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2423, 5l6cF, 0.8411, 1.95, 0.363, 240, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2424, 5l5zT, 0.8411, 1.67, 0.326, 228, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2425, 5l5zF, 0.8411, 1.97, 0.360, 240, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2426, 5l5yT, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2427, 5l5yF, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2428, 5l5uT, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2429, 5l5uF, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2430, 5l5tF, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2431, 5l5sT, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2432, 5l5sF, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2433, 5l5pT, 0.8411, 1.81, 0.296, 244, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2434, 5l5pF, 0.8411, 1.81, 0.296, 244, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2435, 5l5jT, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2436, 5l5jF, 0.8411, 1.95, 0.360, 240, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2437, 5bxnT, 0.8411, 1.90, 0.336, 239, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2438, 5bxnF, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2439, 4qvnT, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2440, 4qvnF, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2441, 4qv6T, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-A49V MUTANT
2442, 1fntR, 0.8411, 1.88, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2443, 5l6bT, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2444, 5l6bF, 0.8410, 1.78, 0.364, 239, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2445, 5l60T, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2446, 5l60F, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2447, 5l5tT, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2448, 5l5qT, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2449, 5l5qF, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2450, 5l5oT, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2451, 5l5oF, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2452, 5l5iT, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2453, 5l5iF, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2454, 5l5bT, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2455, 5l5bF, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2456, 5dsvK, 0.8410, 1.88, 0.336, 243, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2457, 4y8tT, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2458, 4y8tF, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2459, 4r02T, 0.8410, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2460, 4r02F, 0.8410, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2461, 5l68T, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2462, 5l68F, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2463, 5l67T, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2464, 5l67F, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2465, 5l5xT, 0.8409, 1.78, 0.364, 239, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2466, 5l5xF, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2467, 5l5fT, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2468, 5l5fF, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2469, 5dsvE, 0.8409, 1.88, 0.336, 243, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2470, 4qvyT, 0.8409, 1.88, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2471, 4qvyF, 0.8409, 1.88, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2472, 5lajT, 0.8408, 1.88, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2473, 5lajF, 0.8408, 1.88, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2474, 5l5vT, 0.8408, 1.88, 0.336, 243, 226,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2475, 5l5vF, 0.8408, 1.88, 0.336, 243, 226,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2476, 5l5aT, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2477, 5l5aF, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2478, 5cz6T, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2479, 5cz6F, 0.8408, 1.81, 0.296, 244, 226, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2480, 5bxlF, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2481, 4ya4T, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2482, 4ya4F, 0.8408, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2483, 4qvwT, 0.8408, 1.89, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2484, 4qvwF, 0.8408, 1.89, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2485, 4qvlT, 0.8408, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH BORTEZOMIB
2486, 4qvlF, 0.8408, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH BORTEZOMIB
2487, 5l5eT, 0.8407, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2488, 5l5eF, 0.8407, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2489, 5dsvD, 0.8407, 1.88, 0.336, 243, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2490, 5bxlT, 0.8407, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2491, 5bouT, 0.8407, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2492, 5bouF, 0.8407, 1.81, 0.296, 245, 226, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2493, 4ya9T, 0.8407, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2494, 4ya9F, 0.8407, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2495, 4nnwT, 0.8407, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2496, 4nnwF, 0.8407, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2497, 4hnpF, 0.8407, 1.89, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2498, 4r17T, 0.8406, 1.89, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2499, 4r17F, 0.8406, 1.88, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2500, 4qzzT, 0.8406, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH OMURALIDE
2501, 4qzzF, 0.8406, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH OMURALIDE
2502, 4qw1T, 0.8406, 1.88, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2503, 4qw1F, 0.8406, 1.88, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2504, 4qvpT, 0.8406, 1.88, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2505, 4qvpF, 0.8406, 1.88, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2506, 6gopT, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2507, 6gopF, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2508, 5mp9g, 0.8405, 1.88, 0.336, 243, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2509, 5lttT, 0.8405, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2510, 5lttF, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2511, 5fggT, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2512, 5fggF, 0.8405, 1.81, 0.296, 244, 226, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2513, 5dsvG, 0.8405, 1.88, 0.336, 243, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2514, 5d0wT, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2515, 5d0wF, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2516, 5czaT, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2517, 5czaF, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2518, 5cz7T, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2519, 5cz7F, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2520, 5cghT, 0.8405, 1.88, 0.332, 244, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2521, 5cghF, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2522, 4ya2T, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2523, 4ya2F, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2524, 4y8gT, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2525, 4y8gF, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2526, 4y75T, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2527, 4y75F, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2528, 4rurT, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2529, 4rurF, 0.8405, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2530, 4qz7T, 0.8405, 1.88, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2531, 4qz7F, 0.8405, 1.87, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2532, 4qvmT, 0.8405, 1.89, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2533, 4qvmF, 0.8405, 1.89, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2534, 5vfpY, 0.8404, 1.89, 0.336, 243, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2535, 4y9yT, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2536, 4y8rF, 0.8404, 1.82, 0.296, 242, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2537, 4y8pT, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2538, 4y8pF, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2539, 4y6vT, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2540, 4y6vF, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2541, 4qvqT, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2542, 4qvqF, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2543, 4qv1T, 0.8404, 1.90, 0.336, 243, 226, YCP BETA5-M45A MUTANT
2544, 4qv1F, 0.8404, 1.90, 0.336, 243, 226, YCP BETA5-M45A MUTANT
2545, 4quyT, 0.8404, 1.90, 0.336, 243, 226, YCP BETA5-A49S-MUTANT
2546, 4quyF, 0.8404, 1.90, 0.336, 243, 226, YCP BETA5-A49S-MUTANT
2547, 4quxT, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-A49T-MUTANT
2548, 4quxF, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-A49T-MUTANT
2549, 4qlsF, 0.8404, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2550, 4q1sF, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2551, 5fg9F, 0.8403, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2552, 5ahjT, 0.8403, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2553, 5ahjF, 0.8403, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2554, 4y9yF, 0.8403, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2555, 4y8rT, 0.8403, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2556, 4y8mT, 0.8403, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2557, 4y8mF, 0.8403, 1.97, 0.360, 240, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2558, 4y6aT, 0.8403, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2559, 4y6aF, 0.8403, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2560, 4qz4T, 0.8403, 1.90, 0.336, 243, 226, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2561, 4qz4F, 0.8403, 1.90, 0.336, 243, 226, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2562, 4qwuT, 0.8403, 1.89, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2563, 4qwuF, 0.8403, 1.89, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2564, 4qv4T, 0.8403, 1.89, 0.336, 243, 226, YCP BETA5-M45T MUTANT
2565, 4qv4F, 0.8403, 1.89, 0.336, 243, 226, YCP BETA5-M45T MUTANT
2566, 4qv0T, 0.8403, 1.89, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2567, 4qv0F, 0.8403, 1.89, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2568, 4qltT, 0.8403, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2569, 4qltF, 0.8403, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2570, 4qlsT, 0.8403, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2571, 5laiT, 0.8402, 1.89, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2572, 5laiF, 0.8402, 1.90, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2573, 5gjqm, 0.8402, 1.89, 0.332, 244, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2574, 5fgaT, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2575, 5fgaF, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2576, 5fg9T, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2577, 4ya1T, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2578, 4ya1F, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2579, 4y8uT, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2580, 4y8uF, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2581, 4y8sT, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2582, 4y8sF, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2583, 4y8nT, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2584, 4y8nF, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2585, 4y77T, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2586, 4y77F, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2587, 4qz6T, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2588, 4qz6F, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2589, 4qwfT, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2590, 4qwfF, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2591, 4qw6T, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2592, 4qw6F, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2593, 4qw0T, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2594, 4qw0F, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2595, 4qv8T, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-C52F MUTANT
2596, 4qv8F, 0.8402, 1.63, 0.317, 238, 224, YCP BETA5-C52F MUTANT
2597, 4qv5T, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-M45I MUTANT
2598, 4qv5F, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-M45I MUTANT
2599, 4qbyT, 0.8402, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2600, 4qbyF, 0.8402, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2601, 5jhrT, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2602, 5jhrF, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2603, 5fghT, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2604, 5fghF, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2605, 5fg7T, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2606, 5fg7F, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2607, 5dkjF, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2608, 5d0vT, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2609, 5d0vF, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2610, 5cz9F, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2611, 5cggT, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2612, 5cggF, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2613, 4ya7T, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2614, 4ya7F, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2615, 4ya5F, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2616, 4y84T, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2617, 4y84F, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2618, 4y69T, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2619, 4y69F, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2620, 4x6zU, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2621, 4x6zG, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2622, 4qwxT, 0.8401, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2623, 4qwxF, 0.8401, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2624, 4qv7T, 0.8401, 1.90, 0.336, 243, 226, YCP BETA5-A50V MUTANT
2625, 4qv7F, 0.8401, 1.90, 0.336, 243, 226, YCP BETA5-A50V MUTANT
2626, 4no1T, 0.8401, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2627, 4no1F, 0.8401, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2628, 3sdiT, 0.8401, 1.89, 0.336, 243, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2629, 5t0gK, 0.8400, 1.89, 0.336, 243, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2630, 5l54T, 0.8400, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2631, 5l54F, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2632, 5dkjT, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2633, 5d0tT, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2634, 5d0tF, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2635, 5cz9T, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2636, 4ya5T, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2637, 4y8hT, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2638, 4y8hF, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2639, 4y74T, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2640, 4y74F, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2641, 4qz0T, 0.8400, 1.90, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2642, 4qz0F, 0.8400, 1.90, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2643, 4qwlT, 0.8400, 1.90, 0.336, 244, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2644, 4qwlF, 0.8400, 1.90, 0.336, 244, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2645, 4qw7T, 0.8400, 1.90, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2646, 4qw7F, 0.8400, 1.90, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2647, 4qw5T, 0.8400, 1.89, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2648, 4qw5F, 0.8400, 1.89, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2649, 4qw4T, 0.8400, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH CARFILZOMIB
2650, 4qw4F, 0.8400, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH CARFILZOMIB
2651, 4qv9F, 0.8400, 1.90, 0.332, 242, 226, YCP BETA5-C63F MUTANT
2652, 4qluT, 0.8400, 1.93, 0.327, 228, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2653, 4qluF, 0.8400, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2654, 4qlqF, 0.8400, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2655, 4nnnT, 0.8400, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH MG132
2656, 4nnnF, 0.8400, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH MG132
2657, 3nzjT, 0.8400, 1.90, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2658, 3nzjF, 0.8400, 1.90, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2659, 1rypU, 0.8400, 1.90, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2660, 1rypG, 0.8400, 1.90, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2661, 5vfuIA, 0.8399, 1.90, 0.336, 243, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2662, 5vftj, 0.8399, 1.90, 0.336, 243, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2663, 5l55T, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2664, 5l55F, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2665, 5fgeT, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2666, 5fgeF, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2667, 5d0xT, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2668, 5d0xF, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2669, 5d0sT, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2670, 5d0sF, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2671, 4y9zT, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2672, 4y9zF, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2673, 4y8kT, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2674, 4y81T, 0.8399, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2675, 4y81F, 0.8399, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2676, 4qz1T, 0.8399, 1.90, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2677, 4qz1F, 0.8399, 1.90, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2678, 4qv9T, 0.8399, 1.90, 0.336, 243, 226, YCP BETA5-C63F MUTANT
2679, 4qlqT, 0.8399, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2680, 4no9T, 0.8399, 1.90, 0.332, 244, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2681, 4no9F, 0.8399, 1.90, 0.332, 244, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2682, 4hrdF, 0.8399, 1.89, 0.336, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2683, 2ku2B, 0.8399, 1.89, 0.336, 244, 226, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2684, 5t0hI, 0.8398, 1.93, 0.336, 239, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2685, 5mpbR, 0.8398, 1.93, 0.336, 239, 229, 
2686, 5jhsF, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2687, 5fgiT, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2688, 5fgiF, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2689, 5cgfT, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2690, 5cgfF, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2691, 4y8oT, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2692, 4y8oF, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2693, 4y8kF, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2694, 4y7xT, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2695, 4y7xF, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2696, 4y6zT, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2697, 4y6zF, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2698, 4qz5T, 0.8398, 1.91, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2699, 4qz5F, 0.8398, 1.91, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2700, 4qz3T, 0.8398, 1.91, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2701, 4qz3F, 0.8398, 1.90, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2702, 4qw3T, 0.8398, 1.90, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2703, 4qw3F, 0.8398, 1.91, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2704, 4j70F, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2705, 4fzgT, 0.8398, 1.90, 0.332, 244, 226, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2706, 4fzgF, 0.8398, 1.82, 0.394, 237, 226, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2707, 4cr4D, 0.8398, 2.31, 0.352, 250, 233, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2708, 5jhsT, 0.8397, 1.94, 0.362, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2709, 5fgfT, 0.8397, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2710, 5fgfF, 0.8397, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2711, 5d0zT, 0.8397, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2712, 5d0zF, 0.8397, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2713, 4y82T, 0.8397, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2714, 4y82F, 0.8397, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2715, 4r00T, 0.8397, 1.91, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2716, 4r00F, 0.8397, 1.91, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2717, 4qz2F, 0.8397, 1.91, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2718, 4qwkT, 0.8397, 1.91, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2719, 4qwkF, 0.8397, 1.91, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2720, 4ltcF, 0.8397, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2721, 3hyeF, 0.8397, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2722, 5fgdF, 0.8396, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2723, 5dkiT, 0.8396, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2724, 5dkiF, 0.8396, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2725, 4zzgG, 0.8396, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2726, 4y8iT, 0.8396, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2727, 4y8iF, 0.8396, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2728, 4qzwT, 0.8396, 1.90, 0.332, 244, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2729, 4qzwF, 0.8396, 1.90, 0.332, 244, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2730, 4qz2T, 0.8396, 1.91, 0.358, 242, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2731, 4qwrT, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2732, 4qwrF, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2733, 4qwiT, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2734, 4qwiF, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2735, 4qv3T, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-M45V MUTANT
2736, 4qv3F, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-M45V MUTANT
2737, 4no6T, 0.8396, 1.91, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2738, 4no6F, 0.8396, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2739, 4intF, 0.8396, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2740, 3un8F, 0.8396, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2741, 3mg0T, 0.8396, 1.91, 0.336, 243, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2742, 3mg0F, 0.8396, 1.91, 0.336, 243, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2743, 3hyeT, 0.8396, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2744, 5l52T, 0.8395, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2745, 5l52F, 0.8395, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2746, 5fgdT, 0.8395, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2747, 5cz4T, 0.8395, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2748, 5cz4F, 0.8395, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2749, 4z1lT, 0.8395, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2750, 4z1lF, 0.8395, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2751, 4y8lT, 0.8395, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2752, 4y8lF, 0.8395, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2753, 4y70T, 0.8395, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2754, 4y70F, 0.8395, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2755, 4qvvT, 0.8395, 1.91, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2756, 4qvvF, 0.8395, 1.91, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2757, 4no8T, 0.8395, 1.91, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2758, 4no8F, 0.8395, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2759, 4j70T, 0.8395, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2760, 4hnpT, 0.8395, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2761, 4eu2G, 0.8395, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2762, 3gptT, 0.8395, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2763, 3gptF, 0.8395, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2764, 5t0gG, 0.8394, 1.90, 0.332, 244, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2765, 5nifG, 0.8394, 1.90, 0.336, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2766, 5cgiT, 0.8394, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2767, 5cgiF, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2768, 4y8qT, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2769, 4y8qF, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2770, 4y8jT, 0.8394, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2771, 4y8jF, 0.8394, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2772, 4y80T, 0.8394, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2773, 4y80F, 0.8394, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2774, 4y7wT, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2775, 4y7wF, 0.8394, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2776, 4hrdT, 0.8394, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2777, 4hrcF, 0.8394, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2778, 3un8T, 0.8394, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2779, 3nzwF, 0.8394, 1.90, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2780, 4ya3F, 0.8393, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2781, 4ya0F, 0.8393, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2782, 4q1sT, 0.8393, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2783, 4inrF, 0.8393, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2784, 3tddT, 0.8393, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2785, 3tddF, 0.8393, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2786, 3nzwT, 0.8393, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2787, 5fhsT, 0.8392, 1.96, 0.360, 240, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2788, 5fhsF, 0.8392, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2789, 5cz8F, 0.8392, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2790, 4zzgU, 0.8392, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2791, 4ya3T, 0.8392, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2792, 4ya0T, 0.8392, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2793, 4qxjT, 0.8392, 1.91, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2794, 4qxjF, 0.8392, 1.91, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2795, 4qwgF, 0.8392, 1.91, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2796, 4ltcT, 0.8392, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2797, 4lqiF, 0.8392, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2798, 4intT, 0.8392, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2799, 4inrT, 0.8392, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2800, 3mg4F, 0.8392, 1.91, 0.332, 244, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2801, 3d29T, 0.8392, 1.90, 0.332, 244, 226, PROTEASOME INHIBITION BY FELLUTAMIDE B
2802, 3d29F, 0.8392, 1.91, 0.332, 244, 226, PROTEASOME INHIBITION BY FELLUTAMIDE B
2803, 5vfqCA, 0.8391, 1.91, 0.336, 243, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2804, 5nifU, 0.8391, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2805, 5cz8T, 0.8391, 1.92, 0.332, 244, 226, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2806, 5cz5T, 0.8391, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2807, 5cz5F, 0.8391, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2808, 4qwsT, 0.8391, 1.90, 0.332, 244, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2809, 4qwsF, 0.8391, 1.91, 0.332, 244, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2810, 4qwjF, 0.8391, 1.92, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2811, 4qwgT, 0.8391, 1.92, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2812, 4qlvT, 0.8391, 1.92, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2813, 4qlvF, 0.8391, 1.91, 0.332, 244, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2814, 4lqiT, 0.8391, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2815, 3dy3F, 0.8391, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2816, 4y7yT, 0.8390, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2817, 4y7yF, 0.8390, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2818, 4y78T, 0.8390, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2819, 4y78F, 0.8390, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2820, 4qwjT, 0.8390, 1.90, 0.332, 244, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2821, 4jsqT, 0.8390, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2822, 4jsqF, 0.8390, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2823, 4inuF, 0.8390, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2824, 3nzxT, 0.8390, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2825, 3nzxF, 0.8390, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2826, 3gpwT, 0.8390, 1.94, 0.336, 239, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2827, 3gpwF, 0.8390, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2828, 3dy3T, 0.8390, 1.92, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2829, 4qzxT, 0.8389, 1.92, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2830, 4qzxF, 0.8389, 1.92, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2831, 1g0uF, 0.8389, 1.92, 0.336, 243, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2832, 5mp9G, 0.8388, 1.92, 0.336, 243, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2833, 4inuT, 0.8388, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2834, 4gk7F, 0.8388, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2835, 4g4sG, 0.8388, 1.91, 0.336, 243, 226, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2836, 3gpjT, 0.8388, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2837, 3gpjF, 0.8388, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2838, 3e47T, 0.8388, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2839, 3e47F, 0.8388, 1.92, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2840, 4jt0T, 0.8387, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2841, 4jt0F, 0.8387, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2842, 4jsuT, 0.8387, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2843, 4jsuF, 0.8387, 1.92, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2844, 4gk7T, 0.8387, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2845, 3bdmT, 0.8387, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2846, 2fakT, 0.8387, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2847, 2fakF, 0.8387, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2848, 1g65F, 0.8387, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2849, 6epfC, 0.8386, 1.91, 0.332, 244, 226, GROUND STATE 26S PROTEASOME (GS1)
2850, 5vfpBA, 0.8386, 1.91, 0.332, 244, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2851, 4hrcT, 0.8386, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2852, 4fzcT, 0.8386, 1.92, 0.336, 243, 226, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2853, 4fzcF, 0.8386, 1.92, 0.336, 243, 226, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2854, 3dy4T, 0.8386, 1.90, 0.336, 242, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2855, 3dy4F, 0.8386, 1.89, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2856, 3bdmF, 0.8386, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2857, 2zcyT, 0.8386, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2858, 2zcyF, 0.8386, 1.91, 0.336, 246, 226, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2859, 2gplF, 0.8386, 1.91, 0.336, 244, 226, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2860, 1jd2F, 0.8386, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2861, 1g65T, 0.8386, 1.92, 0.332, 244, 226, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2862, 1g0uT, 0.8386, 1.92, 0.332, 244, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2863, 5wviNA, 0.8385, 1.91, 0.332, 244, 226, 
2864, 4v7oG, 0.8385, 1.91, 0.332, 244, 226, 
2865, 3okjT, 0.8385, 1.91, 0.336, 244, 226, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2866, 3okjF, 0.8385, 1.91, 0.336, 244, 226, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2867, 3mg4T, 0.8385, 1.91, 0.332, 244, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2868, 2gplT, 0.8385, 1.91, 0.332, 244, 226, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2869, 4v7oU, 0.8384, 1.91, 0.341, 244, 226, 
2870, 4v7oCB, 0.8384, 1.91, 0.341, 244, 226, 
2871, 3un4T, 0.8384, 1.90, 0.336, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2872, 3un4F, 0.8384, 2.46, 0.361, 249, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2873, 3shjT, 0.8384, 1.93, 0.336, 239, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2874, 3shjF, 0.8384, 1.91, 0.332, 244, 226, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2875, 2ku2C, 0.8384, 1.91, 0.332, 244, 226, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2876, 5m32T, 0.8383, 1.91, 0.332, 244, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2877, 4v7oOA, 0.8383, 1.91, 0.336, 244, 226, 
2878, 6epcA, 0.8382, 1.91, 0.336, 244, 226, GROUND STATE 26S PROTEASOME (GS2)
2879, 5vfrj, 0.8382, 1.91, 0.332, 244, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2880, 4eu2U, 0.8382, 1.92, 0.336, 244, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2881, 1jd21, 0.8382, 1.92, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2882, 5m32B, 0.8381, 1.92, 0.332, 244, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2883, 1z7qU, 0.8381, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2884, 1z7qG, 0.8381, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2885, 5vfoM, 0.8379, 1.91, 0.336, 242, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2886, 3mg8F, 0.8379, 2.30, 0.361, 245, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2887, 2f16F, 0.8378, 1.93, 0.341, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2888, 2f16T, 0.8377, 1.92, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2889, 3oevF, 0.8375, 1.92, 0.332, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2890, 3oeuF, 0.8375, 1.91, 0.332, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2891, 3mg7F, 0.8375, 1.92, 0.332, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2892, 3oevT, 0.8374, 1.93, 0.341, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2893, 3mg8T, 0.8374, 1.93, 0.341, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2894, 5wviCA, 0.8373, 1.92, 0.332, 244, 226, 
2895, 3mg6T, 0.8373, 1.91, 0.332, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2896, 5wviH, 0.8372, 1.91, 0.332, 244, 226, 
2897, 5vfuFA, 0.8372, 1.91, 0.332, 244, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2898, 5vftg, 0.8372, 1.82, 0.396, 237, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2899, 3oeuT, 0.8372, 1.95, 0.291, 240, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2900, 3mg7T, 0.8372, 1.93, 0.341, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2901, 4eu2O, 0.8371, 2.00, 0.360, 246, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2902, 3mg6F, 0.8371, 1.94, 0.336, 239, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2903, 5m32F, 0.8370, 1.92, 0.341, 244, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2904, 5vfqG, 0.8369, 1.91, 0.336, 244, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2905, 5t0jI, 0.8368, 2.06, 0.354, 234, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2906, 3sdkU, 0.8364, 1.92, 0.336, 243, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2907, 5wviBA, 0.8363, 1.92, 0.336, 243, 226, 
2908, 5nifA, 0.8363, 1.98, 0.286, 240, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2909, 4zzgA, 0.8363, 1.86, 0.329, 237, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2910, 3wxrG, 0.8363, 1.93, 0.341, 244, 226, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2911, 3mg4U, 0.8363, 1.93, 0.336, 244, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2912, 5vfpG, 0.8362, 1.87, 0.329, 237, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2913, 5t0hK, 0.8362, 1.87, 0.329, 237, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2914, 3mg7U, 0.8362, 1.87, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2915, 3jcpPA, 0.8362, 1.87, 0.329, 237, 225, 
2916, 5d0wU, 0.8361, 1.87, 0.329, 237, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2917, 6epdC, 0.8360, 2.31, 0.356, 245, 233, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
2918, 5d0wG, 0.8360, 1.87, 0.329, 237, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2919, 4qv9U, 0.8360, 1.94, 0.308, 243, 227, YCP BETA5-C63F MUTANT
2920, 4qv9G, 0.8360, 2.04, 0.360, 240, 228, YCP BETA5-C63F MUTANT
2921, 4ya4U, 0.8359, 2.04, 0.360, 240, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2922, 4ya4G, 0.8359, 1.87, 0.329, 237, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2923, 3mg6U, 0.8359, 1.87, 0.333, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2924, 3jcpP, 0.8359, 1.83, 0.307, 241, 225, 
2925, 5l5bU, 0.8358, 1.87, 0.333, 237, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2926, 5l5bG, 0.8358, 1.88, 0.292, 232, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2927, 5fggU, 0.8358, 1.98, 0.286, 240, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2928, 5czaU, 0.8358, 2.04, 0.352, 250, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2929, 5czaG, 0.8358, 1.84, 0.311, 243, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2930, 5a5bE, 0.8358, 1.91, 0.326, 243, 227, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2931, 4y8rU, 0.8358, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2932, 4qv3U, 0.8358, 1.86, 0.311, 241, 225, YCP BETA5-M45V MUTANT
2933, 4qv3G, 0.8358, 1.88, 0.329, 237, 225, YCP BETA5-M45V MUTANT
2934, 4cr3E, 0.8358, 1.84, 0.307, 243, 225, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2935, 5l55U, 0.8357, 2.00, 0.286, 240, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2936, 5fggG, 0.8357, 1.80, 0.329, 228, 225, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2937, 5fg7U, 0.8357, 1.86, 0.311, 243, 225, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2938, 5fg7G, 0.8357, 1.93, 0.341, 244, 226, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2939, 4y8rG, 0.8357, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2940, 4no9U, 0.8357, 2.06, 0.361, 249, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2941, 3sdiU, 0.8357, 1.86, 0.307, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2942, 3mg8U, 0.8357, 1.86, 0.307, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2943, 5t0jG, 0.8356, 1.86, 0.307, 241, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2944, 5mpag, 0.8356, 1.86, 0.307, 241, 225, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2945, 5l55G, 0.8356, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2946, 5cgfU, 0.8356, 1.85, 0.311, 243, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2947, 5cgfG, 0.8356, 1.93, 0.341, 244, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2948, 5ahjU, 0.8356, 1.94, 0.341, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2949, 5ahjG, 0.8356, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2950, 4ya1U, 0.8356, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2951, 4ya1G, 0.8356, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2952, 4quyU, 0.8356, 1.86, 0.307, 241, 225, YCP BETA5-A49S-MUTANT
2953, 4no9G, 0.8356, 1.86, 0.307, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2954, 4nnnU, 0.8356, 2.23, 0.328, 243, 229, YCP IN COMPLEX WITH MG132
2955, 4eu2A, 0.8356, 1.86, 0.307, 241, 225, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2956, 3wxrO, 0.8356, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2957, 5cggU, 0.8355, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2958, 5cggG, 0.8355, 2.23, 0.328, 243, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2959, 4quyG, 0.8355, 1.86, 0.307, 241, 225, YCP BETA5-A49S-MUTANT
2960, 3un8U, 0.8355, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2961, 5vfuX, 0.8354, 1.86, 0.307, 241, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2962, 5vftM, 0.8354, 1.86, 0.307, 241, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2963, 5gjqG, 0.8354, 1.86, 0.307, 241, 225, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2964, 5fgaU, 0.8354, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2965, 5fgaG, 0.8354, 1.85, 0.311, 240, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2966, 5bxlU, 0.8354, 1.86, 0.311, 243, 225, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2967, 5bxlG, 0.8354, 1.96, 0.355, 240, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2968, 4qwlU, 0.8354, 1.95, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2969, 4qv7U, 0.8354, 1.86, 0.307, 241, 225, YCP BETA5-A50V MUTANT
2970, 4nnnG, 0.8354, 1.86, 0.307, 241, 225, YCP IN COMPLEX WITH MG132
2971, 4g4sA, 0.8354, 1.86, 0.307, 241, 225, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2972, 3sdkF, 0.8354, 1.86, 0.307, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2973, 1g0uU, 0.8354, 1.86, 0.307, 241, 225, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2974, 5vfsG, 0.8353, 1.87, 0.307, 241, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2975, 5vfom, 0.8353, 1.87, 0.307, 241, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2976, 5l5rU, 0.8353, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2977, 5l5rG, 0.8353, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2978, 5l52U, 0.8353, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2979, 5jhrU, 0.8353, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2980, 5dsvH, 0.8353, 1.86, 0.311, 243, 225, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2981, 5d0sU, 0.8353, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2982, 5d0sG, 0.8353, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2983, 4qwlG, 0.8353, 1.86, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2984, 4qv7G, 0.8353, 1.86, 0.307, 243, 225, YCP BETA5-A50V MUTANT
2985, 4no8U, 0.8353, 1.91, 0.296, 240, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2986, 4no8G, 0.8353, 1.91, 0.296, 240, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2987, 4hnpU, 0.8353, 1.69, 0.317, 238, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2988, 3oevG, 0.8353, 1.87, 0.307, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2989, 5vfoL, 0.8352, 1.87, 0.307, 241, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2990, 5l5uU, 0.8352, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2991, 5l52G, 0.8352, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2992, 5jhrG, 0.8352, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2993, 5bxnU, 0.8352, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2994, 5bxnG, 0.8352, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2995, 4qwuU, 0.8352, 2.02, 0.310, 241, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2996, 4qwuG, 0.8352, 1.84, 0.335, 236, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2997, 4qv1U, 0.8352, 1.86, 0.307, 240, 225, YCP BETA5-M45A MUTANT
2998, 4qv1G, 0.8352, 1.91, 0.296, 240, 226, YCP BETA5-M45A MUTANT
2999, 4no1U, 0.8352, 1.90, 0.292, 240, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3000, 4ltcU, 0.8352, 1.87, 0.307, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3001, 4j70U, 0.8352, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3002, 3oevU, 0.8352, 1.86, 0.307, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3003, 6gopU, 0.8351, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3004, 5nifO, 0.8351, 1.78, 0.290, 239, 224, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3005, 5l5uG, 0.8351, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3006, 4zzgO, 0.8351, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3007, 4z1lU, 0.8351, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3008, 4y8hU, 0.8351, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3009, 4y8hG, 0.8351, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3010, 4qz6U, 0.8351, 1.86, 0.311, 241, 225, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3011, 4qv6U, 0.8351, 1.86, 0.311, 243, 225, YCP BETA5-A49V MUTANT
3012, 4qv5U, 0.8351, 1.86, 0.307, 243, 225, YCP BETA5-M45I MUTANT
3013, 4qv5G, 0.8351, 1.70, 0.317, 238, 224, YCP BETA5-M45I MUTANT
3014, 4qv4U, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-M45T MUTANT
3015, 4qv0U, 0.8351, 1.86, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3016, 4qv0G, 0.8351, 1.86, 0.311, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3017, 4no1G, 0.8351, 1.87, 0.307, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3018, 3wxrU, 0.8351, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3019, 3jcpJA, 0.8351, 1.87, 0.307, 241, 225, 
3020, 3jcpJ, 0.8351, 1.87, 0.307, 241, 225, 
3021, 2ku1B, 0.8351, 1.87, 0.307, 241, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3022, 6gopG, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3023, 5vfrM, 0.8350, 1.87, 0.307, 241, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3024, 5t0gJ, 0.8350, 1.86, 0.311, 243, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3025, 4z1lG, 0.8350, 1.87, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3026, 4y9yU, 0.8350, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3027, 4y9yG, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3028, 4y8mU, 0.8350, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3029, 4y8mG, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3030, 4r17U, 0.8350, 1.88, 0.307, 242, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3031, 4r17G, 0.8350, 1.87, 0.307, 241, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3032, 4qzzU, 0.8350, 1.87, 0.311, 241, 225, YCP IN COMPLEX WITH OMURALIDE
3033, 4qzzG, 0.8350, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH OMURALIDE
3034, 4qz6G, 0.8350, 1.86, 0.311, 241, 225, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3035, 4qz0U, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3036, 4qv8U, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT
3037, 4qv8G, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT
3038, 4qv6G, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-A49V MUTANT
3039, 4qv4G, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-M45T MUTANT
3040, 4q1sU, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3041, 4hrcU, 0.8350, 1.87, 0.307, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3042, 3oeuU, 0.8350, 1.89, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3043, 3gpjU, 0.8350, 1.87, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3044, 3gpjG, 0.8350, 1.87, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3045, 1rypO, 0.8350, 1.87, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3046, 5m32G, 0.8349, 1.90, 0.400, 237, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3047, 5l6aU, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3048, 5l6aG, 0.8349, 2.01, 0.286, 240, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3049, 5fgfU, 0.8349, 1.99, 0.332, 239, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3050, 5fgfG, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3051, 5fg9U, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3052, 5fg9G, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3053, 5d0zU, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3054, 5d0zG, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3055, 4ya7U, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3056, 4ya7G, 0.8349, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3057, 4y8pU, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3058, 4y8pG, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3059, 4r00U, 0.8349, 1.86, 0.311, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3060, 4r00G, 0.8349, 1.86, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3061, 4qz0G, 0.8349, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3062, 4qvnU, 0.8349, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3063, 4qvnG, 0.8349, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3064, 4hrdU, 0.8349, 1.87, 0.307, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3065, 3sdkT, 0.8349, 1.87, 0.311, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3066, 1fntU, 0.8349, 1.86, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3067, 5vfqFA, 0.8348, 1.98, 0.310, 243, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3068, 5cz9U, 0.8348, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3069, 5cz9G, 0.8348, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3070, 4x6zO, 0.8348, 1.87, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3071, 4j70G, 0.8348, 1.99, 0.358, 233, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3072, 3un4U, 0.8348, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3073, 3tddU, 0.8348, 1.87, 0.307, 241, 225, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3074, 3tddG, 0.8348, 1.87, 0.307, 241, 225, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3075, 1g65U, 0.8348, 1.87, 0.307, 241, 225, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3076, 1fntG, 0.8348, 1.87, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3077, 5jhsU, 0.8347, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3078, 5fhsU, 0.8347, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3079, 5fhsG, 0.8347, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3080, 5cz8U, 0.8347, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3081, 4y9zU, 0.8347, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3082, 4y9zG, 0.8347, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3083, 4qz5U, 0.8347, 1.87, 0.311, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3084, 4qz5G, 0.8347, 1.87, 0.307, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3085, 4qw1U, 0.8347, 1.87, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3086, 4qw1G, 0.8347, 1.87, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3087, 4qvlU, 0.8347, 1.87, 0.307, 241, 225, YCP IN COMPLEX WITH BORTEZOMIB
3088, 4jsuU, 0.8347, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3089, 4jsuG, 0.8347, 1.86, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3090, 3un4G, 0.8347, 1.85, 0.335, 236, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3091, 3nzjU, 0.8347, 1.97, 0.336, 240, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3092, 3mg7G, 0.8347, 1.90, 0.296, 240, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3093, 3gpwU, 0.8347, 1.87, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3094, 3gptU, 0.8347, 1.87, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3095, 1g0uG, 0.8347, 1.87, 0.311, 241, 225, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3096, 5vfpEA, 0.8346, 1.88, 0.307, 243, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3097, 5t0cY, 0.8346, 1.87, 0.311, 243, 225, 
3098, 5t0cEB, 0.8346, 1.88, 0.307, 243, 225, 
3099, 5l6bU, 0.8346, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3100, 5l6bG, 0.8346, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3101, 5jhsG, 0.8346, 1.97, 0.336, 240, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3102, 5cz8G, 0.8346, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3103, 4ya2U, 0.8346, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3104, 4ya2G, 0.8346, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3105, 4y8tU, 0.8346, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3106, 4y8sU, 0.8346, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3107, 4y8sG, 0.8346, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3108, 4qz3U, 0.8346, 1.87, 0.307, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3109, 4qz3G, 0.8346, 1.87, 0.307, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3110, 4qw7U, 0.8346, 1.87, 0.307, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3111, 4qw5U, 0.8346, 1.87, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3112, 4qw5G, 0.8346, 1.87, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3113, 4qvlG, 0.8346, 1.87, 0.311, 243, 225, YCP IN COMPLEX WITH BORTEZOMIB
3114, 4no6U, 0.8346, 1.87, 0.307, 243, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3115, 4jt0U, 0.8346, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3116, 4jsqU, 0.8346, 1.87, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3117, 3un8G, 0.8346, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3118, 3nzxU, 0.8346, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3119, 3nzjG, 0.8346, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3120, 3mg4G, 0.8346, 1.87, 0.307, 240, 225, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3121, 3mg0U, 0.8346, 1.90, 0.292, 240, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3122, 3gpwG, 0.8346, 1.94, 0.360, 240, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3123, 3gptG, 0.8346, 2.04, 0.295, 240, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3124, 3bdmU, 0.8346, 2.04, 0.295, 240, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3125, 3bdmG, 0.8346, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3126, 1rypA, 0.8346, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3127, 5lttU, 0.8345, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3128, 5lttG, 0.8345, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3129, 5l5aU, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3130, 5l5aG, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3131, 5d0vU, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3132, 5d0vG, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3133, 5cz7U, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3134, 5cz7G, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3135, 5cz6U, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3136, 5cz6G, 0.8345, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3137, 4y8tG, 0.8345, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3138, 4y8kU, 0.8345, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3139, 4y8gU, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3140, 4y8gG, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3141, 4y75U, 0.8345, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3142, 4y75G, 0.8345, 1.87, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3143, 4qw7G, 0.8345, 1.87, 0.307, 243, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3144, 4qw6U, 0.8345, 1.88, 0.307, 243, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3145, 4qvyU, 0.8345, 1.88, 0.307, 243, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3146, 4qvyG, 0.8345, 1.87, 0.307, 243, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3147, 4qvpU, 0.8345, 1.87, 0.311, 243, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3148, 4qvpG, 0.8345, 1.88, 0.307, 243, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3149, 4quxU, 0.8345, 1.88, 0.307, 243, 225, YCP BETA5-A49T-MUTANT
3150, 4quxG, 0.8345, 1.89, 0.307, 243, 225, YCP BETA5-A49T-MUTANT
3151, 4qltU, 0.8345, 1.89, 0.307, 243, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3152, 4qltG, 0.8345, 1.88, 0.307, 243, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3153, 4no6G, 0.8345, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3154, 4lqiU, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3155, 4jt0G, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3156, 4jsqG, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3157, 4intU, 0.8345, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3158, 4inrU, 0.8345, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3159, 4fzgU, 0.8345, 1.88, 0.307, 241, 225, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3160, 3shjU, 0.8345, 1.88, 0.307, 241, 225, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3161, 3sdkG, 0.8345, 1.88, 0.307, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3162, 3nzxG, 0.8345, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3163, 5mpbD, 0.8344, 1.88, 0.307, 241, 225, 
3164, 5l63U, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3165, 5l63G, 0.8344, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3166, 5l61U, 0.8344, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3167, 5l61G, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3168, 5l5hU, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3169, 5l5hG, 0.8344, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3170, 5cgiU, 0.8344, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3171, 4y8lU, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3172, 4y8lG, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3173, 4y8kG, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3174, 4y77U, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3175, 4y70U, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3176, 4v7oO, 0.8344, 1.88, 0.307, 241, 225, 
3177, 4v7oIA, 0.8344, 1.88, 0.307, 241, 225, 
3178, 4v7oA, 0.8344, 1.88, 0.307, 241, 225, 
3179, 4qz4U, 0.8344, 1.87, 0.311, 241, 225, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3180, 4qz4G, 0.8344, 1.88, 0.307, 243, 225, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3181, 4qw6G, 0.8344, 1.87, 0.311, 243, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3182, 4lqiG, 0.8344, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3183, 3shjG, 0.8344, 1.87, 0.307, 243, 225, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3184, 3nzwU, 0.8344, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3185, 3mg6G, 0.8344, 1.87, 0.311, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3186, 3hyeU, 0.8344, 1.88, 0.311, 243, 225, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3187, 5vfrl, 0.8343, 1.88, 0.307, 243, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3188, 5l67U, 0.8343, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3189, 5l67G, 0.8343, 1.99, 0.358, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3190, 5l65U, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3191, 5l65G, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3192, 5l5oU, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3193, 5l5oG, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3194, 5l5fU, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3195, 5l5dU, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3196, 5l5dG, 0.8343, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3197, 5fgeU, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3198, 5fgeG, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3199, 5cgiG, 0.8343, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3200, 5cghU, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3201, 4ya9U, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3202, 4ya9G, 0.8343, 1.93, 0.341, 244, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3203, 4y8uU, 0.8343, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3204, 4y8uG, 0.8343, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3205, 4y7wU, 0.8343, 1.86, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3206, 4y77G, 0.8343, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3207, 4y70G, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3208, 4v7oWA, 0.8343, 1.87, 0.307, 241, 225, 
3209, 4r02U, 0.8343, 1.87, 0.307, 241, 225, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3210, 4qzwU, 0.8343, 1.88, 0.307, 243, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3211, 4qwrU, 0.8343, 1.88, 0.311, 243, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3212, 4qwjU, 0.8343, 1.89, 0.307, 243, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3213, 4qwjG, 0.8343, 1.88, 0.307, 243, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3214, 4qluU, 0.8343, 1.88, 0.307, 243, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3215, 4nnwU, 0.8343, 1.73, 0.317, 238, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3216, 4nnwG, 0.8343, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3217, 4fzgG, 0.8343, 1.88, 0.307, 241, 225, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3218, 3wxrA, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3219, 3okjU, 0.8343, 1.88, 0.307, 241, 225, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3220, 3nzwG, 0.8343, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3221, 3hyeG, 0.8343, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3222, 3e47U, 0.8343, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3223, 1jd22, 0.8343, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3224, 5vfsFA, 0.8342, 1.88, 0.307, 241, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3225, 5l6cU, 0.8342, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3226, 5l66U, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3227, 5l66G, 0.8342, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3228, 5l64U, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3229, 5l64G, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3230, 5l62U, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3231, 5l62G, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3232, 5l5wU, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3233, 5l5pU, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3234, 5l5pG, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3235, 5l5fG, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3236, 5l54U, 0.8342, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3237, 5l54G, 0.8342, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3238, 5cghG, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3239, 4y8jU, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3240, 4y7yU, 0.8342, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3241, 4y7yG, 0.8342, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3242, 4y7wG, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3243, 4qzxU, 0.8342, 1.88, 0.311, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3244, 4qzwG, 0.8342, 1.88, 0.311, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3245, 4qwrG, 0.8342, 1.87, 0.311, 243, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3246, 4qvwU, 0.8342, 1.88, 0.307, 243, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3247, 4qvwG, 0.8342, 1.89, 0.307, 243, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3248, 4qluG, 0.8342, 1.89, 0.307, 243, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3249, 4qlsU, 0.8342, 1.88, 0.307, 243, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3250, 4qlsG, 0.8342, 1.87, 0.311, 243, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3251, 3oeuG, 0.8342, 1.88, 0.311, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3252, 6epdB, 0.8341, 1.93, 0.296, 240, 226, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
3253, 5l6cG, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3254, 5l5xU, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3255, 5l5wG, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3256, 5l5eU, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3257, 5l5eG, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3258, 5d0tU, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3259, 5cz5U, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3260, 4y8qU, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3261, 4y8jG, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3262, 4y82U, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3263, 4qzxG, 0.8341, 1.88, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3264, 4qz7U, 0.8341, 1.88, 0.311, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3265, 4qz7G, 0.8341, 1.88, 0.311, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3266, 4qwiU, 0.8341, 1.88, 0.307, 241, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3267, 4inrG, 0.8341, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3268, 3okjG, 0.8341, 1.87, 0.311, 241, 225, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3269, 3e47G, 0.8341, 1.88, 0.311, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3270, 3d29U, 0.8341, 1.87, 0.311, 241, 225, PROTEASOME INHIBITION BY FELLUTAMIDE B
3271, 2fakU, 0.8341, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3272, 5l5xG, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3273, 5fgiU, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3274, 5fgiG, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3275, 5d0tG, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3276, 5cz5G, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3277, 4y8qG, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3278, 4y82G, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3279, 4y74U, 0.8340, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3280, 4y74G, 0.8340, 2.18, 0.603, 234, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3281, 4y6vU, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3282, 4y6vG, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3283, 4qz2U, 0.8340, 1.88, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3284, 4qz2G, 0.8340, 1.88, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3285, 4qwxU, 0.8340, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3286, 4qwxG, 0.8340, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3287, 4qwiG, 0.8340, 1.88, 0.307, 241, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3288, 4qbyU, 0.8340, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3289, 4qbyG, 0.8340, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3290, 3d29G, 0.8340, 1.88, 0.311, 241, 225, PROTEASOME INHIBITION BY FELLUTAMIDE B
3291, 2fakG, 0.8340, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3292, 1g65G, 0.8340, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3293, 5t0iI, 0.8339, 1.88, 0.307, 241, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3294, 5m2bU, 0.8339, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3295, 5m2bG, 0.8339, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3296, 5lajU, 0.8339, 1.89, 0.307, 243, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3297, 5lajG, 0.8339, 1.88, 0.311, 243, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3298, 5l5tU, 0.8339, 1.90, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3299, 5l5tG, 0.8339, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3300, 5l5sU, 0.8339, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3301, 5l5qU, 0.8339, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3302, 5l5qG, 0.8339, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3303, 5fgdU, 0.8339, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3304, 4y80U, 0.8339, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3305, 4y80G, 0.8339, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3306, 4y6aU, 0.8339, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3307, 4y6aG, 0.8339, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3308, 4y69U, 0.8339, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3309, 4y69G, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3310, 4inuU, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3311, 4fzcU, 0.8339, 1.88, 0.307, 241, 225, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3312, 3sdiG, 0.8339, 1.88, 0.307, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3313, 2gplU, 0.8339, 1.88, 0.311, 241, 225, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3314, 2f16U, 0.8339, 1.88, 0.311, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3315, 5vfrL, 0.8338, 1.88, 0.307, 241, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3316, 5mpaG, 0.8338, 1.88, 0.307, 241, 225, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3317, 5l5zU, 0.8338, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3318, 5l5vU, 0.8338, 1.90, 0.307, 243, 225,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3319, 5l5vG, 0.8338, 1.89, 0.307, 243, 225,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3320, 5l5sG, 0.8338, 1.89, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3321, 5fgdG, 0.8338, 2.37, 0.352, 250, 233, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3322, 5dkjU, 0.8338, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3323, 4y84U, 0.8338, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3324, 4y7xU, 0.8338, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3325, 4y7xG, 0.8338, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3326, 4r18U, 0.8338, 1.88, 0.307, 241, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3327, 4qwkU, 0.8338, 1.89, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3328, 4qwfU, 0.8338, 1.88, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3329, 4qvqU, 0.8338, 1.89, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3330, 4qlvU, 0.8338, 1.89, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3331, 4qlqU, 0.8338, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3332, 4ltcG, 0.8338, 1.88, 0.311, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3333, 4intG, 0.8338, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3334, 4fzcG, 0.8338, 1.89, 0.307, 241, 225, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3335, 5l5zG, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3336, 5l5jU, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3337, 5l5jG, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3338, 5dkjG, 0.8337, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3339, 5bouU, 0.8337, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3340, 5bouG, 0.8337, 1.89, 0.307, 240, 225, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3341, 4y8nU, 0.8337, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3342, 4y8nG, 0.8337, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3343, 4y84G, 0.8337, 1.72, 0.317, 238, 224, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3344, 4rurU, 0.8337, 1.97, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3345, 4r18G, 0.8337, 1.89, 0.307, 241, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3346, 4qwkG, 0.8337, 1.89, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3347, 4qwfG, 0.8337, 1.89, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3348, 4qvqG, 0.8337, 1.88, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3349, 4qlvG, 0.8337, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3350, 4qlqG, 0.8337, 1.89, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3351, 4inuG, 0.8337, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3352, 3dy3G, 0.8337, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3353, 2gplG, 0.8337, 1.88, 0.307, 241, 225, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3354, 2f16G, 0.8337, 1.89, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3355, 5t0gM, 0.8336, 1.88, 0.307, 241, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3356, 5l68U, 0.8336, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3357, 5l68G, 0.8336, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3358, 5l5iU, 0.8336, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3359, 5l5iG, 0.8336, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3360, 4y6zU, 0.8336, 1.89, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3361, 4rurG, 0.8336, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3362, 4qw0U, 0.8336, 1.89, 0.311, 243, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3363, 4qw0G, 0.8336, 1.89, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3364, 4qvvU, 0.8336, 1.89, 0.307, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3365, 3mg8G, 0.8336, 1.89, 0.307, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3366, 3dy3U, 0.8336, 1.89, 0.307, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3367, 6avoG, 0.8335, 1.89, 0.307, 241, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3368, 5vfqF, 0.8335, 1.89, 0.307, 241, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3369, 5vfqEA, 0.8335, 1.89, 0.307, 241, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3370, 5d0xU, 0.8335, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3371, 4ya5U, 0.8335, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3372, 4y8iU, 0.8335, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3373, 4y8iG, 0.8335, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3374, 4y6zG, 0.8335, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3375, 4qxjU, 0.8335, 1.88, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3376, 4qxjG, 0.8335, 1.89, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3377, 4qw4U, 0.8335, 1.89, 0.307, 241, 225, YCP IN COMPLEX WITH CARFILZOMIB
3378, 4qvvG, 0.8335, 1.89, 0.311, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3379, 4q1sG, 0.8335, 1.89, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3380, 4gk7U, 0.8335, 1.91, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3381, 5l5yU, 0.8334, 1.89, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3382, 5d0xG, 0.8334, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3383, 4ya5G, 0.8334, 2.05, 0.295, 240, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3384, 4y78U, 0.8334, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3385, 4y78G, 0.8334, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3386, 4qz1U, 0.8334, 1.89, 0.307, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3387, 4qw4G, 0.8334, 1.89, 0.307, 241, 225, YCP IN COMPLEX WITH CARFILZOMIB
3388, 3dy4U, 0.8334, 1.88, 0.311, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3389, 1iruT, 0.8334, 1.89, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3390, 1iruF, 0.8334, 1.89, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3391, 6avoL, 0.8333, 1.89, 0.307, 241, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3392, 5laiU, 0.8333, 1.89, 0.307, 241, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3393, 5laiG, 0.8333, 1.90, 0.307, 243, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3394, 5l60U, 0.8333, 1.91, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3395, 5l60G, 0.8333, 1.73, 0.317, 234, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3396, 5l5yG, 0.8333, 1.90, 0.296, 240, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3397, 4x6zA, 0.8333, 1.73, 0.317, 238, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3398, 4qz1G, 0.8333, 1.73, 0.317, 238, 224, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3399, 4gk7G, 0.8333, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3400, 3dy4G, 0.8333, 1.89, 0.307, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3401, 5vfsEA, 0.8332, 1.88, 0.311, 241, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3402, 4qvmU, 0.8332, 1.88, 0.311, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3403, 4qvmG, 0.8332, 1.89, 0.311, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3404, 2zcyU, 0.8332, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3405, 2zcyG, 0.8332, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3406, 6epeA, 0.8331, 1.88, 0.307, 241, 225, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3407, 5vfsF, 0.8331, 1.89, 0.307, 241, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3408, 5vfol, 0.8331, 1.90, 0.307, 243, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3409, 5l69U, 0.8331, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3410, 5l69G, 0.8331, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3411, 5cz4U, 0.8331, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3412, 4ya3U, 0.8331, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3413, 4ya3G, 0.8331, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3414, 4hnpG, 0.8331, 1.89, 0.311, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3415, 3unfS, 0.8331, 1.88, 0.307, 241, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3416, 3unfE, 0.8331, 1.88, 0.307, 241, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3417, 3unbu, 0.8331, 1.91, 0.307, 243, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3418, 3unbS, 0.8331, 1.74, 0.317, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3419, 5cz4G, 0.8330, 1.74, 0.317, 238, 224, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3420, 4y81U, 0.8330, 1.73, 0.317, 234, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3421, 4y81G, 0.8330, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3422, 4qwsU, 0.8330, 1.90, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3423, 4qwsG, 0.8329, 1.89, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3424, 4hrdG, 0.8329, 1.89, 0.307, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3425, 5fghU, 0.8328, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3426, 5fghG, 0.8328, 1.90, 0.307, 242, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3427, 4y8oU, 0.8328, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3428, 4y8oG, 0.8328, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3429, 5vfuLA, 0.8327, 1.91, 0.307, 243, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3430, 5vftm, 0.8327, 1.72, 0.317, 238, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3431, 4ya0U, 0.8327, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3432, 4ya0G, 0.8327, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3433, 3unhS, 0.8327, 1.92, 0.307, 243, 225, MOUSE 20S IMMUNOPROTEASOME
3434, 3unhE, 0.8327, 1.92, 0.307, 243, 225, MOUSE 20S IMMUNOPROTEASOME
3435, 3j9iU, 0.8326, 2.09, 0.354, 246, 229, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3436, 3j9iT, 0.8326, 1.93, 0.296, 240, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3437, 3j9iS, 0.8326, 1.72, 0.317, 238, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3438, 3j9iR, 0.8326, 1.74, 0.317, 238, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3439, 3j9iQ, 0.8326, 1.89, 0.307, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3440, 3j9iP, 0.8326, 1.89, 0.307, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3441, 3j9iO, 0.8326, 1.90, 0.307, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3442, 3j9iG, 0.8326, 1.90, 0.307, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3443, 3j9iF, 0.8326, 1.90, 0.307, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3444, 3j9iE, 0.8326, 1.90, 0.307, 243, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3445, 3j9iD, 0.8326, 1.72, 0.312, 238, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3446, 3j9iC, 0.8326, 1.72, 0.312, 238, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3447, 3j9iB, 0.8326, 1.73, 0.312, 238, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3448, 3j9iA, 0.8326, 1.73, 0.312, 238, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3449, 1jd2G, 0.8326, 1.90, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3450, 5vfpF, 0.8325, 1.89, 0.311, 241, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3451, 5vfpDA, 0.8325, 1.89, 0.311, 241, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3452, 4r02G, 0.8325, 1.89, 0.307, 241, 225, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3453, 4hrcG, 0.8325, 1.89, 0.307, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3454, 5vfrm, 0.8324, 1.90, 0.307, 243, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3455, 4r3oF, 0.8324, 1.90, 0.307, 241, 225, HUMAN CONSTITUTIVE 20S PROTEASOME
3456, 4qw3U, 0.8324, 1.90, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3457, 4qw3G, 0.8324, 1.89, 0.311, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3458, 5dsvJ, 0.8323, 1.89, 0.311, 241, 225, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3459, 4r67v, 0.8323, 1.95, 0.296, 240, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3460, 4r67T, 0.8323, 1.95, 0.296, 240, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3461, 4r67h, 0.8323, 1.90, 0.307, 241, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3462, 4r67F, 0.8323, 1.90, 0.307, 241, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3463, 4cr2G, 0.8323, 1.73, 0.312, 238, 224, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3464, 5dkiU, 0.8322, 1.73, 0.312, 238, 224, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3465, 5dkiG, 0.8322, 1.67, 0.407, 224, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3466, 4r3oT, 0.8322, 1.67, 0.407, 224, 221, HUMAN CONSTITUTIVE 20S PROTEASOME
3467, 5mp9a, 0.8319, 1.67, 0.407, 224, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3468, 5mp9A, 0.8318, 1.67, 0.407, 224, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3469, 5lf0E, 0.8318, 1.67, 0.407, 224, 221, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3470, 4qwgU, 0.8318, 1.67, 0.407, 224, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3471, 4qwgG, 0.8318, 1.67, 0.407, 224, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3472, 5lf4E, 0.8316, 1.67, 0.407, 224, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3473, 5lf0S, 0.8316, 1.67, 0.407, 224, 221, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3474, 5t0jM, 0.8315, 1.67, 0.407, 224, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3475, 5lf6E, 0.8315, 1.67, 0.407, 224, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3476, 5lf4S, 0.8315, 1.67, 0.407, 224, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3477, 3uneu, 0.8315, 1.67, 0.407, 224, 221, MOUSE CONSTITUTIVE 20S PROTEASOME
3478, 3mg0G, 0.8315, 1.67, 0.407, 224, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3479, 5lexS, 0.8314, 1.91, 0.311, 243, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3480, 5le5S, 0.8313, 1.74, 0.317, 238, 224, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3481, 5lf7S, 0.8312, 1.75, 0.317, 238, 224, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3482, 5lf6S, 0.8312, 1.91, 0.307, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3483, 5leyE, 0.8312, 1.90, 0.311, 243, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3484, 5lf1S, 0.8311, 1.93, 0.292, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3485, 5vfuW, 0.8310, 1.74, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3486, 5vftL, 0.8310, 1.90, 0.307, 241, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3487, 5lf7E, 0.8310, 1.90, 0.307, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3488, 5lf3S, 0.8310, 1.94, 0.290, 239, 224, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3489, 5lexE, 0.8310, 1.75, 0.317, 238, 224, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3490, 3uneE, 0.8310, 1.75, 0.317, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME
3491, 3unbg, 0.8310, 1.75, 0.317, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3492, 5lf3E, 0.8309, 1.75, 0.317, 238, 224, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3493, 5lf1E, 0.8309, 2.15, 0.339, 245, 227, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3494, 5leyS, 0.8309, 1.90, 0.307, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3495, 3uneS, 0.8308, 1.90, 0.307, 241, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
3496, 5vfuKA, 0.8307, 1.75, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3497, 5le5E, 0.8307, 1.99, 0.305, 241, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3498, 5vftl, 0.8306, 1.97, 0.305, 241, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3499, 5lezS, 0.8306, 1.70, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3500, 3uneg, 0.8306, 1.91, 0.311, 241, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
3501, 1ya7F, 0.8306, 1.91, 0.311, 241, 225, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3502, 5wvkBA, 0.8305, 1.69, 0.318, 233, 223, 
3503, 5lezE, 0.8304, 1.70, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3504, 3unbE, 0.8303, 1.91, 0.296, 240, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3505, 3jcoPA, 0.8302, 1.70, 0.318, 233, 223, 
3506, 3jcoP, 0.8302, 1.69, 0.318, 237, 223, 
3507, 5mpbU, 0.8301, 1.76, 0.312, 238, 224, 
3508, 5a5bG, 0.8300, 1.93, 0.307, 243, 225, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3509, 4cr3G, 0.8300, 1.70, 0.318, 235, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3510, 3jcoJA, 0.8300, 1.70, 0.318, 237, 223, 
3511, 1yauF, 0.8300, 1.70, 0.318, 237, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3512, 5ln3C, 0.8299, 1.70, 0.318, 237, 223, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3513, 5mpcD, 0.8298, 1.70, 0.318, 233, 223, 
3514, 5a0qP, 0.8298, 1.70, 0.318, 237, 223, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3515, 5a0qB, 0.8298, 1.75, 0.317, 238, 224, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3516, 3jcoJ, 0.8298, 1.74, 0.317, 238, 224, 
3517, 5wvkU, 0.8295, 1.71, 0.318, 233, 223, 
3518, 5t0hJ, 0.8295, 1.71, 0.318, 237, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3519, 5t0hM, 0.8294, 1.71, 0.318, 233, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3520, 1yauA, 0.8294, 1.76, 0.312, 238, 224, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3521, 1ya7G, 0.8294, 1.77, 0.312, 238, 224, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3522, 5mpcG, 0.8293, 1.71, 0.318, 233, 223, 
3523, 6epfA, 0.8292, 1.71, 0.318, 233, 223, GROUND STATE 26S PROTEASOME (GS1)
3524, 1yauG, 0.8292, 1.71, 0.318, 235, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3525, 5mpaa, 0.8291, 1.76, 0.312, 238, 224, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3526, 1yauC, 0.8291, 1.77, 0.317, 238, 224, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3527, 1ya7C, 0.8291, 1.71, 0.318, 233, 223, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3528, 2ku2G, 0.8290, 1.77, 0.317, 238, 224, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3529, 3jseG, 0.8289, 1.71, 0.318, 237, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3530, 2ku1D, 0.8289, 1.76, 0.312, 238, 224, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3531, 3jseF, 0.8288, 1.64, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3532, 3jseB, 0.8287, 1.99, 0.332, 244, 226, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3533, 5lexG, 0.8286, 1.71, 0.318, 233, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3534, 1yauB, 0.8286, 1.78, 0.312, 238, 224, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3535, 6epcC, 0.8285, 2.02, 0.341, 244, 226, GROUND STATE 26S PROTEASOME (GS2)
3536, 5lezG, 0.8285, 2.02, 0.341, 244, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3537, 3jseD, 0.8285, 2.02, 0.341, 244, 226, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3538, 3jseC, 0.8285, 2.02, 0.332, 243, 226, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3539, 3jseA, 0.8285, 2.07, 0.336, 245, 226, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3540, 2ku2F, 0.8285, 2.07, 0.336, 245, 226, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3541, 2ku2D, 0.8285, 1.95, 0.307, 243, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3542, 2ku1F, 0.8285, 1.55, 0.414, 222, 220, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3543, 5mpcU, 0.8284, 2.26, 0.359, 261, 231, 
3544, 3jseE, 0.8284, 2.18, 0.363, 240, 226, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3545, 2ku1C, 0.8283, 1.11, 0.631, 214, 214, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3546, 1ya7B, 0.8282, 1.11, 0.631, 214, 214, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3547, 5wviI, 0.8280, 1.95, 0.307, 243, 225, 
3548, 5ln3G, 0.8280, 1.95, 0.307, 243, 225, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3549, 5lf0G, 0.8278, 2.14, 0.335, 244, 227, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3550, 5leyG, 0.8278, 2.03, 0.332, 239, 229, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3551, 1ya7D, 0.8278, 2.12, 0.295, 240, 227, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3552, 1ya7A, 0.8278, 1.56, 0.414, 222, 220, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3553, 5lf3G, 0.8277, 1.66, 0.412, 227, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3554, 1yauD, 0.8277, 2.18, 0.335, 243, 227, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3555, 5mpaf, 0.8276, 2.05, 0.355, 246, 228, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3556, 5mpcR, 0.8275, 1.57, 0.414, 222, 220, 
3557, 2ku2E, 0.8275, 1.93, 0.311, 241, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3558, 1yarG, 0.8275, 1.56, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3559, 1yarF, 0.8274, 1.66, 0.412, 227, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3560, 1yarC, 0.8274, 1.77, 0.401, 237, 222, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3561, 5m32S, 0.8273, 1.66, 0.412, 227, 221, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3562, 5lf7G, 0.8272, 1.91, 0.404, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3563, 5le5G, 0.8272, 1.66, 0.412, 227, 221, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3564, 5dsvM, 0.8272, 1.66, 0.412, 227, 221, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3565, 5t0hG, 0.8271, 1.87, 0.368, 241, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3566, 2ku1E, 0.8271, 1.57, 0.414, 222, 220, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3567, 5lf1G, 0.8270, 2.69, 0.363, 249, 234, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3568, 1yarD, 0.8270, 1.87, 0.368, 241, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3569, 5lf6G, 0.8269, 1.66, 0.412, 227, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3570, 5lf4G, 0.8269, 1.66, 0.412, 227, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3571, 2ku1G, 0.8269, 1.66, 0.412, 227, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3572, 6epfD, 0.8268, 1.82, 0.401, 237, 222, GROUND STATE 26S PROTEASOME (GS1)
3573, 5m32E, 0.8266, 1.81, 0.401, 237, 222, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3574, 5wvkV, 0.8265, 1.81, 0.401, 237, 222, 
3575, 4cr2A, 0.8265, 2.32, 0.338, 243, 228, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3576, 1yarB, 0.8265, 1.67, 0.412, 227, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3577, 3c92U, 0.8264, 1.85, 0.401, 237, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3578, 3c92T, 0.8264, 1.67, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3579, 3c92S, 0.8264, 1.96, 0.350, 242, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3580, 3c92R, 0.8264, 2.06, 0.291, 242, 227, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3581, 3c92Q, 0.8264, 1.88, 0.368, 241, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3582, 3c92P, 0.8264, 1.88, 0.368, 241, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3583, 3c92O, 0.8264, 1.68, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3584, 3c92G, 0.8264, 1.68, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3585, 3c92F, 0.8264, 1.88, 0.368, 241, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3586, 3c92E, 0.8264, 1.59, 0.414, 222, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3587, 3c92D, 0.8264, 1.64, 0.285, 231, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3588, 3c92C, 0.8264, 2.06, 0.363, 240, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3589, 3c92B, 0.8264, 1.68, 0.403, 237, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3590, 3c92A, 0.8264, 1.53, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3591, 4g4sF, 0.8263, 1.55, 0.411, 221, 219, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3592, 6epeB, 0.8261, 1.53, 0.416, 221, 219, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3593, 5t0jK, 0.8261, 1.99, 0.311, 238, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3594, 1fntO, 0.8261, 1.89, 0.368, 241, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3595, 5mpbG, 0.8260, 1.89, 0.368, 241, 223, 
3596, 3jrmG, 0.8260, 1.80, 0.297, 239, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3597, 3jrmB, 0.8260, 2.13, 0.360, 240, 228, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3598, 3jrmA, 0.8260, 1.70, 0.403, 237, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3599, 3jrmD, 0.8259, 1.89, 0.368, 241, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3600, 3jrmC, 0.8259, 1.53, 0.416, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3601, 1fntA, 0.8259, 1.90, 0.368, 241, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3602, 5vy3Y, 0.8258, 1.89, 0.368, 241, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3603, 5vy3W, 0.8258, 1.71, 0.403, 237, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3604, 5vy3U, 0.8258, 2.17, 0.326, 246, 230, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3605, 5vy3S, 0.8258, 2.01, 0.311, 234, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3606, 5vy3Q, 0.8258, 1.98, 0.311, 243, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3607, 5vy3O, 0.8258, 2.04, 0.305, 243, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3608, 5vy3M, 0.8258, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3609, 5vy3K, 0.8258, 1.76, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3610, 5vy3I, 0.8258, 1.76, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3611, 5vy3G, 0.8258, 1.76, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3612, 5vy3E, 0.8258, 1.76, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3613, 5vy3C, 0.8258, 1.76, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3614, 5vy3A, 0.8258, 1.76, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3615, 5vy30, 0.8258, 1.76, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3616, 3jrmF, 0.8258, 1.76, 0.403, 224, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3617, 3c91U, 0.8258, 1.76, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3618, 3c91T, 0.8258, 1.76, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3619, 3c91S, 0.8258, 1.76, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3620, 3c91R, 0.8258, 1.76, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3621, 3c91Q, 0.8258, 1.76, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3622, 3c91P, 0.8258, 1.76, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3623, 3c91O, 0.8258, 1.66, 0.285, 234, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3624, 3c91G, 0.8258, 2.00, 0.612, 234, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3625, 3c91F, 0.8258, 1.90, 0.330, 228, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3626, 3c91E, 0.8258, 2.01, 0.307, 238, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3627, 3c91D, 0.8258, 2.06, 0.336, 243, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3628, 3c91C, 0.8258, 1.70, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3629, 3c91B, 0.8258, 1.70, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3630, 3c91A, 0.8258, 1.70, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3631, 1z7qO, 0.8258, 1.70, 0.412, 227, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3632, 1z7qA, 0.8258, 1.70, 0.412, 227, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3633, 1yarA, 0.8257, 2.02, 0.307, 238, 225, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3634, 4cr4G, 0.8256, 1.56, 0.411, 221, 219, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3635, 3jrmE, 0.8256, 1.56, 0.411, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3636, 1yauE, 0.8255, 1.56, 0.411, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3637, 4zzgT, 0.8252, 1.56, 0.411, 221, 219, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3638, 5vy4Y, 0.8250, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3639, 5vy4W, 0.8250, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3640, 5vy4U, 0.8250, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3641, 5vy4S, 0.8250, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3642, 5vy4Q, 0.8250, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3643, 5vy4O, 0.8250, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3644, 5vy4M, 0.8250, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3645, 5vy4K, 0.8250, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3646, 5vy4I, 0.8250, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3647, 5vy4G, 0.8250, 1.56, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3648, 5vy4E, 0.8250, 1.70, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3649, 5vy4C, 0.8250, 1.75, 0.403, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3650, 5vy4AA, 0.8250, 1.75, 0.403, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3651, 5vy4A, 0.8250, 1.75, 0.403, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3652, 5vy40, 0.8250, 1.75, 0.403, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3653, 5mp9F, 0.8249, 1.75, 0.403, 227, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3654, 3mg8S, 0.8249, 1.75, 0.403, 227, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3655, 5nifT, 0.8248, 1.75, 0.403, 227, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3656, 3sdkS, 0.8248, 1.75, 0.403, 227, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3657, 3dy3E, 0.8248, 1.75, 0.403, 227, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3658, 3dy3S, 0.8247, 1.75, 0.403, 227, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3659, 4hnpS, 0.8246, 1.75, 0.403, 227, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3660, 4zzgF, 0.8245, 1.75, 0.403, 227, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3661, 3sdkE, 0.8245, 1.75, 0.403, 227, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3662, 4intE, 0.8244, 1.75, 0.403, 227, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3663, 4fzgS, 0.8244, 2.19, 0.300, 243, 227, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3664, 4fzgE, 0.8244, 2.19, 0.300, 243, 227, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3665, 3bdmS, 0.8244, 1.56, 0.416, 221, 219, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3666, 4intS, 0.8243, 2.22, 0.335, 245, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3667, 4hnpE, 0.8243, 1.71, 0.412, 227, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3668, 3sdiE, 0.8243, 1.63, 0.414, 222, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3669, 3mg6S, 0.8243, 1.84, 0.284, 232, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3670, 3jtlG, 0.8243, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3671, 3jtlC, 0.8243, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3672, 3jtlB, 0.8243, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3673, 3bdmE, 0.8243, 1.55, 0.416, 221, 219, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3674, 4gk7S, 0.8242, 1.55, 0.416, 221, 219, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3675, 4gk7E, 0.8242, 1.55, 0.416, 221, 219, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3676, 3jtlD, 0.8242, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3677, 3jtlA, 0.8242, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3678, 3gpjS, 0.8242, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3679, 3gpjE, 0.8242, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3680, 4hrdS, 0.8241, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3681, 3jtlF, 0.8241, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3682, 3d29S, 0.8241, 1.55, 0.416, 221, 219, PROTEASOME INHIBITION BY FELLUTAMIDE B
3683, 3d29E, 0.8241, 1.55, 0.416, 221, 219, PROTEASOME INHIBITION BY FELLUTAMIDE B
3684, 2zcyS, 0.8241, 1.55, 0.416, 221, 219, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3685, 2zcyE, 0.8241, 1.55, 0.416, 221, 219, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3686, 6bdfY, 0.8240, 1.82, 0.284, 233, 222, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3687, 6bdfW, 0.8240, 1.85, 0.284, 233, 222, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3688, 6bdfU, 0.8240, 1.85, 0.284, 232, 222, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3689, 6bdfS, 0.8240, 1.85, 0.284, 233, 222, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3690, 6bdfQ, 0.8240, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3691, 6bdfO, 0.8240, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3692, 6bdfM, 0.8240, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3693, 6bdfK, 0.8240, 1.68, 0.285, 232, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3694, 6bdfI, 0.8240, 1.85, 0.284, 233, 222, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3695, 6bdfG, 0.8240, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3696, 6bdfE, 0.8240, 1.69, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3697, 6bdfC, 0.8240, 1.69, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3698, 6bdfA, 0.8240, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3699, 6bdf0, 0.8240, 1.69, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3700, 5nifF, 0.8240, 1.68, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3701, 4fzcS, 0.8240, 1.85, 0.284, 230, 222, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3702, 4fzcE, 0.8240, 1.86, 0.284, 233, 222, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3703, 3jtlE, 0.8240, 1.74, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3704, 3dy4S, 0.8240, 1.74, 0.412, 227, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3705, 3dy4E, 0.8240, 1.74, 0.412, 227, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3706, 1yarE, 0.8240, 1.68, 0.285, 233, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3707, 1ya7E, 0.8240, 1.69, 0.285, 233, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3708, 6epfG, 0.8239, 1.69, 0.285, 233, 221, GROUND STATE 26S PROTEASOME (GS1)
3709, 4hrdE, 0.8239, 1.74, 0.412, 227, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3710, 5wvkO, 0.8238, 1.74, 0.412, 227, 221, 
3711, 3nzjS, 0.8238, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3712, 3mg7S, 0.8238, 1.69, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3713, 1pmaO, 0.8238, 1.68, 0.285, 233, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3714, 1pmaD, 0.8238, 1.74, 0.412, 227, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3715, 4lqiS, 0.8237, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3716, 4lqiE, 0.8237, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3717, 3un8E, 0.8237, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3718, 3nzjE, 0.8237, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3719, 5wviAA, 0.8236, 1.58, 0.416, 221, 219, 
3720, 4eu2F, 0.8236, 1.58, 0.416, 221, 219, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3721, 3un8S, 0.8236, 1.58, 0.416, 221, 219, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3722, 3mg6E, 0.8236, 1.58, 0.416, 221, 219, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3723, 1z7qT, 0.8236, 1.58, 0.416, 221, 219, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3724, 1z7qF, 0.8236, 1.58, 0.416, 221, 219, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3725, 5t0iG, 0.8234, 1.58, 0.416, 221, 219, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3726, 5lajS, 0.8234, 1.58, 0.416, 221, 219, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3727, 5lajE, 0.8234, 1.58, 0.416, 221, 219, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3728, 3oevE, 0.8234, 1.58, 0.416, 221, 219, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3729, 3oeuS, 0.8234, 1.58, 0.416, 221, 219, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3730, 3oeuE, 0.8234, 1.58, 0.416, 221, 219, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3731, 1pmaN, 0.8234, 1.58, 0.416, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3732, 1pmaH, 0.8234, 1.58, 0.416, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3733, 4j70E, 0.8233, 1.69, 0.285, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3734, 1pmaJ, 0.8233, 1.69, 0.285, 233, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3735, 1pmaF, 0.8233, 1.69, 0.285, 233, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3736, 5t0gL, 0.8232, 1.74, 0.412, 227, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3737, 5l5uS, 0.8232, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3738, 5l5uE, 0.8232, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3739, 5dkjS, 0.8232, 1.59, 0.416, 221, 219, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3740, 5dkjE, 0.8232, 1.74, 0.412, 227, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3741, 4r18S, 0.8232, 2.15, 0.288, 245, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3742, 4r18E, 0.8232, 1.69, 0.285, 233, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3743, 4jt0E, 0.8232, 2.00, 0.302, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3744, 4jsqS, 0.8232, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3745, 4jsqE, 0.8232, 1.87, 0.284, 233, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3746, 4j70S, 0.8232, 1.59, 0.406, 221, 219, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3747, 1pmaL, 0.8232, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3748, 1pmaG, 0.8232, 1.70, 0.285, 233, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3749, 1pmaE, 0.8232, 1.70, 0.285, 233, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3750, 5l6cS, 0.8231, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3751, 5l6cE, 0.8231, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3752, 5l67S, 0.8231, 2.00, 0.350, 242, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3753, 5l67E, 0.8231, 1.70, 0.285, 232, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3754, 5l62S, 0.8231, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3755, 5l62E, 0.8231, 1.87, 0.284, 233, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3756, 5l61S, 0.8231, 1.70, 0.285, 234, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3757, 5l61E, 0.8231, 1.70, 0.285, 234, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3758, 5l5zS, 0.8231, 2.18, 0.351, 240, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3759, 5l5zE, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3760, 5l5tS, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3761, 5l5tE, 0.8231, 1.87, 0.284, 233, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3762, 5l5sS, 0.8231, 1.87, 0.284, 233, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3763, 5l5sE, 0.8231, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3764, 5l5pS, 0.8231, 1.59, 0.406, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3765, 5l5pE, 0.8231, 1.59, 0.406, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3766, 4jt0S, 0.8231, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3767, 4jsuS, 0.8231, 1.59, 0.406, 221, 219, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3768, 4jsuE, 0.8231, 1.59, 0.406, 221, 219, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3769, 3un4S, 0.8231, 1.85, 0.317, 238, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3770, 3un4E, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3771, 3mg8E, 0.8231, 1.70, 0.285, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3772, 3mg7E, 0.8231, 1.70, 0.285, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3773, 3mg0S, 0.8231, 1.70, 0.285, 231, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3774, 3mg0E, 0.8231, 1.70, 0.285, 231, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3775, 1pmaM, 0.8231, 1.70, 0.285, 231, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3776, 1pmaI, 0.8231, 1.70, 0.285, 233, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3777, 1pmaC, 0.8231, 1.70, 0.285, 233, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3778, 5lttS, 0.8230, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3779, 5lttE, 0.8230, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3780, 5l69S, 0.8230, 1.60, 0.406, 221, 219, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3781, 5l69E, 0.8230, 1.59, 0.406, 221, 219, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3782, 5l60S, 0.8230, 1.59, 0.406, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3783, 5l60E, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3784, 5l5vS, 0.8230, 1.70, 0.285, 231, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3785, 5l5vE, 0.8230, 1.70, 0.285, 231, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3786, 5l5qS, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3787, 5l5qE, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3788, 5l5jS, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3789, 5l5jE, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3790, 5cz7S, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3791, 5cz7E, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3792, 4qw0S, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3793, 4qw0E, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3794, 4qvyS, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3795, 4qvyE, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3796, 4q1sE, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3797, 1pmaA, 0.8230, 1.70, 0.285, 231, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3798, 1fntF, 0.8230, 1.70, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3799, 5l6bS, 0.8229, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3800, 5l6bE, 0.8229, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3801, 5l64S, 0.8229, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3802, 5l64E, 0.8229, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3803, 5l63S, 0.8229, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3804, 5l63E, 0.8229, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3805, 5l5xS, 0.8229, 1.87, 0.284, 233, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3806, 5l5xE, 0.8229, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3807, 5l5wS, 0.8229, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3808, 5l5wE, 0.8229, 1.60, 0.406, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3809, 5l5oS, 0.8229, 1.60, 0.406, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3810, 5l5oE, 0.8229, 1.60, 0.406, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3811, 5l5iS, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3812, 5l5iE, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3813, 5l5hS, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3814, 5l5hE, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3815, 5fgaS, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3816, 5fgaE, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3817, 5d0tE, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3818, 5cz6S, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3819, 5cz6E, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3820, 4x6zF, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3821, 4qzzS, 0.8229, 1.70, 0.285, 231, 221, YCP IN COMPLEX WITH OMURALIDE
3822, 4qzzE, 0.8229, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH OMURALIDE
3823, 4inrE, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3824, 4hrcE, 0.8229, 1.70, 0.285, 231, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3825, 1pmaK, 0.8229, 1.70, 0.285, 231, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3826, 1fntT, 0.8229, 1.70, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3827, 6gopS, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3828, 6gopE, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3829, 5mpaA, 0.8228, 1.70, 0.285, 233, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3830, 5l6aS, 0.8228, 1.60, 0.406, 221, 219, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3831, 5l6aE, 0.8228, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3832, 5l68S, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3833, 5l68E, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3834, 5l66S, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3835, 5l66E, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3836, 5l65S, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3837, 5l65E, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3838, 5l5yS, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3839, 5l5yE, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3840, 5l5fS, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3841, 5l5fE, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3842, 5l5eS, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3843, 5l5eE, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3844, 5l5aS, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3845, 5l5aE, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3846, 5dkiS, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3847, 5dkiE, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3848, 5d0tS, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3849, 4qz6S, 0.8228, 1.71, 0.285, 231, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3850, 4qz6E, 0.8228, 1.71, 0.285, 231, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3851, 4qvvS, 0.8228, 1.71, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3852, 4qvvE, 0.8228, 1.71, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3853, 4qvlE, 0.8228, 1.71, 0.285, 232, 221, YCP IN COMPLEX WITH BORTEZOMIB
3854, 3nzwS, 0.8228, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3855, 3nzwE, 0.8228, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3856, 2fakE, 0.8228, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3857, 1rypF, 0.8228, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3858, 5l5rS, 0.8227, 1.60, 0.406, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3859, 5l5dS, 0.8227, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3860, 5l5dE, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3861, 5l5bS, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3862, 5fghS, 0.8227, 2.09, 0.310, 241, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3863, 5fghE, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3864, 5fgfS, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3865, 5fgfE, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3866, 5fg9S, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3867, 5fg9E, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3868, 5d0xS, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3869, 5d0xE, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3870, 5czaS, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3871, 5czaE, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3872, 5cgfS, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3873, 5cgfE, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3874, 4x6zT, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3875, 4r00S, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3876, 4r00E, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3877, 4qvlS, 0.8227, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH BORTEZOMIB
3878, 4qv6S, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-A49V MUTANT
3879, 4qv6E, 0.8227, 1.70, 0.285, 231, 221, YCP BETA5-A49V MUTANT
3880, 4qv0S, 0.8227, 1.70, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3881, 4qv0E, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3882, 4ltcE, 0.8227, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3883, 3shjE, 0.8227, 1.71, 0.285, 231, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3884, 3hyeE, 0.8227, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3885, 2fakS, 0.8227, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3886, 5m2bS, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3887, 5m2bE, 0.8226, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3888, 5l5rE, 0.8226, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3889, 5l5bE, 0.8226, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3890, 5fg7S, 0.8226, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3891, 5fg7E, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3892, 5bxlS, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3893, 5bxlE, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3894, 5bouS, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3895, 5bouE, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3896, 4y9zS, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3897, 4y9zE, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3898, 4y8uS, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3899, 4y8uE, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3900, 4y8rS, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3901, 4y8rE, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3902, 4y70S, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3903, 4y70E, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3904, 4y69S, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3905, 4y69E, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3906, 4qz5S, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3907, 4qz5E, 0.8226, 1.71, 0.285, 232, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3908, 4qz3S, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3909, 4qz3E, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3910, 4qvwS, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3911, 4qvwE, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3912, 4qvpS, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3913, 4qvpE, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3914, 4qv8S, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT
3915, 4qv8E, 0.8226, 1.71, 0.285, 233, 221, YCP BETA5-C52F MUTANT
3916, 4quyS, 0.8226, 1.71, 0.285, 233, 221, YCP BETA5-A49S-MUTANT
3917, 4quyE, 0.8226, 1.71, 0.285, 233, 221, YCP BETA5-A49S-MUTANT
3918, 4quxS, 0.8226, 1.72, 0.285, 233, 221, YCP BETA5-A49T-MUTANT
3919, 4quxE, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49T-MUTANT
3920, 4nnnS, 0.8226, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH MG132
3921, 4nnnE, 0.8226, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH MG132
3922, 4inrS, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3923, 3wxrF, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3924, 3shjS, 0.8226, 1.71, 0.285, 231, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3925, 3hyeS, 0.8226, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3926, 3gpwS, 0.8226, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3927, 3gpwE, 0.8226, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3928, 3gptE, 0.8226, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3929, 2gplS, 0.8226, 1.71, 0.285, 231, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3930, 2gplE, 0.8226, 1.71, 0.285, 231, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3931, 5mp9f, 0.8225, 1.71, 0.285, 231, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3932, 5ln3D, 0.8225, 1.71, 0.285, 231, 221, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3933, 5cz9S, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3934, 5cz9E, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3935, 4y9yS, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3936, 4y9yE, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3937, 4y8mS, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3938, 4y8mE, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3939, 4y8jS, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3940, 4y8jE, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3941, 4y7wS, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3942, 4y7wE, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3943, 4y6aS, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3944, 4y6aE, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3945, 4qwuS, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3946, 4qwuE, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3947, 4qvmS, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3948, 4qvmE, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3949, 4qv9S, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT
3950, 4qv9E, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT
3951, 4qv7S, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-A50V MUTANT
3952, 4qv7E, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-A50V MUTANT
3953, 4ltcS, 0.8225, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3954, 3nzxS, 0.8225, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3955, 3nzxE, 0.8225, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3956, 3mg4E, 0.8225, 1.71, 0.285, 232, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3957, 3jcpOA, 0.8225, 1.71, 0.285, 233, 221, 
3958, 3jcpO, 0.8225, 1.71, 0.285, 233, 221, 
3959, 3gptS, 0.8225, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3960, 3e47E, 0.8225, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3961, 5fggS, 0.8224, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3962, 5fggE, 0.8224, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3963, 5fgeS, 0.8224, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3964, 5fgeE, 0.8224, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3965, 5cghS, 0.8224, 2.22, 0.309, 248, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3966, 5cghE, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3967, 5cggS, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3968, 5cggE, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3969, 5bxnS, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3970, 5bxnE, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3971, 4z1lE, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3972, 4ya7S, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3973, 4ya7E, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3974, 4ya5S, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3975, 4ya5E, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3976, 4ya4S, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3977, 4ya4E, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3978, 4ya1S, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3979, 4ya1E, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3980, 4y8nS, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3981, 4y8nE, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3982, 4y80S, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3983, 4y80E, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3984, 4y7yS, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3985, 4y7yE, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3986, 4y74S, 0.8224, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3987, 4y74E, 0.8224, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3988, 4y6vS, 0.8224, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3989, 4y6vE, 0.8224, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3990, 4rurS, 0.8224, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3991, 4rurE, 0.8224, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3992, 4qwjS, 0.8224, 1.72, 0.285, 233, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3993, 4qwjE, 0.8224, 1.71, 0.285, 233, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3994, 4qvqE, 0.8224, 1.72, 0.285, 233, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3995, 4qv1S, 0.8224, 1.72, 0.285, 231, 221, YCP BETA5-M45A MUTANT
3996, 4qv1E, 0.8224, 1.72, 0.285, 231, 221, YCP BETA5-M45A MUTANT
3997, 4nnwS, 0.8224, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3998, 4nnwE, 0.8224, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3999, 3e47S, 0.8224, 1.72, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4000, 5vfoJ, 0.8223, 1.72, 0.285, 231, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4001, 5laiS, 0.8223, 1.72, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4002, 5laiE, 0.8223, 1.72, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4003, 5jhsS, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4004, 5jhsE, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4005, 5jhrS, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4006, 5jhrE, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4007, 5fhsS, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4008, 5fhsE, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4009, 5fgiS, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4010, 5fgiE, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4011, 5fgdS, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4012, 5fgdE, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4013, 5d0wS, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4014, 5d0wE, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4015, 5cz8S, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4016, 5cz8E, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4017, 5a0qS, 0.8223, 1.71, 0.285, 231, 221, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4018, 5a0qE, 0.8223, 1.71, 0.285, 231, 221, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4019, 4z1lS, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4020, 4y8iS, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4021, 4y8iE, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4022, 4r02E, 0.8223, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4023, 4qwkS, 0.8223, 1.71, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4024, 4qwkE, 0.8223, 1.71, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4025, 4qwiS, 0.8223, 1.71, 0.285, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4026, 4qwiE, 0.8223, 1.71, 0.285, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4027, 4qw7E, 0.8223, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4028, 4qw4E, 0.8223, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH CARFILZOMIB
4029, 4qw1S, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4030, 4qw1E, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4031, 4qvqS, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4032, 4qvnS, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4033, 4qvnE, 0.8223, 1.72, 0.285, 233, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4034, 1g65E, 0.8223, 2.04, 0.338, 239, 225, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4035, 5d0vS, 0.8222, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4036, 5d0vE, 0.8222, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4037, 5d0sS, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4038, 5d0sE, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4039, 5cz4S, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4040, 4ya0S, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4041, 4ya0E, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4042, 4y8pS, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4043, 4y8pE, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4044, 4y8lS, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4045, 4y8lE, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4046, 4r17S, 0.8222, 1.72, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4047, 4r17E, 0.8222, 1.72, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4048, 4r02S, 0.8222, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4049, 4qzwS, 0.8222, 1.72, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4050, 4qzwE, 0.8222, 1.72, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4051, 4qz4S, 0.8222, 1.30, 0.349, 215, 215, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4052, 4qz4E, 0.8222, 1.30, 0.349, 215, 215, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4053, 4qwrS, 0.8222, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4054, 4qwrE, 0.8222, 1.72, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4055, 4qw7S, 0.8222, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4056, 4qw4S, 0.8222, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH CARFILZOMIB
4057, 4qv3E, 0.8222, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT
4058, 3tddS, 0.8222, 1.72, 0.285, 231, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4059, 3tddE, 0.8222, 1.72, 0.285, 231, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4060, 5cz4E, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4061, 4ya9S, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4062, 4ya9E, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4063, 4ya3S, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4064, 4ya3E, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4065, 4y78S, 0.8221, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4066, 4y78E, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4067, 4y77S, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4068, 4y77E, 0.8221, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4069, 4qz7E, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4070, 4qwlE, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4071, 4qw6S, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4072, 4qw6E, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4073, 4qw5S, 0.8221, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4074, 4qw5E, 0.8221, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4075, 4qw3S, 0.8221, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4076, 4qw3E, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4077, 4qv4S, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45T MUTANT
4078, 4qv4E, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45T MUTANT
4079, 4qv3S, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT
4080, 4no9S, 0.8221, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4081, 4no9E, 0.8221, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4082, 4no1S, 0.8221, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4083, 4no1E, 0.8221, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4084, 4eu2T, 0.8221, 1.72, 0.285, 231, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4085, 2f16E, 0.8221, 1.72, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4086, 5d0zS, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4087, 5d0zE, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4088, 5cz5S, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4089, 5cz5E, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4090, 4y8qS, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4091, 4y8qE, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4092, 4y8oS, 0.8220, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4093, 4y8oE, 0.8220, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4094, 4y8kS, 0.8220, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4095, 4y8kE, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4096, 4y82S, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4097, 4y82E, 0.8220, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4098, 4y7xS, 0.8220, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4099, 4y7xE, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4100, 4y75S, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4101, 4y75E, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4102, 4y6zS, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4103, 4y6zE, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4104, 4qz7S, 0.8220, 1.72, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4105, 4qwlS, 0.8220, 1.72, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4106, 2f16S, 0.8220, 1.72, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4107, 5cgiS, 0.8219, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4108, 5cgiE, 0.8219, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4109, 4y81S, 0.8219, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4110, 4y81E, 0.8219, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4111, 4qwfS, 0.8219, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4112, 4qwfE, 0.8219, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4113, 4no8S, 0.8219, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4114, 4no8E, 0.8219, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4115, 4hrcS, 0.8219, 1.72, 0.285, 231, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4116, 1rypT, 0.8219, 1.72, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4117, 6epfE, 0.8218, 1.72, 0.285, 231, 221, GROUND STATE 26S PROTEASOME (GS1)
4118, 5l52S, 0.8218, 1.72, 0.285, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4119, 5l52E, 0.8218, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4120, 4y8tS, 0.8218, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4121, 4y8tE, 0.8218, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4122, 4qxjS, 0.8218, 1.72, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4123, 4qxjE, 0.8218, 1.72, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4124, 4qwxE, 0.8218, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4125, 4qv5S, 0.8218, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT
4126, 4qv5E, 0.8218, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT
4127, 4inuE, 0.8218, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4128, 5l55E, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4129, 4y8sS, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4130, 4qzxS, 0.8217, 1.72, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4131, 4qzxE, 0.8217, 1.72, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4132, 4qz0S, 0.8217, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4133, 4qz0E, 0.8217, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4134, 4qwxS, 0.8217, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4135, 4qlqS, 0.8217, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4136, 4qlqE, 0.8217, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4137, 5l55S, 0.8216, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4138, 4y8sE, 0.8216, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4139, 4qz2S, 0.8216, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4140, 4qz2E, 0.8216, 1.72, 0.285, 233, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4141, 4qz1S, 0.8216, 1.72, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4142, 4qz1E, 0.8216, 1.72, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4143, 4qwsS, 0.8216, 1.72, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4144, 4qwsE, 0.8216, 1.72, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4145, 4q1sS, 0.8216, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4146, 3wxrT, 0.8216, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4147, 3oevS, 0.8216, 1.72, 0.285, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4148, 3mg4S, 0.8216, 1.72, 0.285, 231, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4149, 1g0uE, 0.8216, 1.73, 0.285, 233, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4150, 4qwgS, 0.8215, 1.71, 0.285, 233, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4151, 4qwgE, 0.8215, 2.15, 0.323, 233, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4152, 5ahjE, 0.8214, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4153, 4inuS, 0.8214, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4154, 3okjS, 0.8214, 1.72, 0.285, 231, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4155, 3okjE, 0.8214, 1.72, 0.285, 231, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4156, 1g65S, 0.8214, 1.72, 0.285, 231, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4157, 6epeC, 0.8213, 1.72, 0.285, 231, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4158, 5l54S, 0.8213, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4159, 5l54E, 0.8213, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4160, 5ahjS, 0.8213, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4161, 4y8hS, 0.8213, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4162, 4y8hE, 0.8213, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4163, 4y8gS, 0.8213, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4164, 4y84S, 0.8213, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4165, 4y84E, 0.8213, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4166, 4qlsE, 0.8213, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4167, 4no6S, 0.8213, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4168, 4no6E, 0.8213, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4169, 3sdiS, 0.8213, 1.73, 0.285, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4170, 5mpaF, 0.8212, 1.73, 0.285, 231, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4171, 4y8gE, 0.8212, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4172, 4qlsS, 0.8212, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4173, 5vfqD, 0.8211, 1.73, 0.285, 231, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4174, 4ya2S, 0.8210, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4175, 4ya2E, 0.8210, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4176, 4qltS, 0.8210, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4177, 4qltE, 0.8210, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4178, 4qbyS, 0.8210, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4179, 4qbyE, 0.8210, 1.72, 0.285, 233, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4180, 4qluS, 0.8209, 1.73, 0.285, 232, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4181, 4qluE, 0.8209, 1.73, 0.285, 233, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4182, 5a5bF, 0.8208, 1.74, 0.285, 233, 221, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4183, 4cr3F, 0.8208, 1.72, 0.285, 230, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4184, 4v7oT, 0.8206, 1.73, 0.285, 231, 221, 
4185, 4v7oBB, 0.8206, 1.73, 0.285, 231, 221, 
4186, 4qlvS, 0.8206, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4187, 4qlvE, 0.8206, 1.73, 0.285, 233, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4188, 6epdA, 0.8205, 1.73, 0.285, 233, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4189, 4v7oNA, 0.8205, 1.73, 0.285, 233, 221, 
4190, 4v7oF, 0.8205, 1.73, 0.285, 233, 221, 
4191, 5vfrJ, 0.8203, 2.30, 0.339, 249, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4192, 5wvkT, 0.8200, 1.73, 0.285, 231, 221, 
4193, 1jd2E, 0.8198, 1.73, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4194, 5mpbF, 0.8197, 1.74, 0.285, 231, 221, 
4195, 4cr4A, 0.8197, 1.73, 0.285, 231, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4196, 1g0uS, 0.8194, 1.73, 0.285, 231, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4197, 6epeG, 0.8193, 1.73, 0.285, 231, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4198, 5vfpD, 0.8186, 1.73, 0.285, 231, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4199, 6epfF, 0.8185, 1.73, 0.285, 231, 221, GROUND STATE 26S PROTEASOME (GS1)
4200, 5mpbA, 0.8185, 1.73, 0.285, 231, 221, 
4201, 5lexU, 0.8185, 1.74, 0.285, 231, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4202, 5t0hL, 0.8184, 1.74, 0.285, 231, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4203, 5lezU, 0.8184, 1.73, 0.285, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4204, 1jd2Z, 0.8183, 1.87, 0.284, 233, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4205, 5lf3U, 0.8182, 1.73, 0.285, 231, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4206, 5lf0U, 0.8181, 1.73, 0.285, 231, 221, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4207, 5lf7U, 0.8180, 1.57, 0.321, 228, 224, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4208, 5fmgP, 0.8180, 2.05, 0.338, 239, 225, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4209, 5fmgB, 0.8180, 1.74, 0.285, 231, 221, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4210, 5fmgS, 0.8179, 1.74, 0.285, 231, 221, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4211, 5fmgE, 0.8179, 1.74, 0.285, 231, 221, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4212, 5leyU, 0.8178, 1.74, 0.285, 231, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4213, 5lf1U, 0.8177, 1.74, 0.285, 231, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4214, 5lf6U, 0.8175, 1.74, 0.285, 231, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4215, 5t0jL, 0.8174, 1.74, 0.285, 231, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4216, 5mpcO, 0.8173, 1.74, 0.285, 231, 221, 
4217, 5ln3A, 0.8172, 1.88, 0.284, 233, 222, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4218, 5lf4U, 0.8171, 1.88, 0.284, 233, 222, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4219, 6epeF, 0.8169, 1.76, 0.285, 234, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4220, 5mpbT, 0.8166, 1.76, 0.285, 234, 221, 
4221, 5mpbO, 0.8166, 1.74, 0.285, 231, 221, 
4222, 5wviX, 0.8155, 1.74, 0.285, 231, 221, 
4223, 5t0iK, 0.8154, 2.18, 0.348, 246, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4224, 6epcG, 0.8150, 1.76, 0.285, 234, 221, GROUND STATE 26S PROTEASOME (GS2)
4225, 5dsvC, 0.8149, 1.76, 0.285, 234, 221, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4226, 5t0iL, 0.8148, 2.06, 0.338, 239, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4227, 3jcoOA, 0.8147, 1.84, 0.284, 233, 222, 
4228, 3jcoO, 0.8147, 1.75, 0.285, 233, 221, 
4229, 6epcF, 0.8140, 1.92, 0.284, 231, 222, GROUND STATE 26S PROTEASOME (GS2)
4230, 5wvkAA, 0.8138, 2.23, 0.304, 243, 227, 
4231, 6epcE, 0.8137, 1.76, 0.285, 230, 221, GROUND STATE 26S PROTEASOME (GS2)
4232, 6epeD, 0.8134, 2.18, 0.292, 245, 226, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4233, 5wviY, 0.8134, 1.75, 0.317, 238, 224, 
4234, 4g4sD, 0.8127, 2.05, 0.338, 239, 225, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
4235, 6epdG, 0.8122, 1.98, 0.308, 238, 224, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4236, 5mpcA, 0.8113, 2.07, 0.307, 241, 225, 
4237, 5wviD, 0.8111, 2.00, 0.367, 235, 221, 
4238, 5wviF, 0.8109, 1.98, 0.317, 238, 224, 
4239, 5le5U, 0.8109, 1.99, 0.367, 235, 221, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4240, 4v7oR, 0.8104, 1.77, 0.285, 233, 221, 
4241, 4v7oLA, 0.8104, 1.99, 0.367, 235, 221, 
4242, 4v7oZA, 0.8103, 1.99, 0.367, 235, 221, 
4243, 4v7oD, 0.8103, 1.99, 0.367, 235, 221, 
4244, 5mpcT, 0.8099, 1.26, 0.528, 212, 212, 
4245, 4cr2F, 0.8099, 1.26, 0.528, 212, 212, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4246, 3ipmF, 0.8091, 1.60, 0.332, 217, 217, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4247, 3ipmE, 0.8091, 1.60, 0.332, 217, 217, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4248, 3ipmD, 0.8091, 2.00, 0.367, 235, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4249, 3ipmC, 0.8091, 2.00, 0.367, 235, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4250, 3ipmB, 0.8091, 2.00, 0.367, 235, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4251, 3ipmA, 0.8091, 1.94, 0.317, 238, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4252, 3ipmG, 0.8090, 2.07, 0.311, 241, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4253, 5t0iM, 0.8070, 2.22, 0.360, 239, 228, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4254, 5mpcF, 0.8057, 2.00, 0.367, 235, 221, 
4255, 5a5bA, 0.8050, 2.05, 0.308, 238, 224, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4256, 4cr3A, 0.8050, 1.91, 0.284, 233, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4257, 5fmgQ, 0.8047, 2.10, 0.307, 241, 225, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4258, 5fmgC, 0.8047, 2.22, 0.341, 245, 226, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4259, 5t0jH, 0.8045, 2.08, 0.320, 228, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4260, 4cr4F, 0.8044, 2.47, 0.284, 245, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4261, 5fmgO, 0.8041, 1.81, 0.297, 234, 219, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4262, 5fmgA, 0.8041, 2.01, 0.317, 238, 224, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4263, 6epcD, 0.8036, 1.84, 0.281, 233, 221, GROUND STATE 26S PROTEASOME (GS2)
4264, 5t0jJ, 0.8025, 1.84, 0.281, 233, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4265, 5ln3F, 0.8012, 1.84, 0.281, 233, 221, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4266, 6epeE, 0.8007, 2.17, 0.307, 238, 225, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4267, 5fmgT, 0.7999, 1.97, 0.284, 233, 222, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4268, 5fmgF, 0.7999, 2.24, 0.323, 233, 226, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4269, 6epdE, 0.7937, 2.14, 0.333, 246, 225, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4270, 5a0qR, 0.7922, 2.16, 0.305, 243, 226, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4271, 5a0qD, 0.7922, 1.53, 0.379, 220, 214, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4272, 6epdF, 0.7916, 2.56, 0.281, 245, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4273, 5wviZ, 0.7911, 2.16, 0.304, 241, 224, 
4274, 5wviG, 0.7910, 1.34, 1.000, 250, 250, 
4275, 5t0iJ, 0.7907, 2.19, 0.305, 243, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4276, 6epdD, 0.7864, 2.27, 0.341, 245, 226, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4277, 5fmgR, 0.7864, 1.87, 0.372, 232, 218, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4278, 5fmgD, 0.7864, 1.61, 0.358, 227, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4279, 5fmgU, 0.7855, 1.61, 0.358, 227, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4280, 5fmgG, 0.7855, 1.61, 0.358, 227, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4281, 5ts0G, 0.7799, 1.61, 0.358, 227, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4282, 5a0qU, 0.7782, 1.93, 0.285, 233, 221, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4283, 5a0qG, 0.7782, 2.04, 0.284, 233, 222, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4284, 5trgP, 0.7778, 1.96, 0.412, 227, 221, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4285, 5trsA, 0.7759, 1.96, 0.412, 227, 221, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4286, 5thoS, 0.7751, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4287, 5trgA, 0.7748, 1.96, 0.412, 227, 221, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4288, 5trrA, 0.7743, 1.96, 0.412, 227, 221, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4289, 5tryA, 0.7742, 1.96, 0.412, 227, 221, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4290, 5thoG, 0.7741, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4291, 5trsP, 0.7739, 2.40, 0.295, 240, 227, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4292, 5ts0A, 0.7734, 2.09, 0.284, 231, 222, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4293, 5thoA, 0.7734, 2.35, 0.305, 243, 226, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4294, 5trsC, 0.7730, 2.35, 0.305, 243, 226, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4295, 5ts0T, 0.7729, 1.61, 0.347, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4296, 5tryQ, 0.7728, 1.61, 0.347, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4297, 5trrP, 0.7728, 2.23, 0.596, 232, 225, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4298, 3mi0F, 0.7728, 2.09, 0.284, 233, 222, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4299, 3mfeI, 0.7727, 1.82, 0.312, 219, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4300, 5trsD, 0.7726, 1.82, 0.312, 219, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4301, 5ts0U, 0.7724, 2.49, 0.323, 246, 229, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4302, 5ts0Q, 0.7724, 2.27, 0.338, 239, 225, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4303, 3mkaA, 0.7724, 2.14, 0.315, 233, 222, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4304, 5tryS, 0.7723, 2.57, 0.320, 233, 228, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4305, 5tryF, 0.7721, 1.61, 0.329, 219, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4306, 3mkaU, 0.7719, 1.61, 0.329, 219, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4307, 3h6iQ, 0.7719, 2.60, 0.322, 233, 227, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4308, 2fhgW, 0.7717, 1.62, 0.341, 214, 211, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4309, 2fhgQ, 0.7716, 1.62, 0.341, 214, 211, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4310, 2fhgI, 0.7716, 2.35, 0.308, 238, 224, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4311, 2fhgF, 0.7716, 2.12, 0.285, 233, 221, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4312, 2fhgA, 0.7716, 2.12, 0.285, 233, 221, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4313, 2fhgU, 0.7715, 2.42, 0.316, 239, 225, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4314, 2fhgO, 0.7715, 2.69, 0.330, 246, 230, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4315, 2fhgM, 0.7715, 1.64, 0.388, 215, 209, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4316, 2fhgD, 0.7715, 1.64, 0.388, 215, 209, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4317, 2fhgB, 0.7715, 2.13, 0.231, 219, 216, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4318, 2fhg1, 0.7715, 2.13, 0.231, 219, 216, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4319, 5ts0B, 0.7714, 2.11, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4320, 2fhgY, 0.7714, 1.66, 0.304, 209, 207, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4321, 2fhgS, 0.7714, 1.66, 0.304, 209, 207, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4322, 2fhgK, 0.7714, 2.08, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4323, 5ts0E, 0.7713, 2.11, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4324, 5trrS, 0.7713, 2.29, 0.181, 221, 216, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4325, 5trgS, 0.7713, 2.06, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4326, 5trgO, 0.7713, 2.07, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4327, 5thoE, 0.7712, 2.08, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4328, 5ts0P, 0.7711, 2.09, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4329, 5ts0C, 0.7711, 2.17, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4330, 5trsU, 0.7710, 2.09, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4331, 5trrU, 0.7710, 2.09, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4332, 5trrT, 0.7710, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4333, 3mfeK, 0.7710, 2.11, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4334, 5trrE, 0.7709, 2.12, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4335, 5thoO, 0.7708, 2.21, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4336, 3mkaF, 0.7708, 2.33, 0.182, 220, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4337, 3mkaM, 0.7707, 2.03, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4338, 5trsS, 0.7705, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4339, 5trsE, 0.7705, 2.05, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4340, 2fhhW, 0.7705, 2.12, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4341, 2fhhO, 0.7705, 2.37, 0.181, 222, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4342, 2fhhD, 0.7705, 2.19, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4343, 5ts0D, 0.7704, 2.11, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4344, 5trgU, 0.7704, 2.39, 0.181, 221, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4345, 2fhhU, 0.7704, 2.22, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4346, 2fhhM, 0.7704, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4347, 2fhhA, 0.7704, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4348, 5ts0R, 0.7703, 2.31, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4349, 5tryP, 0.7703, 2.31, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4350, 2fhhY, 0.7703, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4351, 2fhhS, 0.7703, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4352, 2fhhK, 0.7703, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4353, 2fhhI, 0.7703, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4354, 2fhhF, 0.7703, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4355, 2fhhB, 0.7703, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4356, 5tryU, 0.7702, 2.31, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4357, 3hfaB, 0.7702, 2.02, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4358, 3h6iF, 0.7702, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4359, 2fhhQ, 0.7702, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4360, 2fhh1, 0.7702, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4361, 5trsB, 0.7700, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4362, 5ts0S, 0.7699, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4363, 5trsT, 0.7699, 2.15, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4364, 5trrC, 0.7699, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4365, 5trgE, 0.7698, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4366, 5trrO, 0.7697, 2.15, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4367, 5thoU, 0.7697, 2.08, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4368, 5thoF, 0.7696, 2.01, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4369, 5tryE, 0.7695, 2.01, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4370, 5tryD, 0.7695, 2.07, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4371, 5thoT, 0.7695, 2.01, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4372, 5thoR, 0.7695, 2.08, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4373, 3mkaS, 0.7695, 2.15, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4374, 5thoC, 0.7694, 2.30, 0.182, 221, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4375, 5tryR, 0.7692, 2.49, 0.181, 224, 216, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4376, 3mkaB, 0.7692, 2.16, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4377, 3h6fQ, 0.7691, 2.09, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4378, 5trgT, 0.7690, 2.33, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4379, 3mfeB, 0.7689, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4380, 5trsO, 0.7688, 2.33, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4381, 5trrG, 0.7688, 2.09, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4382, 5trrD, 0.7687, 2.02, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4383, 5thoP, 0.7686, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4384, 5lzpD, 0.7685, 2.33, 0.181, 220, 215, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4385, 3mkaW, 0.7685, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4386, 3mkaK, 0.7685, 2.10, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4387, 3h6fW, 0.7685, 2.12, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4388, 3h6iW, 0.7684, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4389, 3h6fF, 0.7683, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4390, 2h6jB, 0.7683, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4391, 5trgQ, 0.7682, 2.33, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4392, 5trgD, 0.7682, 2.33, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4393, 3h6iK, 0.7682, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4394, 5trsG, 0.7681, 2.02, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4395, 5thoQ, 0.7681, 1.91, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4396, 5tryT, 0.7680, 2.10, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4397, 5tryC, 0.7680, 2.33, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4398, 3mkaO, 0.7679, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4399, 2h6jA, 0.7679, 2.04, 0.185, 216, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4400, 1q5qC, 0.7679, 2.18, 0.183, 218, 213, THE RHODOCOCCUS 20S PROTEASOME
4401, 3h6iA, 0.7678, 2.10, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4402, 1q5qF, 0.7678, 2.08, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME
4403, 1q5qE, 0.7678, 2.15, 0.183, 218, 213, THE RHODOCOCCUS 20S PROTEASOME
4404, 1q5qD, 0.7678, 2.11, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME
4405, 1q5qB, 0.7678, 2.04, 0.185, 216, 211, THE RHODOCOCCUS 20S PROTEASOME
4406, 1q5qA, 0.7678, 2.11, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME
4407, 5ts0O, 0.7677, 2.11, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4408, 2h6jG, 0.7677, 2.11, 0.184, 217, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4409, 1q5qG, 0.7677, 2.10, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME
4410, 5tryG, 0.7676, 2.11, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4411, 5trsQ, 0.7676, 2.34, 0.187, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4412, 2h6jF, 0.7676, 2.11, 0.184, 217, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4413, 2h6jD, 0.7676, 2.11, 0.184, 217, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4414, 2h6jE, 0.7675, 2.36, 0.182, 220, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4415, 2h6jC, 0.7675, 2.20, 0.184, 217, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4416, 1q5rF, 0.7675, 2.12, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4417, 1q5rE, 0.7675, 2.05, 0.185, 216, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4418, 1q5rD, 0.7675, 2.13, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4419, 1q5rB, 0.7675, 2.05, 0.185, 216, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4420, 1q5rA, 0.7675, 2.06, 0.185, 216, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4421, 1q5rG, 0.7674, 2.14, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4422, 1q5rC, 0.7674, 2.13, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4423, 3mkaQ, 0.7673, 2.22, 0.184, 221, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4424, 3h6fK, 0.7670, 2.39, 0.182, 221, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4425, 5trrB, 0.7669, 2.17, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4426, 5trgB, 0.7668, 2.19, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4427, 5trgG, 0.7667, 2.07, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4428, 3mfeS, 0.7667, 2.30, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4429, 3mkaY, 0.7666, 2.15, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4430, 5thoD, 0.7665, 2.28, 0.183, 223, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4431, 3h6i1, 0.7665, 2.25, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4432, 3krdF, 0.7664, 2.07, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4433, 3h6iI, 0.7663, 2.09, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4434, 3h6f1, 0.7663, 2.06, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4435, 3mkaD, 0.7662, 2.05, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4436, 5trgC, 0.7660, 2.31, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4437, 5thoB, 0.7660, 2.31, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4438, 3h6iM, 0.7659, 2.29, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4439, 3mi0U, 0.7658, 2.08, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4440, 3h6iU, 0.7658, 2.29, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4441, 5tryB, 0.7656, 2.29, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4442, 5trsR, 0.7656, 2.29, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4443, 3h6fA, 0.7653, 2.29, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4444, 3mka1, 0.7652, 2.29, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4445, 5trgF, 0.7651, 2.08, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4446, 3mi0O, 0.7651, 2.31, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4447, 5trrQ, 0.7649, 2.29, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4448, 3mi0M, 0.7649, 2.07, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4449, 3mi0K, 0.7648, 2.09, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4450, 5trsF, 0.7646, 2.31, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4451, 3krdY, 0.7645, 2.31, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4452, 3h6fS, 0.7645, 2.31, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4453, 3mi0S, 0.7643, 2.31, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4454, 3h6iO, 0.7639, 2.32, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4455, 3mi01, 0.7637, 2.32, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4456, 3h6fO, 0.7637, 2.32, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4457, 3h6iS, 0.7636, 2.32, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4458, 5trrR, 0.7635, 2.32, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4459, 5ts0F, 0.7634, 2.32, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4460, 3hfaA, 0.7634, 2.32, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4461, 3h6fI, 0.7634, 2.29, 0.183, 222, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4462, 3mi0Y, 0.7633, 2.01, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4463, 5lzp2, 0.7632, 2.03, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4464, 3krdI, 0.7632, 2.03, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4465, 5lzp4, 0.7631, 2.09, 0.185, 216, 211, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4466, 5tryO, 0.7630, 2.03, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4467, 5lzp0, 0.7630, 2.24, 0.183, 224, 213, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4468, 5lzp6, 0.7629, 2.10, 0.185, 216, 211, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4469, 5lzpY, 0.7628, 2.02, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4470, 5lzp8, 0.7627, 2.11, 0.185, 216, 211, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4471, 5lzpW, 0.7626, 2.02, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4472, 3mfeY, 0.7626, 2.02, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4473, 3hfaS, 0.7626, 2.30, 0.183, 222, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4474, 3hfa1, 0.7626, 2.11, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4475, 3hfaW, 0.7625, 2.05, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4476, 3hfaQ, 0.7624, 2.17, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4477, 5trgR, 0.7623, 2.19, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4478, 3krdS, 0.7623, 2.05, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4479, 3hfaO, 0.7623, 2.05, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4480, 3hfaM, 0.7623, 2.13, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4481, 3mi0W, 0.7622, 2.04, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4482, 3hfaU, 0.7622, 2.41, 0.183, 219, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4483, 3hfaK, 0.7622, 2.06, 0.181, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4484, 3hfaI, 0.7622, 2.20, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4485, 3hfaF, 0.7622, 2.07, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4486, 3h6iB, 0.7622, 2.19, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4487, 5trrF, 0.7621, 2.24, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4488, 3krdW, 0.7619, 2.13, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4489, 3h6fM, 0.7619, 2.18, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4490, 3h6fD, 0.7619, 2.07, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4491, 3mi0A, 0.7618, 2.25, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4492, 3krd1, 0.7618, 2.08, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4493, 3hfaY, 0.7618, 2.15, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4494, 5lzpH, 0.7616, 2.09, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4495, 5lzpJ, 0.7615, 2.08, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4496, 3mi0I, 0.7614, 2.08, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4497, 3h6fB, 0.7612, 2.09, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4498, 3mi0Q, 0.7611, 2.03, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4499, 3mfeA, 0.7611, 2.01, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4500, 3krdK, 0.7610, 2.30, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4501, 3krdQ, 0.7607, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4502, 3h6fU, 0.7606, 2.14, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4503, 3mi0D, 0.7605, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4504, 5lzpS, 0.7603, 2.15, 0.185, 216, 211, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4505, 3h6iD, 0.7602, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4506, 3krdO, 0.7601, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4507, 3hfaD, 0.7601, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4508, 3mfeO, 0.7591, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4509, 3mfe1, 0.7591, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4510, 3h6fY, 0.7590, 1.98, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4511, 3krdU, 0.7589, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4512, 3hf9I, 0.7587, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4513, 6bgoN, 0.7585, 2.04, 0.187, 214, 209, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4514, 5lzpQ, 0.7583, 2.05, 0.187, 214, 209, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4515, 3krdA, 0.7583, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4516, 5lzpB, 0.7582, 2.12, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4517, 3mkaI, 0.7582, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4518, 6bgoJ, 0.7578, 2.05, 0.187, 214, 209, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4519, 5lzpM, 0.7578, 2.31, 0.190, 216, 211, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4520, 3krdM, 0.7575, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4521, 3mfeD, 0.7574, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4522, 3krdB, 0.7569, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4523, 3krdD, 0.7567, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4524, 3mfeQ, 0.7564, 2.06, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4525, 3hf9y, 0.7561, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4526, 6bgoK, 0.7560, 2.11, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4527, 3h6iY, 0.7560, 2.18, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4528, 6bgoO, 0.7559, 2.03, 0.187, 214, 209, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4529, 6bgoM, 0.7559, 2.17, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4530, 6bgoL, 0.7559, 2.13, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4531, 6bgoI, 0.7559, 2.07, 0.187, 214, 209, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4532, 6bgoH, 0.7559, 2.16, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4533, 6bgoG, 0.7559, 2.13, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4534, 6bgoF, 0.7559, 2.34, 0.180, 216, 211, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4535, 6bgoE, 0.7559, 2.07, 0.187, 214, 209, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4536, 6bgoD, 0.7559, 2.22, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4537, 6bgoC, 0.7559, 2.06, 0.187, 214, 209, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4538, 6bgoA, 0.7559, 2.18, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4539, 6bglO, 0.7559, 2.10, 0.187, 214, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4540, 6bglN, 0.7559, 2.09, 0.187, 214, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4541, 6bglM, 0.7559, 2.10, 0.187, 214, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4542, 6bglL, 0.7559, 2.21, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4543, 6bglK, 0.7559, 2.01, 0.187, 213, 208, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4544, 6bglJ, 0.7559, 2.14, 0.187, 214, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4545, 6bglI, 0.7559, 2.03, 0.187, 213, 208, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4546, 6bglH, 0.7559, 2.07, 0.187, 214, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4547, 6bglG, 0.7559, 2.01, 0.187, 213, 208, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4548, 6bglF, 0.7559, 2.03, 0.183, 213, 208, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4549, 6bglE, 0.7559, 2.12, 0.187, 214, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4550, 6bglD, 0.7559, 1.96, 0.188, 212, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4551, 6bglC, 0.7559, 2.40, 0.184, 219, 212, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4552, 6bglA, 0.7559, 2.11, 0.187, 214, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4553, 3hf9s, 0.7559, 2.16, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4554, 3mfeU, 0.7557, 2.13, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4555, 3hf9b, 0.7555, 2.26, 0.186, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4556, 3hf9f, 0.7554, 2.46, 0.184, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4557, 3hf9u, 0.7553, 2.14, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4558, 3hf9K, 0.7550, 2.14, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4559, 3hf9i, 0.7548, 2.05, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4560, 3hf9S, 0.7547, 2.08, 0.183, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4561, 3hf9B, 0.7546, 2.10, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4562, 3hf9k, 0.7545, 2.07, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4563, 3mi0B, 0.7543, 1.94, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4564, 3hf9A, 0.7542, 2.26, 0.186, 219, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4565, 3hf9U, 0.7539, 2.10, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4566, 3hf9w, 0.7538, 2.26, 0.186, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4567, 3hf91, 0.7538, 2.26, 0.186, 219, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4568, 3hf9O, 0.7537, 2.26, 0.186, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4569, 3hf9d, 0.7537, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4570, 3hf9Q, 0.7533, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4571, 3hf9o, 0.7532, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4572, 3hf9a, 0.7532, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4573, 3hf9Y, 0.7523, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4574, 3hf9q, 0.7523, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4575, 3hf93, 0.7511, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4576, 3mfeW, 0.7490, 2.26, 0.186, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4577, 3hf9D, 0.7475, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4578, 3hf9m, 0.7438, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4579, 3hf9M, 0.7358, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4580, 5a0qO, 0.7270, 2.26, 0.186, 215, 210, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4581, 5a0qA, 0.7270, 2.26, 0.186, 215, 210, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4582, 5a0qT, 0.7228, 2.26, 0.186, 215, 210, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4583, 5a0qF, 0.7227, 2.26, 0.186, 215, 210, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4584, 3h4pl, 0.7095, 2.26, 0.186, 215, 210, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4585, 3h4pk, 0.7092, 2.26, 0.186, 215, 210, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4586, 3h4pj, 0.7090, 2.26, 0.186, 215, 210, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4587, 3h4pe, 0.7090, 2.26, 0.186, 215, 210, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4588, 3h4pc, 0.7088, 2.26, 0.186, 215, 210, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4589, 3h4pn, 0.7087, 2.26, 0.186, 215, 210, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4590, 3h4pi, 0.7087, 2.26, 0.186, 215, 210, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4591, 3h4pg, 0.7087, 1.98, 0.189, 211, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4592, 3h4pb, 0.7087, 2.03, 0.188, 212, 207, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4593, 3h4pf, 0.7086, 1.96, 0.189, 211, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4594, 3h4pa, 0.7086, 1.98, 0.189, 211, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4595, 3h4pd, 0.7077, 1.96, 0.189, 211, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4596, 3h4ph, 0.7074, 1.99, 0.189, 211, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4597, 3h4pm, 0.7073, 1.96, 0.189, 211, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4598, 6bdfZ, 0.7057, 1.97, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4599, 6bdfX, 0.7057, 1.98, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4600, 6bdfV, 0.7057, 1.98, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4601, 6bdfT, 0.7057, 2.24, 0.183, 213, 208, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4602, 6bdfR, 0.7057, 1.98, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4603, 6bdfP, 0.7057, 1.99, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4604, 6bdfN, 0.7057, 1.97, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4605, 6bdfL, 0.7057, 1.98, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4606, 6bdfJ, 0.7057, 1.98, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4607, 6bdfH, 0.7057, 1.98, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4608, 6bdfF, 0.7057, 1.99, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4609, 6bdfD, 0.7057, 1.98, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4610, 6bdfB, 0.7057, 1.99, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4611, 6bdf1, 0.7057, 1.95, 0.185, 210, 205, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4612, 3j9iZ, 0.7042, 2.00, 0.189, 211, 206, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4613, 3j9iY, 0.7042, 1.96, 0.185, 210, 205, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4614, 3j9iX, 0.7042, 1.90, 0.191, 209, 204, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4615, 3j9iW, 0.7042, 2.04, 0.185, 210, 205, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4616, 3j9iV, 0.7042, 1.97, 0.187, 208, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4617, 3j9iN, 0.7042, 1.87, 0.190, 205, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4618, 3j9iM, 0.7042, 1.64, 0.365, 195, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4619, 3j9iL, 0.7042, 1.64, 0.365, 195, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4620, 3j9iK, 0.7042, 1.59, 0.339, 195, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4621, 3j9iJ, 0.7042, 1.59, 0.339, 195, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4622, 3j9iI, 0.7042, 2.20, 0.254, 202, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4623, 3j9iH, 0.7042, 2.20, 0.254, 202, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4624, 3j9i2, 0.7042, 2.21, 0.254, 202, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4625, 3j9i1, 0.7042, 2.07, 0.250, 202, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4626, 2h6jN, 0.7039, 2.07, 0.250, 202, 192, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4627, 2h6jK, 0.7038, 2.07, 0.250, 202, 192, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4628, 2h6jJ, 0.7038, 2.07, 0.250, 202, 192, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4629, 2h6jM, 0.7037, 2.07, 0.250, 202, 192, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4630, 5vy4Z, 0.7034, 2.21, 0.254, 202, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4631, 5vy4X, 0.7034, 2.08, 0.250, 202, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4632, 5vy4V, 0.7034, 2.07, 0.250, 202, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4633, 5vy4T, 0.7034, 2.09, 0.250, 202, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4634, 5vy4R, 0.7034, 2.10, 0.250, 202, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4635, 5vy4P, 0.7034, 2.09, 0.250, 202, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4636, 5vy4N, 0.7034, 2.25, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4637, 5vy4L, 0.7034, 2.25, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4638, 5vy4J, 0.7034, 2.25, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4639, 5vy4H, 0.7034, 2.25, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4640, 5vy4F, 0.7034, 2.25, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4641, 5vy4D, 0.7034, 2.25, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4642, 5vy4BA, 0.7034, 2.25, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4643, 5vy4B, 0.7034, 2.25, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4644, 5vy41, 0.7034, 2.25, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4645, 2h6jI, 0.7034, 2.25, 0.187, 201, 193, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4646, 2h6jL, 0.7033, 2.25, 0.187, 201, 193, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4647, 2h6jH, 0.7031, 2.25, 0.187, 201, 193, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4648, 1yauM, 0.7029, 2.25, 0.187, 201, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4649, 5vy3Z, 0.7028, 2.25, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4650, 5vy3X, 0.7028, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4651, 5vy3V, 0.7028, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4652, 5vy3T, 0.7028, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4653, 5vy3R, 0.7028, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4654, 5vy3P, 0.7028, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4655, 5vy3N, 0.7028, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4656, 5vy3L, 0.7028, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4657, 5vy3J, 0.7028, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4658, 5vy3H, 0.7028, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4659, 5vy3F, 0.7028, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4660, 5vy3D, 0.7028, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4661, 5vy3B, 0.7028, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4662, 5vy31, 0.7028, 2.29, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4663, 3jrmM, 0.7027, 2.29, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4664, 3jrmI, 0.7026, 2.77, 0.185, 242, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4665, 3jrmK, 0.7025, 2.78, 0.185, 242, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4666, 3jrmH, 0.7025, 2.78, 0.185, 242, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4667, 3jrmN, 0.7024, 2.77, 0.185, 242, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4668, 3jrmL, 0.7024, 2.29, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4669, 3jseM, 0.7023, 2.29, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4670, 1yarM, 0.7023, 2.29, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4671, 1q5rN, 0.7023, 2.29, 0.187, 203, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4672, 1q5rM, 0.7023, 2.29, 0.187, 203, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4673, 1q5rL, 0.7023, 2.29, 0.187, 203, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4674, 1q5rJ, 0.7023, 2.29, 0.187, 203, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4675, 1q5rH, 0.7023, 2.29, 0.187, 203, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4676, 3jseK, 0.7022, 2.29, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4677, 1q5rK, 0.7022, 2.29, 0.187, 203, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4678, 1q5rI, 0.7022, 2.29, 0.187, 203, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4679, 3jseH, 0.7020, 2.29, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4680, 1yauJ, 0.7020, 2.29, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4681, 1ya7M, 0.7020, 2.29, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4682, 3jseN, 0.7019, 2.29, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4683, 3jseL, 0.7019, 2.29, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4684, 3jrmJ, 0.7019, 2.78, 0.185, 242, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4685, 3c92M, 0.7019, 2.78, 0.185, 242, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4686, 3c921, 0.7019, 2.78, 0.185, 242, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4687, 3c91M, 0.7019, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4688, 3c911, 0.7019, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4689, 1yauI, 0.7019, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4690, 1ya7K, 0.7019, 2.31, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4691, 1ya7I, 0.7019, 2.31, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4692, 1pmaX, 0.7019, 2.31, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4693, 1pmaT, 0.7019, 2.31, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4694, 1yauK, 0.7018, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4695, 3jtlM, 0.7017, 2.31, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4696, 3c92W, 0.7017, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4697, 3c92I, 0.7017, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4698, 3c91W, 0.7017, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4699, 3c91I, 0.7017, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4700, 1yauH, 0.7017, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4701, 1pmaY, 0.7017, 2.31, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4702, 1pmaP, 0.7017, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4703, 3jtlN, 0.7016, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4704, 3jtlK, 0.7016, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4705, 3jtlJ, 0.7016, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4706, 3jtlI, 0.7016, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4707, 3jtlH, 0.7016, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4708, 1yarK, 0.7016, 2.32, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4709, 1ya7H, 0.7016, 2.32, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4710, 1pma2, 0.7016, 3.07, 0.177, 251, 203, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4711, 3jtlL, 0.7015, 3.07, 0.172, 251, 203, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4712, 3c92X, 0.7015, 3.07, 0.177, 251, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4713, 3c92N, 0.7015, 3.07, 0.172, 251, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4714, 3c92J, 0.7015, 3.07, 0.177, 251, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4715, 3c922, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4716, 3c91X, 0.7015, 3.08, 0.177, 251, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4717, 3c91N, 0.7015, 3.07, 0.172, 251, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4718, 3c91J, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4719, 3c912, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4720, 1yarI, 0.7015, 2.32, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4721, 1ya7J, 0.7015, 2.33, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4722, 1pmaU, 0.7015, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4723, 1pmaQ, 0.7015, 2.39, 0.192, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4724, 1yarJ, 0.7014, 2.32, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4725, 1pmaV, 0.7014, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4726, 3jseJ, 0.7013, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4727, 3jseI, 0.7013, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4728, 3c92Z, 0.7013, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4729, 3c92L, 0.7013, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4730, 3c91Z, 0.7013, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4731, 3c91L, 0.7013, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4732, 1ya7N, 0.7013, 2.32, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4733, 1pmaS, 0.7013, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4734, 1pma1, 0.7013, 2.33, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4735, 3c92V, 0.7012, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4736, 3c92H, 0.7012, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4737, 3c91V, 0.7012, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4738, 3c91H, 0.7012, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4739, 1yauN, 0.7012, 2.32, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4740, 1yauL, 0.7012, 2.32, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4741, 1pmaZ, 0.7012, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4742, 1pmaB, 0.7012, 2.33, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4743, 1yarH, 0.7011, 2.33, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4744, 1ya7L, 0.7011, 2.33, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4745, 1pmaW, 0.7011, 2.33, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4746, 1yarN, 0.7010, 2.33, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4747, 1yarL, 0.7010, 2.32, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4748, 3c92Y, 0.7007, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4749, 3c92K, 0.7007, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4750, 3c91Y, 0.7007, 2.33, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4751, 3c91K, 0.7007, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4752, 1pmaR, 0.7007, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4753, 3mkaG, 0.7004, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4754, 3mfeF, 0.7004, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4755, 3mkaJ, 0.7003, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4756, 1j2qN, 0.7000, 2.32, 0.187, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4757, 1j2qJ, 0.7000, 2.32, 0.187, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4758, 1j2qI, 0.7000, 2.32, 0.187, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4759, 1j2qH, 0.7000, 2.33, 0.187, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4760, 3mkaT, 0.6999, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4761, 1j2qM, 0.6999, 2.32, 0.187, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4762, 1j2qL, 0.6999, 2.32, 0.187, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4763, 1j2qK, 0.6999, 2.33, 0.187, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4764, 2z5cC, 0.6998, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4765, 2z5cF, 0.6997, 2.39, 0.192, 203, 193, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4766, 3mkaL, 0.6995, 2.39, 0.192, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4767, 3mkaC, 0.6994, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4768, 3mkaN, 0.6981, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4769, 3mkaP, 0.6974, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4770, 3mkaV, 0.6972, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4771, 3mkaH, 0.6968, 2.34, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4772, 3mkaR, 0.6967, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4773, 3mka2, 0.6964, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4774, 3gpjJ, 0.6959, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4775, 3gpjX, 0.6958, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4776, 3d29J, 0.6958, 2.33, 0.187, 203, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
4777, 4intJ, 0.6957, 2.33, 0.187, 203, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4778, 3sdiJ, 0.6957, 2.34, 0.187, 203, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4779, 3d29X, 0.6957, 2.33, 0.187, 203, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
4780, 3bdmJ, 0.6957, 2.33, 0.187, 203, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4781, 1g65X, 0.6957, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4782, 4intX, 0.6956, 2.34, 0.187, 203, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4783, 4inrX, 0.6956, 2.33, 0.187, 203, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4784, 3mkaE, 0.6956, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4785, 3bdmX, 0.6956, 2.35, 0.187, 203, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4786, 1g65J, 0.6956, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4787, 4jsqX, 0.6955, 2.33, 0.187, 203, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4788, 4jsqJ, 0.6955, 2.33, 0.187, 203, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4789, 4inrJ, 0.6955, 2.33, 0.187, 203, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4790, 3okjJ, 0.6955, 2.33, 0.187, 203, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4791, 3nzwX, 0.6955, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4792, 3nzwJ, 0.6955, 3.11, 0.172, 251, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4793, 3mfeM, 0.6955, 2.01, 0.198, 212, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4794, 2zcyX, 0.6955, 3.11, 0.172, 252, 203, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4795, 2zcyJ, 0.6955, 2.33, 0.238, 202, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4796, 3okjX, 0.6954, 2.33, 0.238, 202, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4797, 4jsuX, 0.6952, 2.34, 0.238, 202, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4798, 4jsuJ, 0.6952, 2.34, 0.238, 202, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4799, 3nzxX, 0.6952, 3.11, 0.172, 250, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4800, 3nzxJ, 0.6952, 2.34, 0.238, 202, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4801, 4inuX, 0.6951, 2.34, 0.238, 202, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4802, 4inuJ, 0.6951, 2.34, 0.238, 202, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4803, 3mg0J, 0.6950, 1.23, 0.302, 189, 182, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4804, 3mg0X, 0.6949, 1.23, 0.302, 189, 182, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4805, 3nzjX, 0.6948, 3.11, 0.172, 251, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4806, 3nzjJ, 0.6948, 3.12, 0.172, 250, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4807, 2f16X, 0.6948, 3.20, 0.162, 252, 204, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4808, 2f16J, 0.6948, 2.88, 0.175, 250, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4809, 4ltcX, 0.6947, 2.89, 0.175, 249, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4810, 4ltcJ, 0.6947, 3.01, 0.179, 249, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4811, 3un4X, 0.6947, 2.75, 0.176, 246, 199, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4812, 3un4J, 0.6947, 2.89, 0.175, 246, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4813, 4q1sJ, 0.6946, 2.05, 0.188, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4814, 4hrcX, 0.6946, 2.05, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4815, 4hrdJ, 0.6945, 2.06, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4816, 3sdiX, 0.6945, 2.25, 0.182, 198, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4817, 3hf9W, 0.6945, 2.06, 0.188, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4818, 5trrI, 0.6944, 2.06, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4819, 5trgK, 0.6944, 2.05, 0.183, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4820, 4jt0X, 0.6944, 2.25, 0.187, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4821, 4jt0J, 0.6944, 2.26, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4822, 4gk7J, 0.6944, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4823, 3wxrY, 0.6944, 2.90, 0.175, 248, 200, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4824, 4gk7X, 0.6943, 2.05, 0.183, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4825, 3gptX, 0.6943, 2.06, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4826, 3gptJ, 0.6943, 2.25, 0.182, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4827, 3dy3X, 0.6943, 2.25, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4828, 3dy3J, 0.6943, 2.25, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4829, 1g0uX, 0.6943, 2.06, 0.194, 198, 191, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4830, 5lzpI, 0.6942, 2.06, 0.194, 198, 191, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4831, 3un8J, 0.6942, 2.06, 0.194, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4832, 3hyeJ, 0.6942, 1.87, 0.196, 194, 189, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4833, 3gpwX, 0.6942, 2.06, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4834, 3gpwJ, 0.6942, 2.06, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4835, 2fakX, 0.6942, 2.06, 0.194, 198, 191, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4836, 2fakJ, 0.6942, 2.07, 0.194, 198, 191, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4837, 1jd2Q, 0.6942, 2.07, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4838, 4fzgX, 0.6941, 2.07, 0.194, 198, 191, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4839, 4fzgJ, 0.6941, 2.07, 0.194, 198, 191, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4840, 3mi0L, 0.6941, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4841, 3mg4J, 0.6941, 2.26, 0.182, 198, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4842, 3hyeX, 0.6941, 2.06, 0.194, 198, 191, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4843, 2gplX, 0.6941, 2.07, 0.188, 198, 191, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4844, 2gplJ, 0.6941, 2.08, 0.188, 198, 191, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4845, 1rypK, 0.6941, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4846, 1g0uJ, 0.6941, 2.07, 0.194, 198, 191, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4847, 5ts0W, 0.6940, 2.07, 0.194, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4848, 5trrW, 0.6940, 2.08, 0.194, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4849, 3un8X, 0.6940, 2.08, 0.194, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4850, 3dy4X, 0.6940, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4851, 3dy4J, 0.6940, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4852, 5trrL, 0.6939, 2.07, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4853, 5trgL, 0.6939, 2.08, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4854, 4hrcJ, 0.6939, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4855, 3ipmM, 0.6939, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4856, 3ipmK, 0.6939, 1.82, 0.197, 193, 188, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4857, 1rypY, 0.6939, 2.52, 0.173, 222, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4858, 5trgI, 0.6938, 2.52, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4859, 4lqiX, 0.6938, 2.27, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4860, 4lqiJ, 0.6938, 2.27, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4861, 3mg8J, 0.6938, 2.08, 0.188, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4862, 3ipmL, 0.6938, 2.28, 0.177, 198, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4863, 3ipmJ, 0.6938, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4864, 3ipmI, 0.6938, 2.08, 0.194, 198, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4865, 3ipmH, 0.6938, 2.08, 0.194, 198, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4866, 5trgY, 0.6937, 2.07, 0.183, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4867, 4hnpJ, 0.6937, 2.07, 0.183, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4868, 3ipmN, 0.6937, 2.28, 0.182, 198, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4869, 5trsW, 0.6936, 2.52, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4870, 5trrb, 0.6936, 2.29, 0.182, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4871, 4hrdX, 0.6936, 2.08, 0.194, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4872, 4hnpX, 0.6936, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4873, 3tddX, 0.6936, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4874, 3tddJ, 0.6936, 2.09, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4875, 1jd2J, 0.6936, 2.08, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4876, 5trrZ, 0.6935, 2.09, 0.194, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4877, 5thoW, 0.6935, 2.09, 0.188, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4878, 5lzpK, 0.6935, 2.09, 0.188, 198, 191, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4879, 5lzpC, 0.6935, 2.54, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4880, 4q1sX, 0.6935, 2.08, 0.188, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4881, 3shjX, 0.6935, 2.08, 0.194, 198, 191, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4882, 3shjJ, 0.6935, 2.09, 0.188, 198, 191, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4883, 3mg6J, 0.6935, 2.08, 0.188, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4884, 3e47X, 0.6935, 2.09, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4885, 3e47J, 0.6935, 2.08, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4886, 5thoL, 0.6934, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4887, 5lzpE, 0.6934, 2.52, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4888, 5ts0K, 0.6933, 2.29, 0.182, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4889, 5trrY, 0.6933, 2.08, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4890, 5trgX, 0.6933, 2.08, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4891, 3oevJ, 0.6933, 2.53, 0.173, 223, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4892, 5trsY, 0.6932, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4893, 5trsL, 0.6932, 2.09, 0.183, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4894, 5thoI, 0.6932, 2.40, 0.193, 203, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4895, 5lzpR, 0.6932, 2.40, 0.193, 203, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4896, 4fzcX, 0.6932, 2.10, 0.194, 198, 191, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4897, 4fzcJ, 0.6932, 2.52, 0.173, 222, 196, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4898, 3mg4X, 0.6932, 2.09, 0.188, 198, 191, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4899, 5ts0I, 0.6931, 2.09, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4900, 5trra, 0.6931, 2.09, 0.194, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4901, 5trgV, 0.6931, 2.40, 0.193, 203, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4902, 4j70J, 0.6931, 2.40, 0.193, 203, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4903, 3sdkJ, 0.6931, 2.40, 0.193, 203, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4904, 5ts0L, 0.6930, 2.40, 0.193, 203, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4905, 5tryb, 0.6930, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4906, 5thoV, 0.6930, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4907, 5tryW, 0.6929, 2.40, 0.193, 203, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4908, 5trya, 0.6929, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4909, 5trsI, 0.6929, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4910, 5trga, 0.6929, 2.09, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4911, 5lzpT, 0.6929, 2.10, 0.188, 198, 191, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4912, 4j70X, 0.6929, 2.09, 0.194, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4913, 3mi0N, 0.6929, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4914, 3mi0J, 0.6929, 2.09, 0.194, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4915, 3mi0E, 0.6929, 2.53, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4916, 3mi02, 0.6929, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4917, 3hfaV, 0.6929, 2.53, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4918, 3hfaG, 0.6929, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4919, 3hfaC, 0.6929, 2.09, 0.188, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4920, 5tryZ, 0.6928, 2.09, 0.194, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4921, 5trrV, 0.6928, 2.10, 0.194, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4922, 3sdkX, 0.6928, 2.10, 0.188, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4923, 3oeuJ, 0.6928, 2.09, 0.194, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4924, 3mg7J, 0.6928, 2.10, 0.188, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4925, 3hfaZ, 0.6928, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4926, 3hfaT, 0.6928, 2.53, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4927, 3hfaP, 0.6928, 2.55, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4928, 3hfaN, 0.6928, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4929, 3hfaL, 0.6928, 2.54, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4930, 3hfaE, 0.6928, 2.11, 0.188, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4931, 3hfa2, 0.6928, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4932, 5thob, 0.6927, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4933, 5lzpU, 0.6927, 2.54, 0.173, 222, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4934, 5lzpG, 0.6927, 2.53, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4935, 3mi0X, 0.6927, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4936, 3hfaX, 0.6927, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4937, 3hfaR, 0.6927, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4938, 3hfaJ, 0.6927, 2.54, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4939, 3hfaH, 0.6927, 2.55, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4940, 5ts0b, 0.6926, 2.61, 0.173, 223, 197, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4941, 5trsK, 0.6926, 2.10, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4942, 5trsb, 0.6926, 2.11, 0.194, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4943, 5trsa, 0.6926, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4944, 5thoY, 0.6926, 2.56, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4945, 5lzpO, 0.6926, 2.54, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4946, 1fntK, 0.6926, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4947, 5tryL, 0.6925, 2.55, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4948, 5trsV, 0.6925, 2.55, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4949, 5thoZ, 0.6925, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4950, 5thoK, 0.6925, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4951, 3mg6X, 0.6925, 2.10, 0.188, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4952, 5ts0Z, 0.6924, 2.55, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4953, 5lzpN, 0.6924, 2.55, 0.173, 222, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4954, 5lzpA, 0.6924, 2.55, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4955, 3mi0T, 0.6924, 2.55, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4956, 1fntY, 0.6924, 2.57, 0.173, 226, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4957, 5ts0a, 0.6923, 2.57, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4958, 5tryK, 0.6923, 2.57, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4959, 5tryI, 0.6923, 2.54, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4960, 5trrK, 0.6923, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4961, 5trgH, 0.6923, 2.13, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4962, 5lzpF, 0.6923, 2.10, 0.194, 198, 191, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4963, 3mi0H, 0.6923, 2.12, 0.188, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4964, 3mi0G, 0.6923, 2.58, 0.173, 224, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4965, 6bgoZ, 0.6922, 2.58, 0.173, 223, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4966, 6bgoY, 0.6922, 2.58, 0.173, 222, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4967, 6bgoX, 0.6922, 2.57, 0.173, 223, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4968, 6bgoW, 0.6922, 2.58, 0.173, 222, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4969, 6bgoV, 0.6922, 2.58, 0.173, 223, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4970, 6bgoU, 0.6922, 2.57, 0.173, 222, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4971, 6bgoT, 0.6922, 2.55, 0.173, 223, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4972, 6bgoS, 0.6922, 2.55, 0.173, 223, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4973, 6bgoR, 0.6922, 2.55, 0.173, 222, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4974, 6bgoQ, 0.6922, 2.56, 0.173, 223, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4975, 6bgoP, 0.6922, 2.58, 0.173, 224, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4976, 6bgoc, 0.6922, 2.58, 0.173, 222, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4977, 6bgob, 0.6922, 2.58, 0.173, 222, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4978, 6bgoa, 0.6922, 2.58, 0.173, 223, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4979, 6bglZ, 0.6922, 2.55, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4980, 6bglY, 0.6922, 2.56, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4981, 6bglX, 0.6922, 2.56, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4982, 6bglW, 0.6922, 2.56, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4983, 6bglV, 0.6922, 2.54, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4984, 6bglU, 0.6922, 2.55, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4985, 6bglT, 0.6922, 2.10, 0.188, 198, 191, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4986, 6bglS, 0.6922, 2.55, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4987, 6bglR, 0.6922, 2.56, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4988, 6bglQ, 0.6922, 2.55, 0.173, 222, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4989, 6bglP, 0.6922, 2.55, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4990, 6bglc, 0.6922, 2.12, 0.188, 198, 191, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4991, 6bglb, 0.6922, 2.54, 0.173, 222, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4992, 6bgla, 0.6922, 2.61, 0.173, 234, 197, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4993, 5ts0V, 0.6922, 2.55, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4994, 5tryY, 0.6922, 2.55, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4995, 5trrM, 0.6922, 2.11, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4996, 5trgW, 0.6922, 2.55, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4997, 5thoa, 0.6922, 2.56, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4998, 5lzpL, 0.6922, 2.62, 0.173, 222, 197, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4999, 3oeuX, 0.6922, 2.56, 0.173, 223, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
5000, 3mi0C, 0.6922, 2.56, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
